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 It is well established that biofilm formed on tooth surfaces is the major 
culprit for caries and periodontal disease development. The critical early event of 
biofilm formation is the specific interaction of microorganisms with the acquired 
enamel pellicle. This pellicle is formed from adsorbing proteins from saliva, and 
perhaps also from gingival crevicular fluid. The purpose of this project was two 
fold: first, to investigate the extent of serum protein adsorption in a salivary 
protein environment, and second, to investigate the colonization of salivary 
pellicles by early microbial colonizers. Hydroxyapatite (HA) was incubated with 
saliva and serum and adsorbing proteins were identified by LC-ESI-MS/MS. To 
investigate competition among salivary and serum proteins for adsorption to HA 
proteins were labeled with specific CyDyes, mixed in various ratios and 
incubated with HA. The early phase of oral biofilm formation in vivo was studied 
on teeth exposed to the oral environment. The harvested biofilm samples were 
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analyzed with the Human Oral Microbiome Identification Microarray containing 
407 different microbial probes. In the pure saliva- and serum-derived pellicles 
eighty-two and eighty-four proteins were identified. Concomitant presence of 
salivary and serum proteins showed that salivary protein adsorbers effectively 
competed with serum proteins adsorbers for the HA surface. Specifically acidic 
proline-rich protein, cystatin, statherin and amylase proteins in saliva competed 
off apolipoprotein, C-reactive protein, peroxiredoxin-1 and albumin. In vivo 
evidence supported the replacement of serum proteins by salivary proteins. The 
studies with oral biofilm formed in vivo led to the identification of 92 species with 
streptococci being the most abundant early colonizers. High frequency detection 
was furthermore made with Haemophilus parainfluenzae, Gemella haemolysans, 
Slackia exigua and Rothia species. Eight uncultivated phylotypes were detected. 
While there is a significant amount of serum protein emanating from the gingival 
sulcus, their ability to participate in dental pellicle formation is likely reduced in 
the presence of strong salivary protein adsorbers. Furthermore, the early pellicle 
colonizers exhibit considerable bacterial diversity and include non-cultivable 
species. These findings will be helpful in designing target-specific approaches for 
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1.1. Oral fluid 
Oral fluid commonly referred to as “saliva” takes its origin from exocrine 
secretions. Salivary secretions are produced by the major and minor salivary 
glands. There are three major salivary glands which are each present in pairs: 
the parotid, submandibular and sublingual glands. Additionally, there are about 
600 to 1000 minor salivary glands (Holsinger and Bui 2007) that are distributed 
throughout the oral soft tissues, with the greatest density in the buccal and labial 
mucosa. Parotid secretion enters the oral cavity through two parotid ducts, 
known as Stensen’s ducts, that are located in the buccal mucosa at the level of 
the first / second maxillary molar. Submandibular and sublingual secretions enter 
the oral cavity through the two Wharton’s ducts located in the sublingual mucosa 
immediately adjacent to the lingual frenum. Several small ducts derived form the 
sublingual glands enter the oral cavity bilaterally in the posterior sublingual space 
(Figure 1.1).  
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Figure 1.1. Anatomical locations of the three major salivary glands and their 
associated salivary ducts (Encyclopedia Britannica, 2016). 
 
 
The minor salivary glands are much smaller in size having with a single secretory 
duct opening into the oral cavity at multiple locations in the oral mucosa. The fluid 
accumulating in the oral cavity represents a combination of these salivary 
secretions and is called whole saliva (WS) (Schipper et al., 2007). WS however 
does not contain only the exocrine secretions from the various glands, it contains 
additional non-exocrine components derived from gingival crevicular fluid, 
microorganisms, mammalian cells and food debris (Hu et al., 2006). The 
mammalian cells consist predominantly of desquamated oral epithelial cells and 
leukocytes. 
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1.1.1. Types of Glandular Salivary Secretion 
Each salivary gland produces a specific type of secretion that is directly 
dependent on its acinar cell type. The main secretory cell types are called serous 
or mucous cells. These acinar cells form a globular structure with an opening into 
a single intercalated duct and this globular structure is called an acinus. Serous 
acini release a watery protein secretion with little or no large molecular weight 
glycosylated proteins. Mucous acini produce a viscous secretion since it contains 
significant amounts of salivary mucins. Mixed, or seromucous acini contain both 
types of secretory cells, with commonly one secretory type predominating. The 
parotid gland is made entirely of serous acini. The other major salivary glands 
are mixed, containing both serous as well as mucous acini. The submandibular 
gland contains more serous acini whereas the sublingual gland contains more 
mucous acini. The minor salivary glands are either mucous or seromucous in 
nature (Holsinger and Bui 2007). The differences in acinar cell types are reflected 
in differences in the proteins each gland synthesizes. For instance, parotid 
secretion is rich in amylase (Schneyer, 1956), proline-rich proteins (Oppenheim 
et al., 1971), agglutinins (gp-340) (Malamud et al., 1981), statherin (Schlesinger 
and Hay, 1977) and histatins (Oppenheim et al., 1988) and are free of mucins. 
Submandibular secretion is the main source of cystatins (Rathman et al., 1990) 
and the mucins 5B (MUC 5B; formerly known as MG1) and 7 (MUC 7; formerly 
known as MG2) (Reddy et al., 1992). This gland also synthesizes proline-rich 
proteins, statherins and histatins. Like submandibular secretions, sublingual 
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secretions contain high concentrations of salivary mucins as well  (Loomis et al., 
1987; Veerman et al., 1996).  
 
1.1.2. Composition of Saliva 
1.1.2.1. Inorganic Constituents of Saliva 
The term “saliva” is ambivalent, since it doesn’t differentiate between salivary 
secretions as they exit the ductal systems and whole saliva, which is the mixed 
fluid accumulating in the oral cavity. In the salivary research domain it is 
therefore important to differentiate between pure salivary secretions and whole 
saliva. Pure salivary secretions are sterile and contain electrolytes and 
characteristic gland specific proteins which are present in their native form. 
Whole saliva, on the other hand, is also called oral fluid and represents a mixture 
of exocrine secretion coming into contact with the oral microbiome, gingival 
crevicular fluid, a variety of hosts cells and food debris. Whole saliva, therefore, 
is a turbid suspension since it contains cellular elements. Removal of these 
cellular components by centrifugation leads to a clear solution known as whole 
saliva supernatant (WSS), which is amenable to biochemical investigation. 
Investigations focusing on the cellular components exploit WS sediment as their 
starting material.  The non-cellular fraction of WS is composed of both of organic 
and inorganic constituents. The inorganic constituents consist mostly of 
electrolytes, which are listed in table 1.1. Their concentrations depend to various 
degrees on salivary flow rate, type and duration of stimulation (Dawes and Dong, 
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1995). The values given in the table represent ranges of electrolyte 
concentrations valid for both salivary secretions and WS. The overall ionic 
strength of salivary secretions and WS can range from 10-50% of the ionic 
strength of serum (Boackle, 1991), indicating that oral fluid is always hypotonic at 
all physiological flow rates. The only electrolyte showing higher concentrations in 
saliva than what is found in serum is phosphate, ranging between 4.0- 8.0 mM 
per liter in saliva. While salivary and serum calcium levels are both 1.0 mM per 
liter. The electrolytes calcium and phosphate are important because their salivary 
ion product is equal or higher than the dissociation constant of hydroxyapatite 
(HA), the major mineral of tooth enamel. This indicates that salivary secretion 
and WS are always supersaturated with respect to HA. The consequence of 
supersaturation should result in the precipitation of calcium phosphates from oral 
fluids, but such precipitation does not occur. The reason for this is the function of 
specific salivary proteins which are calcium-phosphate precipitation inhibitors 
preventing both primary (spontaneous) and secondary (crystal growth) 
precipitation. For example, acidic proline rich proteins are effective inhibitors of 
calcium phosphate crystal growth but not primary calcium-phosphate 
precipitation. On the other hand, statherin inhibits both crystal growth of calcium 
phosphate salts and spontaneous precipitations of calcium phosphate from 
supersaturated solutions (Hay et al. 1979).  
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Table 1.1. Major Inorganic Constituents of Whole Saliva. Adapted from Dawes & 
Dong 1995. 
 
Compound Concentration (mM) 
Calcium 0.9 
Phosphate 4.0- 8.0 
Sodium 3- 90 
Chloride 12- 50 
Potassium 5- 10 
Bicarbonate 1- 60 
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1.1.2.2. Organic Constituents of Saliva 
Salivary proteins constitute the majority of the organic constituents of glandular 
salivary secretions. In WS several of these salivary proteins undergo proteolytic 
degradation (Helmerhorst, 2007). Classical biochemical isolation and 
characterization work has led to much insight into the structure and function of 
the prevalent salivary proteins. One of the most surprising findings of these 
structural studies was the consistently found polymorphism associated with 
salivary proteins. About 20 major protein families of saliva represent over 95% of 
the total salivary proteins content (Ruhl, 2012). Functional investigations on 
saliva indicate that most of its protective function is related to salivary 
macromolecules. Proteome studies employing mass spectrometry carried out in 
more recent years revealed the presence of 914 proteins in parotid and 917 in 
submandibular/sublingual secretion (Denny et al., 2008). Similar studies on the 
proteome and peptidome of WS indicated the presence of more than 2,000 
proteins and peptides (Amado et al., 2010; Bandhakavi et al., 2009; Denny et al., 
2008; Loo et al., 2010; Siqueira et al., 2008; Vitorino et al., 2004). Further studies 
including quantitative approaches showed that most of these components are 
present below nanomolar concentrations. It is unlikely that these low abundant 
components have a significant functional role in oral defense mechanisms. 
These components, however, are present at concentration levels adequate for 
other cellular functions, e.g. signal transduction and cell to cell communication. 
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The glandular salivary proteins belong to several major protein families: 
the proline-rich proteins (acidic, basic and basic glycoprotein); histatins (histidine-
rich proteins); cystatins (cysteine-containing proteins); statherins (tyrosine-rich 
proteins); amylases (glycosylated and non-glycosylated) (Kauffman et al., 1973), 
and mucins MG1 and MG2 (MUC5B and MUC7). Also present in WS are several 
enzymes (e.g. lysozyme and carbonic anhydrase) and proteins derived from 
serum (e.g. albumin and transferrin). The major intrinsic salivary proteins are 
shown according to their relative abundance in Figure 1.2. It is readily evident 
that 50% of the salivary proteome is composed of amylase (Ruhl, 2012).. It is 
interesting to note that the ten major protein families comprising amylase, total 
PRP, cystatins, mucin 5B, secretory immunoglobulin A (S-IgA), mucin 7, 
statherins, carbonic-anhydrase, histatins, lysozyme, albumin, secretory 
component of S-IgA, IgG and IgM account for 99% of the total salivary proteome 
(Ruhl, 2012).  
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Figure 1.2. Proteins species in human saliva and their relative abundances. Shown 
are the major intrinsic proteins of human saliva according to their reported relative 
percent abundances. Abbreviations: PRPs, Proline-rich proteins; S-IgA, Secretory 
immunoglobulin A; SC, Secretory component of S-IgA; SAG, Salivary agglutinin or 
gp340; PSP-SPLUNC2, Parotid secretory protein-short palate, lung and nasal epithelium 
clone 2; SLPI, Secretory leukocyte peptidase inhibitor. Figure from Ruhl, 2012. 
 
1.1.3. Functional Roles of Salivary proteins 
The ability to separate and isolate salivary proteins has allowed researchers to 
investigate functional properties associated with these proteins (Levine et al., 
1969; Bennick and Connell, 1971; Oppenheim et al., 1971; Baum et al., 1976; 
Bennick, 1982; Isemura et al., 1984; Isemura et al., 1986; 1987; Oppenheim et 
al., 1986; Lamkin and Oppenheim, 1993) (Figure 1.3). Salivary proteins are 
essential for maintaining oral health by exhibiting multiple functions, including 
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digestion, antimicrobial activities, roles in microbial aggregation and microbial 
elimination, tooth remineralization and protection against demineralization and 
lubrication (Lamkin and Oppenheim, 1993). A very important function of some 
salivary proteins is their role in maintaining saliva supersaturated with respect to 
calcium-phosphate salts, including in hydroxyapatite, which is the most stable 




Figure 1.3. Multifunctional roles of salivary proteins.  Adapted from Levine, 1993. 
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1.1.3.1. Structure and Function of Acidic Proline-rich Proteins (aPRPs) 
Proline- rich proteins are characterized by high amounts of proline, glutamine 
and glycine residues in their structure. aPRP-1, aPRP-2 and parotid IEF variant 
slow (aPIF-s) are 150 amino acids in length, and share their primary structures 
with the exceptions of the residues occupying positions 4 and 50. Positions 4 and 
50 are occupied in aPRP-1 by Asp and Asn, in aPRP-2 by Asp and Asp and in 
aPIF-s Asn and Asp. aPRP-3, aPRP-4 and aPIF-f are 106 residues in length, due 
to proteolytic cleavage after residue 106 (Arg) and their primary structures are 
identical to the N-terminal 106 residues of aPRP-1, aPRP-2 and aPIF-s (Figure 
1.4). Both the long and the short forms of these PRPs contain a very hydrophilic 
and acidic N-terminal domain of 30 residues, which are negatively charged at 
neutral pH by virtue of the presence of glutamic acid, aspartic acid and 
phosphoserine residues. This functional domain has been shown to be 
responsible for the binding of aPRP to HA and to inhibit crystal growth of calcium 
phosphate salts (Hay, 1967; Hay and Moreno, 1979). These parameters have 
been studied in great detail by Moreno in 1979 explaining in biochemical terms 
the mechanisms protection against demineralization (Moreno et al., 1979). 
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Figure 1.4. Primary Structure of aPRP1. Figure from Lamkin and Oppenheim, 1993. 
Figure based on the data from Oppenheim et al. 1971 and Bennick et al. 1979. 
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1.1.3.2. Structure and Function of Statherin 
Another avid hydroxyapatite binding protein is statherin, which is 43 amino acid 
residues in length (Hay, 1973). Statherin also exhibits a bipolar primary structure 
with the N-terminal region being very negatively charged by virtue of two vicinal 
phosphoserines and glutamic acid residues, while the larger C-terminal segment 
has a hydrophobic character being enriched with respect to tyrosine, glutamine 
and proline (Figure 1.5).  In addition to crystal growth inhibition of calcium 
phosphate salts, statherin is the only salivary protein inhibiting spontaneous 
precipitation of calcium phosphate salts from supersaturated solutions such as 
whole saliva (Moreno et al., 1979; Schlesinger et al., 1987; Schlesinger et al., 
1989; Schwartz et al., 1992). There are three statherin variants, SV1, SV2 and 
SV3 (Jensen et al., 1991). All variants contain phosphorylated serine residues at 
position 2 and 3. The variant SV1 and SV3, show both loss of phenylalanine at 
their c-termini, due to proteolytic cleavage. The variant SV2 and SV3 miss 10 
residues which occupy positions 6-15 in intact statherin, indicating an alternative 
splicing event of statherin mRNA leading to the excision of exon 4. Another 
statherin variant has been described in WS resulting from transglutaminase-2 
mediated cyclization of the protein after its secretion into the oral cavity (Cabras 
et al., 2006).  
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Figure 1.5. Primary Structure of Statherin.  Figure based on data of Schlesinger and 
Hay, 1977  
1.1.3.3. Bacteria Binding by PRPs and Statherin 
A number of oral bacteria can bind to PRPs, but only after adsorption to HA has 
occurred. Bacteria binding specifically to adsorbed PRPs are Streptococcus 
gordonii, Actinomyces viscosus and Streptococcus mutans (Gibbons and Hay, 
1988; 1989; Gibbons et al., 1991). Bacteria binding to adsorbed statherins are 
Actinomyces viscosus, Porphyromonas gingivalis and Fusobacterium nucleatum, 
(Gibbons and Hay, 1988; 1989; Gibbons et al., 1991; Xie et al., 1991; Amano et 
al., 1996). These observations clearly revealed the importance of conformational 
changes in pellicle proteins transitioning from the solution state to the adsorbed 
state (Gibbons and Hay, 1988; Gibbons et al., 1988). Statherin, for example, is 
structurally disordered in aqueous solution and upon adsorption to HA, the 
protein’s C-terminal region folds into an alpha-helix, exposing the oral bacterial 
recognition sites that are not accessible when the protein is in solution (Goobes 
et al., 2006a; Goobes et al., 2006b).  By a similar mechanism, adhesins from S. 
gordonni and A. viscosus bind to segments of PRPs called cryptotopes, which 
become exposed as a result of a conformational change when PRPs adsorbs to 
HA. This mechanism provides binding sites for bacteria once the salivary 
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proteins are adsorbed to tooth surfaces, while the same proteins would not 
interact with the bacteria when both are in solution. This indicates that the protein 
adsorbed to the HA surface is an important determinant in the early tooth 
colonization by bacteria.  
1.1.3.4. Structure and Function of Cystatins 
Submandibular secretions contain five different cystatins which all contain four 
cysteine residues forming two intra chain disulfide bonds. The salivary cystatins 
SA, SA-I and SA-III are 121 residues in length while cystatin SN and cystatin S 
are 8 residues shorter as a result of posttranslational cleavage at the N-terminus 
of cystatin SA-I and SA-III, respectively (Isemura et al., 1984; Isemura et al., 
1986; 1987). Cystatins S and SA-III are phosphorylated proteins whereas 
cystatin SA, SA-I and SA-III are not (Shomers et al., 1982; Lamkin et al., 1991). 
Cystatins SA-I, S, SA-III and SN are known to bind to hydroxyapatite (Vacca 
Smith and Bowen, 2000; Yao et al., 2001; Siqueira et al., 2007; Vitorino et al., 
2008; Siqueira and Oppenheim, 2009). A major function of cystatins is their 
capacity to inhibit cysteine proteases such as cathepsin, suggesting they play a 
protective role by inhibiting the degradation of host peptides and proteins 
(Isemura et al., 1987; Saitoh and Isemura, 1993).   
Salivary proteins, for the most part, are multifunctional, and can perform more 
than one role while other salivary proteins exhibit overlapping functions. Another 
interesting feature of salivary proteins is their amphifunctionality, which means 
that one protein can exhibit functions that can be either protective or potentially 
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harmful to the host (Levine, 1993). For instance, acidic proline rich proteins 
(aPRPs) and statherins after adsorption to HA prevent crystal growth on the tooth 
surface. However, these proteins once adsorbed can also promote the 
attachment of specific bacteria leading to plaque accumulation. Besides the 
amphifunctional properties associated with one protein, many salivary proteins 
form heterotypic complexes in the oral cavity as a result of protein-protein 
interactions (Iontcheva et al., 1997). These protein-protein complexes may 
enhance the properties of the proteins participating within the complex and this 
may result in new and unique role in the maintenance of homeostasis in the oral 
environment (Soares et al., 2003; Soares et al., 2004; Siqueira et al.,2012; Moffa 
et al., 2015). 
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1.1.4. The WS Proteome and Peptidome 
The WS proteome is very dynamic, in the sense that several proteins undergo 
post-translational and post-secretory modifications (Helmerhorst and 
Oppenheim, 2007).  
As a consequence, all three glandular secretions clearly differ in protein content 
from WS. While WS could be expected to be a mixture of all glandular 
secretions, it contains dramatically lower levels of e.g. proline-rich proteins, 
statherins and histatins than pure glandular secretions as shown in Figure 1.6 
(Helmerhorst and Oppenheim, 2007).  
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Figure 1.6. Comparison of the protein composition of parotid secretion (PS) and 
whole-saliva (WS). Aliquots (100 μl) were analyzed by cationic PAGE (upper panel), or 
anionic PAGE (lower panel), for visualization of histatins and aPRPs, respectively (Baum 
et al., 1977; Davis, 1964; Ornstein, 1964). Lanes 1 to 4 contain lanes from four 
individuals, respectively. Figure from Helmerhorst and Oppenheim, 2007. 
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1.1.4. Gingival Crevicular Fluid 
Gingival crevicular fluid (GCF) is a physiological transudate that emanates from 
the gingival sulcus located between tooth and marginal gingiva, constantly 
bathing the cervical area of the tooth (Brill and Krasse, 1958). GCF originates 
from capillaries in the gingival corium (Egelberg, 1967) and contains components 
of serum, immune cells, connective tissue proteins, epithelial cells and bacteria 
as shown in Figure 1.7 (Attstrom and Egelberg, 1971; Ohlsson et al., 1974; 
Page, 1992; Asikainen et al., 2010). The existence of GCF was described for the 
first time over 110 years ago being a serum like fluid seeping from the gingival 
sulcus (Black, 1899). In the early 1950’s Waerhaug focused on the anatomy of 
the gingival sulcus and its transformation into a gingival pocket at the onset of 
periodontal disease (Waerhaug, 1952). In the following years, the pioneering 
studies of Brill and coworkers laid the foundation for understanding the 
physiology of the formation of GCF and its composition. Through the use of 
fluorescein injected intravenously in dogs, the authors demonstrated that there is 
permeability between the oral epithelium and the junctional epithelium lining the 
gingival pocket, since the fluorescein could be detected with filter papers placed 
at the origin of the gingival sulcus (Brill and Krasse, 1958). The same approach 
was used in humans, showing that fluorescein could be detected in the gingival 
pockets 2 hrs after oral intake of fluorescein capsules (Brill and Bjorn, 1959). 
These authors also showed that inflammation and stimulation of the gingival 
margin caused by mechanical movements, as occurring during tooth brushing 
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and chewing, increased the GCF flow rate (Brill, 1959). The noted escalation in 
permeability of the vessels of the tooth-supportive tissues, and the relation to 
GCF flow, was further investigated by Egelberg (Egelberg, 1967). Importantly, it 
has been recognized that in the healthy gingival crevice the emanating fluid is a 
transudate, which changes into an inflammatory exudate under conditions of 




Figure 1.7 - Schematic representation of dental soft and hard tissues and gingival 
crevicular fluid (GCF) flow. Figure adapted from D.Heller personal slides. 
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1.1.5. GCF collection 
The original GCF collection techniques consisted of adsorbing paper strips 
applied intracrevicularly or extracrevicularly. The intracrevicular method is most 
frequently used, and can be performed superficially with a filter paper strip placed 
near the entrance of the gingival crevice,  or more deeply placed  by insertion 
until a minimum amount of mechanical resistance is felt (Griffiths, 2003). The 
extracrecicular method consists of strips being placed over the gingival crevice 
region in an attempt to minimize trauma. Due to the potential of artefactual 
results with the techniques described caused by the drying process of the gingiva 
as well as micro lesions introduced by filter paper strips or inserting glass 
capillaries into the sulcus, another more physiological collection method was 
developed. This principally represents a gingival washing technique where 
individualized acrylic appliances covered the entire maxilla with the exception of 
a small space along the maxillary gingival margin. Gingival fluid produced by an 
entire maxilla was collected by slowly pumping 10 mL of saline over the entire 
collection area over the period of 1.0 hour. This method clearly avoids any 
physical manipulation of the gingival margin nor irritation by drying the gingival 
tissues (Oppenheim, 1970).  
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1.1.6. GCF Flow and Composition 
In the healthy sulcus the production of GCF is very low with a flow rate of 3-8 
μL/h. Under conditions of gingival inflammation however, the GCF flow increases 
drastically to a rate of 20-137 μL/hour (Goodson, 2003). The electrophoretic 
pattern of gingival fluid collected under periodontal disease conditions mimics 
that of a dilute serum as shown in Figure 1.8 (Schenkein and Genco, 1977). 
 
Figure 1.8 – Electrophoretic separation pattern of GCF (G) and serum (S) proteins 
in two individuals (Subjects A and B). Adapted from Oppenheim, 2008. 
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1.1.7. Proteomic analysis of GCF 
A large-scale proteomic analysis of GCF has only recently been performed. The 
first of this kind of proteome analysis of GCF collected from periodontally healthy 
sites led to the identification of 190 proteins (Carneiro et al., 2012).  The 
proteome of GCF collected from periodontally afflicted sites has also been 
analyzed and compared with GCF collected from healthy sites. Baliban and 
coworkers (Baliban et al., 2012) have identified 230 proteins in both healthy and 
disease samples combined, of which 123 proteins were only found in the 
diseased samples and 79 were only found in the healthy samples. This proteome 
analysis also allowed for the identification of possible protein biomarkers that 
could distinguish between the presence or absence of periodontal disease. 
Candidate protein biomarkers for periodontal health included angiotensinogen, 
clusterin and thymidine phosphorylase. Candidate biomarkers for periodontal 
disease included neutrophil derived defensin-1, carbonic anhydrase-1 and 
elongation factor 1-gamma. 
1.1.8. The mixing of GCF and salivary secretions in the oral cavity 
The origin of serum albumin in saliva has been investigated with biochemical 
techniques (Oppenheim, 1970). Oppenheim and coworkers compared the 
electrophoretic banding patterns in serum and saliva and observed that gingival 
crevicular fluid, even in clinically healthy subjects, is the major source of serum 
albumin present in WS. GCF emanates from the gingival crevice into the oral 
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cavity, where it mixes with glandular secretions contributing to the protein 
composition of WS. Consequently, in the direct surroundings of the tooth surface, 
a gradient of serum and salivary proteins can be expected to form from the 






Figure 1.9. Scheme of gingival crevicular fluid proteins versus whole 
salivary proteins on the tooth surface. 
 
GCF is the primary source of serum-derived components in WS, such as 
albumin, transferrin, alpha-2-macroglobulin, lactoferrin and IgG, IgA, and IgM 
(Taubman, 1974; Holt and Mestecky, 1975; Levine and Beeley, 1976; 
Tatevossian and Newbrun, 1981; Taylor and Preshaw, 2016).  More recently, 
  26 
mass spectrometry approaches have led to the identification of several plasma 
proteins among the over 2,000 proteins in WS (Bandhakavi et al., 2009,Grassi et 
al., 2016). As many as 33% of the proteins present in WS overlap with the 
human plasma proteome (Yan et al., 2009, Grassi et al., 2016) showing that a 
significant number of salivary proteins are serumnal in origin, and therefore likely 
derived from GCF.  
 
1.2. Hydroxyapatite (HA) 
Dental enamel is roughly 95% to 98% composed of inorganic matter, that 
consists mainly of calcium and phosphate crystals in the form of hydroxyapatite 
Ca10(PO4)6OH2 (Kay et al., 1964). Some of these crystals are not pure 
hydroxyapatite, since they are carbonated or contain trace minerals such as 
strontium, magnesium, lead, zinc or fluoride. The organic portion of dental 
enamel represents 1% to 2% of its total composition and is made up of organic 
matter, particularly enamel matrix derived proteins called enamelins and 
amelogenins (Glimcher et al., 1964; McGuire et al., 2014).   
 
1.3. Acquired Enamel Pellicle (AEP) 
Dawes et al. 1963 proposed the term “acquired enamel pellicle” for the thin 
organic material covering the entire mineral surfaces of teeth exposed to the oral 
environment. This structure was described by these authors as an acellular, 
bacteria-free layer of predominantly protein acquired after tooth eruption. The 
  27 
source of this integument has been the focus of many studies and found to be 
the result of a selective adsorption process of salivary proteins and peptides to 
the enamel surface (Armstrong, 1966; Leach et al., 1967; Armstrong and 
Hayward, 1968; Hay, 1969; Mayhall, 1970; Al-Hashimi and Levine, 1989; 
Schupbach et al., 2001; Yao et al., 2001; Siqueira et al., 2007; Vitorino et al., 
2008; Siqueira and Oppenheim, 2009; Siqueira et al., 2010; Siqueira et al., 2012; 
Lee et al., 2013). This process is very fast since pellicle matter can be detected 
within seconds of exposure of teeth to the oral environment (Hannig, 1999).  The 
thickness of this primary layer increases within about 30 minutes from 10 to 20 
nm (Lendenmann et al., 2000; Vacca Smith and Bowen, 2000). Salivary proteins 
that exhibit high affinity for HA are known as “pellicle precursors” (Lendenmann 
et al., 2000). Among these pellicle precursors are statherin, acidic PRPs, 
cystatins and histatins (Hay, 1973; Jensen et al., 1992). This AEP formation 
process is initiated mainly through ionic bonds with the enamel mineral, and to a 
lesser extent via van der Waals and hydrophobic interactions among the first 
layers of pellicle proteins (Hannig and Joiner, 2006). The next step of pellicle 
formation involves protein-protein interactions, defined as a maturation stage 
where the pellicle can reach about 1000 nm thickness in 60-90 minutes (Hannig, 
1999; Hannig and Joiner, 2006).  The primary pellicle precursor proteins, acidic 
PRPs, statherin and histatin-1, may furthermore undergo crosslinking reactions 
catalyzed by oral transglutaminase derived from oral epithelial cells, generating 
new protein structures with potential novel functions (Yao et al., 1999). Formation 
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of these types of crosslinks could involve both salivary as well as non-salivary 
proteins without primary affinity for HA to be incorporated after crosslinking into 
the AEP. 
The composition of the AEP has been studied by various classical biochemical 
methods and by proteomic approaches resulting in the identification of increasing 
numbers of pellicle constituents. Among the proteins and glycoproteins identified, 
are histatins, cystatins, lysozyme, lactoferrin, alpha-amylase, carbonic 
anhydrase, mucin, glycosyltransferase and several plasma components such as 
albumin, immunoglobulin and fibrinogen (Armstrong and Hayward, 1968; 
Armstrong, 1970; Sonju and Rolla, 1973; Lamkin et al., 2001; Schupbach et al., 
2001; Yao et al., 2001; Yao et al., 2003; Vitorino et al., 2006; Vitorino et al., 2007; 
Siqueira et al., 2007; Vitorino et al., 2008; Siqueira and Oppenheim, 2009; Lee et 
al., 2013). With mass spectrometric bottom-up approaches 130 proteins in 
human pellicle material have been identified (Siqueira et al., 2007). Using a 
similar approach but avoiding the initial tryptic fragmentation step 78 native 
pellicle peptides originating from 29 proteins could be fully characterized 
(Siqueira and Oppenheim, 2009).  
A major function of the AEP is related to lubrication, thereby protecting teeth from 
detrimental abrasive forces (Tabak et al., 1982). An important role in this 
lubricating function is attributed to glycoproteins containing O-linked or N-linked 
carbohydrates. The AEP constituents with lubricating functions include mucins, 
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agglutinins and proline-rich glycoprotein (Hahn Berg et al., 2004; Hatton et al., 
1985, Levine et al., 1987). Some AEP proteins have antimicrobial properties and 
may fulfill these functions on the tooth surface, e.g. lysozyme (Salton, 1957), 
lactoperoxidase (Roger et al., 1994) and histatins (Yin et al., 2003; Vukosavljevic 
et al., 2012). Other AEP proteins are involved in inflammatory responses, e.g. 
IgG and complement factor C3 (Li et al., 2004b; Siqueira et al., 2007; Siqueira et 
al., 2012). The AEP serves as a perm-selective membrane allowing small ions 
such as Ca2+ and HPO4
3- to pass thru the pellicle allowing acid-induced 
demineralization zones in the subsurface enamel to remineralize and thus 
protecting the hard tissues against progression of an incipient caries lesion 
(Hannig and Balz, 2001; Siqueira et al., 2010; Vukosavljevic et al., 2014). This 
enamel repair, however, can only occur if the acid generating bacterial layer has 
been removed. Another important effect of the AEP is the fact that its surface 
dictates molecular interactions with the surface chemistries of the earliest 
colonizers, thereby playing a very important role in the selective microbial 
colonization of the tooth surface and consequently in the earliest phases of 
dental biofilm formation (Gibbons et al., 1990). 
 
1.3.1. Pioneer Studies of In Vitro Experimental Pellicles 
Since only minute amounts of AEP protein can be harvested from tooth surfaces 
in vivo, early attempts to characterize AEP proteins have been fraught with 
difficulties. To overcome this, researchers have used in vitro models of enamel, 
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such as hydroxyapatite powder or discs, to study the adsorption of salivary 
proteins. One of the first investigators of the composition of the AEP was Hay in 
1967. He studied the adsorption of salivary proteins onto hydroxyapatite and 
enamel powders and characterized them by electrophoresis  (Hay, 1967). Since 
the adsorption of proteins may be influenced by the ionic strength, pH, redox 
potential and the ionic composition of saliva, the preferred salivary source used 
was WS instead of glandular secretion as WS directly surrounds the oral hard 
tissues. The authors showed a very selective adsorption of proteins to 
hydroxyapatite, where some salivary proteins displayed clearly a higher affinity 
than others. In this study different ratios of saliva to HA were used to optimize 
experimental conditions providing at least a certain excess of protein available. 
The data indicated a clear competition for a limited number of adsorption sites 
and that the adsorption was very fast, since most proteins adsorbed in the first 
few minutes after surface exposure to the protein solution. Comparison of in vitro 
with in vivo AEP pellicles were carried out with Ornstein and Davis disc gel 
electrophoresis (Davis, 1964) indicating similarities between in vitro and in vivo 
pellicles. A subsequent study focused on the interaction of parotid glandular 
secretion derived proteins with HA (Hay, 1973). Only 7 proteins from the total 
salivary secretion exhibited a high affinity for HA and one of the strongest 
adsorbers was determined to be the aPRPs (Oppenheim et al., 1971). These 
authors confirmed the selectivity of salivary protein adsorption to HA. 
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1.3.2. Kinetics of protein binding to HA 
Analysis of the thermodynamics of adsorption of individual proteins  showed that 
statherin has more than double the maximum number of adsorption sites (N) 
than PRP-3 (Moreno et al., 1978). On the other hand, the latter protein has a 
much higher affinity (K) for apatite surfaces. Furthermore, the adsorption 
characteristic of both proteins was found to fit the Langmuir model of protein 
adsorption and the salivary protein adsorption to HA was found to be driven by 
an increase in entropy (Moreno et al., 1984). Table 1.2 summarizes the important 
N (maximum number of sites) and K (affinity) values that were found for several 
pure salivary proteins adsorbing to HA. 
 
Table 1.2. HA Adsorption parameters of pellicle proteins fitted to a Langmuir 








Statherin 0.8 21.09 (Moreno et al., 1984) 5380 
aPRP3 0.16 26.0  (Moreno et al., 1984) 11320 
aPRP1 0.20 26.7  (Moreno et al., 1984) 1600 
aPRP2 0.20 18.1  (Moreno et al., 1982) 1600 
aPRP4 0.18 21.0  (Moreno et al., 1982) 11320 
Histatin 5 0.29  0.16  (Johnsson et al., 1993) 3037 
Serum 
Albumin 
0.054  1.17 (Hlady and Flredi-
Milhofer, 1978) 
69000 
MG1 6.14 x 10-4 8.670  
 
(Tabak et al., 1985) 1000000 
MG2 
6.0 x 10-5 
3.77  (Tabak et al., 1985) 120-
150000 
Cystatin SN 0.22 0.42 (Johnsson et al., 1991) 16,388 
Cystatin S 0.15 0.45 (Johnsson et al., 1991) 16,214 
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1.3.7. In Vivo AEP Composition 
The in vitro model of salivary protein adsorption to hydroxyapatite is not able to 
fully satisfy diverse dynamic conditions present in the oral cavity. Not 
surprisingly, many differences have been described between in vivo and in vitro 
pellicle. To collect the minute amounts found in the in vivo AEP, a non-abrasive 
method of collection involving the mechanical and chemical removal of pellicle 
samples was developed (Yao et al., 2001). In the same study, the mass 
spectrometry approach was used to identify intact salivary proteins such as 
albumin, lysozyme, cystatin and statherin, in the in vivo pellicles. “Shotgun” 
proteomics approaches have allowed the identification of 130 proteins and 
peptides in the in vivo AEP. These proteins are derived from glandular salivary 
secretions, gingival crevicular fluid, host cell and bacterial products (Siqueira et 
al., 2007). The in vivo identification of AEP peptides was subsequently achieved 
in the presence and absence of trypsin digestion followed by MALDI TOF/TOF 
analysis (Vitorino et al., 2008).  More than 90 proteins/peptides were identified 
including the pellicle precursors statherin, acidic PRPs and histatins. In a similar 
fashion, a 10 kDa molecular weight cut-off membrane followed by a high-
resolution gel filtration chromatography method were used to identify 78 native 
pellicle peptides with molecular weights ranging from 0.7 kDa to 4 kDa (Siqueira 
and Oppenheim, 2009). Furthermore, quantitative mass spectrometry 
approaches have been used to investigate the dynamic process of in vivo AEP 
formation (Lee et al., 2013). An interesting finding was that the abundance of 
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important salivary proteins, such as histatin 1, decreased over time while other 
pellicle precursors such as statherin showed a relatively constant abundance.  
 
1.4. Saliva-Microorganism Interactions 
 
1.4.1. Adhesin- Receptor Interactions 
The early colonizers of the tooth surface are specific microorganisms that have 
the ability to attach to the AEP (Scannapieco, 1994). The specific mechanisms of 
how these interactions occur and lead to different microbial species interactions 
have been extensively described (Rosan, 1981; Rosan et al., 1982; Gibbons et 
al., 1985; Kolenbrander and Andersen, 1990; Ruhl et al., 2004; Ambatipudi et al., 
2010;). For instance, Streptococci express adhesins, specifically α-amylase-
binding protein A, Antigen I/II, SspA/SspB and surface lectins that recognize 
receptors on proteins in the acquired enamel pellicle (Nobbs et al., 2009). 
 
1.5. Oral Colonizers of Dental Biofilm 
Early studies on the oral biofilm have used bacterial culture methodologies to 
identify the main cultivable biofilm colonizers (Ritz, 1967; Socransky et al., 1977; 
Loesche and Syed, 1978; Theilade et al., 1982; Nyvad and Kilian, 1987; 1990). 
These types of studies were restricted to the cultivable portion of the biofilm. The 
data of several of these studies showed a dominance of a limited number of 
species such as Streptococcus and Actinomyces. Nyvad and Kilian (1987) 
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described the predominant early microflora on human enamel and root surface in 
an in situ study of dental plaque formation. Within the first 24 hours, streptococci 
and Gram-positive pleomorphic rods dominated the microflora. The relative 
proportion of Streptococcus oralis increased significantly within the observation 
period while the proportion of Streptococcus salivarius and arginine-positive 
Streptococcus mitis showed a tendency to decline. Actinomyces species 
adsorbed to the tooth surfaces within the first 4 hours but did not increase their 
relative proportions until after 8-12 hours, possibly due to the relatively long 
doubling time of Actinomyces. In another study it was shown that as plaque 
matures, the proportions of facultative and anaerobic filamentous genera, such 
as Actinomyces, Corynebacterium, Fusobacterium, and Veillonella, increase 
gradually (Listgarten et al., 1975; Listgarten, 1976; Nyvad and Fejerskov, 1987a; 
b).  
A pioneering molecular characterization of human biofilm was carried out 
in our laboratory  (Li et al., 2004a). For this study the “Checkerboard” DNA-DNA 
hybridization technique was employed to identify the presence of 40 different 
bacterial strains in 0, 2, 4 and 6 hours in biofilm formed in vivo. The data shed 
light on the succession pattern of early pellicle colonization where streptococcus 
counts increase over time, Actinomyces increased solely in the first 2 hours. 
Interestingly, Porphyromonas gingivalis and Treponema denticola were among 
the early colonizers, however at much lower levels. The limitation of this study 
was the number of species amenable for identification since there were only 
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probes for 40 different cultivable species available at that time. More recently, 
Diaz et al. (2006) used the 16S rRNA gene sequencing technology and a 
retrievable enamel chip harvesting biofilms formed in situ to characterize the 
biofilms formed after 4 and 8 hours of plaque development. In order to visualize 
biofilm architecture, the fluorescence in situ hybridization (FISH) technique was 
applied as well. This in situ investigation of biofilm maturation identified at least 
97 different species and some phylotypes. The non-cultivable species were 
found for the first time in this study and they were tentatively assigned to the 
Clostridia and Flavobacteria genera. 
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2. Rationale and aim of the study 
There is an unmet need for improved measures to prevent dental biofilm 
induced diseases since caries as well as periodontal disease manifestations take 
their origins from the adverse effects of colonizing microorganism leading to 
these opportunistic infections. The development of new treatments will be greatly 
enhanced by a detailed understanding of the incipient processes that lead to the 
formation of dental biofilm. Characterization of the initial microflora and the 
biochemical factors that influence bacterial tooth colonization, are the first steps 
in understanding, at the molecular level, the processes that cause the subtle 
transition from health to disease. The development of means to interfere with this 
transition would represent novel approaches to prevent the ensuing pathologies.   
There are two aims associated with this project: 
I. To gain insights into the AEP formation at the very site where gingival 
fluid emanates into the oral environment and mixes with whole saliva. While 
much is known about the molecular makeup of the AEP there is a paucity of 
information on the effect of gingival fluid on AEP formation in the critical area of 
the tooth adjacent to the gingival margin. Experiments to be carried out are 
designed to gain information on the possible competition between serum-derived 
proteins and saliva based proteins during the formation of the AEP at the gingiva-
tooth interface. 
II. To obtain a more detailed insight into the composition of the incipient 
biofilm formation using the powerful tools provided by the HOMIM technology. 
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This modern technology is capable of identifying 400 different cultivable and 
uncultivable oral microbial species. The application of this modern molecular 
technique will be the first time attempts will be made to gain large scale insights 
into the very early phases of oral biofilm formation in vivo. 
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ABSTRACT 
 
The protein environment of the oral hard and soft tissues is dictated by the 
biochemistry of salivary proteins. An exception applies to the space immediately 
above the gingival sulcus, where serum proteins emanate in the form of gingival 
fluid, creating a serum-saliva gradient from the sulcus decreasing towards the 
tooth incisal edge. The aims of this study were to define the major salivary and 
serum components adsorbing to hydroxyapatite, to study competition for 
adsorption among them, and to validate the competition observations in an in 
vivo saliva/serum pellicle model. Hydroxapatite powder (HA) was incubated with 
saliva and serum and adsorbing proteins were identified by LC-ESI-MS/MS. To 
study competition, the saliva/serum proteins were labeled with CyDyes, mixed in 
various proportions and incubated with hydroxyapatite. For the in vivo 
competition assessment, in a split mouth design half of buccal tooth surfaces 
were coated with serum, and half with saliva. After exposure to the oral 
environment for 0 min and 2 h, the pellicles were analyzed by SDS PAGE. In 
pure saliva- and serum-derived pellicles eighty-two and eighty-four proteins were 
identified, respectively. Concomitant presence of salivary and serum proteins 
showed that salivary protein adsorbers effectively competed with serum proteins 
adsorbers for the HA surface. Specifically; acidic proline-rich protein, cystatin and 
statherin proteins competed off apolipoproteins, complement C3, and 
serotransferrin. In vivo evidence supported the replacement of serum proteins by 
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salivary proteins. In conclusion, while there is a significant amount of serum 
protein emanating from the gingival sulcus, their ability to participate in dental 
pellicle formation is likely reduced in the presence of strong salivary protein 
adsorbers. It is feasible that serum proteins may adsorb effectively subgingivally 
when there is no co-exposure to saliva.  
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INTRODUCTION 
 
The microenvironment of the gingival sulcus is dictated by a serumnal 
transudate under healthy gingival conditions (Brill and Krasse, 1958), which can 
transform into an exudate with the onset of gingivitis (Loe and Holm-Pedersen, 
1965). This locally released serum protein-containing solution is called gingival 
crevicular fluid. As it exits the sulcular space, mixing with saliva occurs in the oral 
environment (Oppenheim, 1970). Consequently, the cervical portions of teeth, 
especially in gingivitis patients, are subjected to a protein environment that differs 
significantly from a typical salivary milieu, and includes the presence of both 
saliva and serum/blood-derived proteins and peptides (Carlen et al., 2003). In 
fact there may be a gradient from the crevicular space to the most coronal 
aspects of the tooth. Exposure of teeth to proteinaceous oral environments leads 
to the formation of a tooth integument composed almost entirely of proteins and 
this structure is known as the acquired enamel pellicle (AEP). It is likely that the 
serumnal constituents in proximity to the gingival sulcus can promote a type of 
AEP formation different in composition than that strictly formed in a salivary 
environment. Under conditions of gingivitis, the gingival crevicular fluid flow is 
increased (Goodson, 2003). It is thus quite possible that under such conditions, 
the cervical portion of the teeth will contain a pellicle that is enriched in serumnal 
constituents in contrast to pellicles formed under gingivally healthy conditions. 
Furthermore, it can be hypothesized that pellicles formed under gingivitis 
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conditions favor the adsorption of periodontitis-associated proteolytic Gram-
negative species such as P. gingivalis, which require heme-derived iron as a 
necessary ingredient for growth (Olczak et al., 2001). Colonization with such 
species may further predispose the subject to progress from gingivitis to 
periodontitis (Carlen et al., 2003; Biyikoglu et al., 2012; Rudiger et al., 2012; 
Lourenco et al., 2014). 
The AEP forms the substratum for the attachment of the early colonizers 
(Kolenbrander and London, 1993). It is therefore possible that the changing 
protein environment in the vicinity of the gingival sulcus has downstream effects 
on the bacterial composition and characteristics of the early biofilm. The aim of 
this study was to examine which saliva and serum proteins adsorb to 
hydroxyapatite (HA) using LC-ESI-MS/MS. This approach permitted insights into 
the competition for attachment sites among the serum and saliva-derived 
proteins. We also conducted an investigation into the composition of 
experimental pellicles formed on serum- and saliva-coated tooth surfaces in vivo. 
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MATERIAL AND METHODS 
 
Saliva and Serum Sample Collection and Processing 
The present study was approved by the Institutional Review Board of Boston 
University Medical Center (approval # H-23334). Prior to enrollment, individuals 
gave their informed consent to participate in the study. For the in vitro studies, 
human serum (HS) from a male donor with blood type AB was commercially 
obtained (Mediatech, Manassas, VA). For the in vivo studies, fresh HS was used 
to coat the tooth surfaces (see details below). Masticatory stimulated whole 
saliva (WS) was collected from three subjects chewing on parafilm. The sample 
was collected on ice and immediately centrifuged to preserve salivary protein 
integrity (Thomadaki et al., 2011). The supernatant (WSS) was used for all 
experiments. 
 
In vitro pellicle formation by saliva and serum on HA surfaces 
A 1.0 mL aliquot of mixed WSS containing 1.0 mg/mL protein or 1:70 diluted HS 
containing 1.0 mg/mL protein were mixed with 800 μL binding buffer containing 
0.04 M Tris and 0.05 M NaCl, pH 6.8. The 1.8 mL mixture was then added to 5 
mg of hydroxyapatite (HA). The suspensions were incubated while rotating end 
over end at 37°C for 0, 5, 30, 60, 240 min. After centrifugation, the 1.8 mL 
supernatant containing the unadsorbed proteins was removed and kept on ice. 
HA with the adsorbed WSS and HS proteins were washed three times in 1 mL of 
  44 
binding buffer and then dissolved in 1.8 mL of 0.2 M EDTA (pH 7.5) at room 
temperature for one hr. Adsorbed and unadsorbed proteins were concentrated 
and desalted (Amicon Ultra filter, 3 kDa) to a final volume of 300 μL. 
 
SDS-PAGE and in-gel protein digestion 
Proteins in 20 µL aliquots of the unadsorbed and adsorbed protein fractions were 
mixed with 5 μL of 5x sample buffer, separated by 4-12% SDS PAGE and silver-
stained (Chevallet et al., 2006). Selected bands were excised and subjected to a 
modified in-gel trypsin digestion procedure as previously described (Shevchenko 
et al., 1996). In brief, gel pieces were washed and dehydrated with pure 
acetonitrile, completely dried in a speed-vac and rehydrated by adding 50 mM 
ammonium bicarbonate solution containing 12.5 ng/µL modified sequencing-
grade trypsin (Promega, Madison, WI). After incubation at 37ºC for 16h, the 
extracts were dried in a speed-vac and stored at 4ºC until analysis.  
 
Peptide sequencing and protein identification by LC-MS/MS 
A nano-scale C18 reverse-phase HPLC capillary column was packed as 
described (Peng and Gygi, 2001). The samples were loaded via a Famos auto 
sampler (LC Packings, San Francisco CA) and were eluted with increasing 
concentrations of solvent B (97.5% acetonitrile, 0.1% formic acid). After elution 
they were subjected to electrospray ionization, and then entered into an LTQ 
Orbitrap Velos Pro ion-trap mass spectrometer (Thermo Fisher Scientific, 
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Waltham, MA).  Peptides were detected, isolated, and fragmented to produce a 
tandem mass spectrum of specific fragment ions for each peptide. Peptide 
sequences were determined by matching protein databases with the acquired 
fragmentation pattern using the Sequest program (Thermo Fisher Scientific, 
Waltham, MA) (Eng et al., 1994). All databases included a reversed version of all 
the sequences and the data were filtered applying a DeltaCN value of >0.1 and 
Xcorr values of >2.0 and 3.0 for Z=2+ and 3+, ensuring a less than 1-2% peptide 
false discovery rate.   
 
HA adsorption and visualization of CyDye-labeled WSS and HS protein 
The pH of aliquots of 1 mL of WSS or diluted serum (each 1.0 mg/mL) was 
adjusted to pH 8.5 with NaOH. Subsequently, 20 μL of 0.4 mM CyDye working 
solution was added, Cy3 for WSS and Cy5 for HS. Samples were further 
processed according to the manufacturer’s instructions (Lumiprobe, Hallandale 
Beach, Florida). The labeled proteins were mixed with 800 μL binding buffer and 
incubated with 5 mg HA, either in pure form, or at various WSS:HS mixtures of 
1:9, 1:1, and 9:1 (v/v). The bound and unbound proteins were recovered and 
desalted as described above. Electrophoresis was carried of 160 µl sample 
aliquots in sample buffer not containing the bromophenol tracking dye (which 
interferes with Cy5). The protein gels were scanned using a LAS-4000 
Luminescent Imager Analyzer (Fujifilm, Pittsburg, PA), using for Cy3 a 
laser/emission filter set of 520/575 nm and for Cy5 a filter set of 630/670 nm. The 
  46 
images were overlayed with FIJI imaging software (Schindelin et al., 2012). After 
CyDye Imaging the gels were silver stained as described above. 
 
 
In vivo pellicle formation on serum-coated tooth surfaces 
The buccal tooth surfaces in both arches excluding second and third molars in 
one subject were thoroughly cleaned using a prophylaxis hand piece with rubber 
cup as described (Heller et al., 2016). In a split mouth study design, two-thirds of 
the cleaned coronal surfaces of incisor, canines and pre-molars of the upper and 
lower right arch were covered immediately after tooth cleaning with 5 μL of 
undiluted serum derived from the same subject. Exposures to the oral 
environment following prophylaxis were 0 min (subject closed the mouth and 
immediately thereafter the sample was collected), 30 min and 120 min. During 
this pellicle maturation phase, the subject was asked to refrain from eating, 
drinking (except water) or tooth brushing. For the collection of AEP, a collection 
strip (electrode wick filter paper, Bio- Rad, Hercules, CA) pre-soaked in 3% citric 
acid was used to swipe the coronal buccal surfaces of incisors, canines and pre-
molars.  
 
Protein recovery from the collection strips 
Proteins were recovered from the collection strips by electroelution essentially as 
described (Siqueira et al., 2007). Briefly, 30 μL of SDS sample buffer was added 
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to the strips, and after boiling for 5 min, the strips along with sample buffer were 
placed directly into one of the 10 wells of a precast 4-12% SDS-PAGE gel 
(BioRad). Gel electrophoresis was carried out as described above. 
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RESULTS 
 
Protein Identification of in vitro formed pellicles 
The first aim was to define the kinetic patterns of WSS and HS protein adsorption 
to HA, and to identify the adsorbed proteins by mass spectrometry. Experimental 
pellicles on HA powder were formed for 0, 5, 30, 60, 240 min with WSS or diluted 
HS as the protein sources. Proteins adsorbed to HA (Fig. 1A) were separated by 
SDS PAGE and visualized by silver staining. The selectivity of WSS protein 
adsorption to HA was readily observed, since the protein patterns of diluted WSS 
(Fig. 1A, lane 2a) differed distinctly from HA-adsorbed protein patterns (Fig. 1, 
lanes 3-7). WSS proteins with molecular weights (MW) of ~70 kDa and below 25 
kDa rapidly adsorbed, most within the first 5 min of incubation (Fig. 1A, lanes 3 to 
7). The adsorbing proteins from HS are shown in Fig. 1B. The specificity of the 
adsorption could be demonstrated by comparison of a diluted HS sample to the 
adsorbing fractions (lanes 2a vs lanes 3 to 7). The prominent adsorbing proteins 
exhibited MW values of ~67 kDa and ~77 kDa. In contrast to WSS proteins, HS 
protein adsorption occurred at a slower but distinctly incremental rate (Fig. 1B, 
lanes 3 to 7).  
To identify the specific protein components in the WSS- and HS-derived pellicles, 
protein bands were in-gel digested and analyzed by LC-ESI-MS/MS. The excised 
protein bands of WSS pellicles were given numbers and the HS-pellicles were 
given letters (Fig. 1), in ascending orders from low to high MW. All proteins 
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identified in the WSS and HS pellicles are listed in Supplemental Tables 1 and 2. 
They are ordered according to their abundance, which was based on the percent 
contribution of the proteins to the total proteins in the sample, which was 
determined from the ion peak area in the MS1 spectrum. In total, 82 proteins 
were found in the WSS-derived pellicles and 84 proteins in the HS-derived 
pellicles. The proteins listed in Fig. 1A and 1B were selected based on three 
criteria indicated in the legend. Salivary proteins identified in the WSS pellicles 
included statherin, acidic proline-rich proteins (aPRPs), cystatin S, cystatin SN, 
α-amylase 1, carbonic anhydrase 6 and lactoperoxidase (Fig. 1A), consistent 
with their known affinity for HA (Siqueira et al., 2012). Adsorbed HS proteins 
included albumin, apolipoprotein A-I (apoA-I), serotransferrin and annexin A1 
(Fig. 1B), some of which have previously been shown to adsorb to HA (Carlen et 
al., 1998) and to be present in pellicle formed in vivo (Siqueira et al., 2007).  
  








Figure 1. Identification of proteins in WSS and HS adsorbing to HA. (A) WSS 
pellicles and (B) HS pellicles formed after various time intervals with HA. Lane 1, MW 
standard; lane 2, original WSS and HS samples; lane 2a, diluted WSS and HS samples; 
lanes 3-7, adsorbed fractions harvested after 0, 5, 30, 60 and 240 min incubation with 
HA. Proteins in selected excised bands were identified by LC-ESI-MS/MS. Shown are 
proteins identified by >2 peptides, with theoretical MWs matching their apparent MWs in 
the gels +/- 10 kDa, and that were among the 95% most abundant proteins identified.   
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Glycosylated and phosphorylated proteins represented a large fraction of the 
adsorbed WSS and HS proteins (Fig. 2), larger than their reported fractions in the 
WSS and HS proteomes (Carrascal et al., 2010; Gonzalez-Begne et al., 2011; 
Loo et al., 2010; Nanjappa et al., 2014; Salih et al., 2010; Yang et al., 2005) 
suggesting their enrichment on the tooth surface. It should be pointed out though 
that different search programs were used to determine the phosphorylated and 
glycosylated proteins in WSS and HS on the one hand and the adsorbed WSS 
and HS on the other hand, which may have under-estimated the number of post-
translationally modified proteins in WSS and HS. 
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Figure 2. Phosphorylation and glycosylation of WSS and HS proteins adsorbed to 
HA. Post-translational modifications of adsorbed proteins were determined based on 
their annotations in the databases at www.uniprot.org, www.phosphosite.org and/ or 
www.unicarbkb.org websites. The post-translational modifications of whole WSS and HS 
were based on the literature for the WSS proteome (Loo et al., 2010), WSS 
glycoproteome (Gonzalez-Begne et al., 2011), WSS phosphoproteome (Salih et al., 
2010), HS proteome (Nanjappa et al. 2013), HS glycoproteome (Yang et al. 2005) and 
HS phosphoproteome (Carrascal et al. 2010). The gray segment represents the fraction 
of the proteome minus the confirmed glycoproteome or phosphoproteome fractions. 
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Competition between WSS and HS proteins for adsorption sites on HA  
To investigate relative affinities of WSS and HS proteins for HA, a competition 
assay was carried out. For the separate visualization of WSS and HS proteins in 
the mixture, proteins in these two sources were labeled with the fluorescent dyes 
Cy3 and Cy5, respectively (Unlu et al., 1997) where WSS proteins appear in 
green and HS proteins in red (Fig. 3). The Cy3 and Cy5 labels did not generate a 
cross-talk when excited in a mixture at the Cy5 and Cy3 wavelengths, 
respectively (Fig. 3A, lane 2 and Figure 3B, lane 1). HA was incubated with Cy3-
labeled WSS, Cy5-labeled HS, or with mixtures of the two in a 1:1, 9:1 and 1:9 
ratio (v/v). . Labeling with Cy dyes did not affect the binding of the proteins to HA, 
since the adsorption patterns in Fig. 3D (silver-stained CyDye gels) mimicked the 
adsorption patterns of the WSS and HS proteins not labeled with CyDyes. As 
expected, the labeled fractions incubated with HA containing only WSS or HS 
proteins showed exclusively green and red-labeled proteins. In the 1:1, 9:1 and 
1:9 mixtures of WSS and HS, the effect of competition for binding to HA could 
clearly be observed. For instance, lower molecular weight proteins from HS (<50 
kDa) as well as higher MW proteins (>75 kDa) that adsorbed to HA in the 
absence of WSS proteins (Fig. 3C, lane 2) did not adsorb when WSS was 
present. This is evident in Fig. 3C, lanes 3-5, containing increasing amounts of 
HS proteins, where all represent a significant presence of WSS proteins even 
when the WSS protein amounted to only 10% of the total incubation mixture. The 
adsorbed proteins in the CyDye gel (Fig. 3D) were identified by comparison to 
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the patterns in Fig.1A and B (Supplemental Fig. 1). Direct MS analysis of 
proteins in the CyDye gel was also performed (pending). The results showed that 
salivary aPRP, cystatins and statherins in saliva displaced complement C3, 
serotransferrin, apolipoprotein C-III (apoC-III), apolipoprotein A-II (apoA-II) and 




Figure 3. Electrophoretic separation and visualization of CyDye-labeled proteins 
from WSS and HS adsorbing to hydroxyapatite. (A) proteins visualized by excitation 
of the Cy3 dye;  (B) proteins visualized by excitation of the Cy5 dye; (C) Overlay of 
images in A and B; (D) Silver-staining of the CyDye gel. Lane 1, WSS; lane 2, HS; lane 
3-5: WSS:HS mixtures at 1:1, 9:1 and 1:9 (v/v), resp.  
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The displacement was quantified by densitometric analysis of the black and white 
image of the CyDye gel  (Supplemental Fig. 2), and is shown for each of these 
proteins in Fig. 4. In the various HS:WSS mixtures, the most dramatic increases 
in binding were observed for aPRPs, statherin and cystatin in WSS and the most 
rapid displacement was noted for the apolipoproteins (apoC-III, apoA-II and 




Figure 4. Densitometry analysis of selected proteins in experimental pellicles from 
WSS, HS and WSS:HS mixtures formed on HA. For quantitations the black and white 
images of the Cy3 and Cy5-stained gels were used and protein bands selected are 
shown in Supplemental Fig. 2. Identifications were made by comparison to Fig. 1. 
Plotted are the theoretical percentage of the various proteins and their actual 
percentages relative to the band intensity in the pure WSS and HS pellicle samples.  
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In vivo pellicle formation on WSS and HS coated enamel surfaces 
To investigate the effect of HS on the pellicle composition in vivo, a split mouth 
design was employed, where one half the dentition was coated with HS and the 
other half was uncoated (Fig. 5, left panel). The AEP samples were collected 
after 0, 30 and 120 minutes of pellicle maturation after prophylaxis. In the AEP 
sample collected immediately after prophylaxis from the HS-coated surfaces (Fig. 
4, right panel), a clear presence of HS proteins was observed. In the 30 min 
(data not shown) and 120 min AEP samples, many of the HS proteins (labeled 
“a”) had clearly disappeared, whereas salivary proteins (labeled “b”) appeared 
and the patterns of adsorbed proteins became more similar to that of natural 
AEP. The displaced “a” bands represented peroxiredoxin-1, serotransferrin, 
complement factor B, complement factor C3, gelsolin and the collagen (I) α-2 
chain, whereas the primary adsorbing salivary proteins “b” were represented by 
aPRPs, statherin, cystatins and prolactin-inducible protein. Several of these 
proteins were consistent with those identified in the in vitro competition assay. 
  




Figure 5. Composition of in vivo formed pellicles on uncoated and HS-coated 
tooth surfaces in a split mouth design. Proteins were harvested after 0 and 120 min, 
subjected to SDS PAGE and visualized by silver staining. Note that the serum banding 
pattern in the 0 min sample (lane 3) had completely disappeared in the 120 min sample 
(lane 4), and resembled that of the WSS pellicle patterns in lanes 1 and 2  harvested 
from uncoated tooth surfaces.  
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DISCUSSION 
 
The present study provided insights into the dynamic process of pellicle 
formation involving salivary and serum proteins. The major observations were 
that the presence of salivary proteins causes desorption of serum proteins. The 
implication of this finding is that in vivo, it is likely that at the gingival margin of 
the tooth surface such an exchange of adsorbing proteins takes place. 
Consequently, the theoretical gradient of saliva and serum proteins from the 
gingival margin may not be quantitatively reflected in the ratio of salivary and 
serum proteins adsorbing to the tooth surface. The in vitro data provide evidence 
for this where we demonstrate that WSS proteins are more effective adsorbers to 
the tooth surface than HS proteins, since the in vivo pellicle formed after HS 
coating was almost entirely WSS protein derived. 
Amylase and albumin represent the most abundant proteins in WSS and HS, and 
both proteins adsorbed to HA. In the CyDye-labeled mixtures incubated with HA, 
their actual adsorption levels were similar to their calculated adsorption levels, 
showing neither preferential adsorption nor displacement by other proteins in the 
mixture. In contrast, statherin/cystatin and aPRPs in WSS showed unusually 
strong adsorption in the mixtures while serum apolipoproteins (apoC-III, apoA-II, 
or apoA-I) were rapidly displaced. The aPRPs represent a family of structurally 
related proteins. Their concentration in whole saliva ranges from 190 to 304 
μg/mL (Campese et al., 2009). As their name suggests, these proteins are 
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proline-rich, and also contain a high content of glutamine and glycine residues. 
Important to this study is that all PRPs are highly homologous and 
phosphorylated at residues 8 and 22 at the N-terminus, contributing to the acidic 
nature of these proteins (Bennick, 1987). The strong adsorption of aPRPs to HA 
has been well established in vitro (Hay, 1973) and in situ showing that 
approximately 37% of the early AEP were aPRPs (Bennick et al., 1983). 
Functionally, aPRPs have been shown to inhibit calcium phosphate crystal 
growth, and their main function in the oral cavity is related to the protection of 
enamel, a property they share with the also phosphorylated statherin proteins 
(Hay, 1967; Moreno et al., 1979). 
Among the proteins in HS with affinity for HA were apoliproteins apoA-I, apoA-II 
and apoC-III. These proteins, whose combined serum concentration exceeds 1.2 
mg/mL (Schaefer et al., 1982), form non-covalent nano-assemblies with lipids, 
termed lipoproteins. The main function of lipoproteins is to mediate transport and 
metabolism of plasma lipids (Curtiss et al., 2006). Both aPRPs and 
apolipoproteins are acidic and may potentially form electrostatic interactions with 
positively charged groups on the surface of the HA crystal lattice. More 
specifically, apolipoproteins are comprised of class- -helices with 
large apolar faces that bind lipid surface, and a characteristic radial distribution of 
charged residues (Segrest et al., 1994). Acidic residues in class-A helices form a 
linear array in the middle of the polar helical face, flanked by basic residues 
running along the polar-apolar interface. Apolipoproteins such as apoA-I can bind 
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Ca2+, perhaps via the array of acidic residues. A similar binding may potentially 
occur at the HA surface; in addition, arrays of basic residues in apolipoprotein α-
helices may potentially interact with phosphate groups at the HA surface.   
When HA was incubated with a mixture of WSS and HS, aPRPs strongly 
adsorbed whereas the apolipoproteins rapidly desorbed. It is feasible that the 
aPRPs displaced the apolipoproteins by competition for the same binding sites, 
although this remains to be established.  An interesting property of the aPRPs is 
that they undergo drastic conformational changes upon adsorption to HA 
(Elangovan et al. 2007). In solution the protein adopts polyproline type II (PPII) 
helical conformation and random coil structures, whereas in the adsorbed state 
β-turns and antiparallel β-sheets predominated. By comparison, apoA-I in 
solution forms a kinked helix bundle structure comprised of amphipathic α-helices 
(Mei and Atkinson, 2011). While it is well-established that apolipoproteins can 
adopt multiple conformations in the lipid-free, lipid-poor, and lipid-rich states 
(Gursky and Atkinson, 1996; Gursky, 2015), there is little information on their 
interaction with the HA surface (Rosengren et al., 2002) or possible 
conformational changes induced by such interactions. We speculate that 
differences in the physical complementarity between the proteins and the HA 
surface, as well as differences in the extent of phosphorylation between aPRPs 
and apoA-I, along with possible conformational changes at the HA surface give 
aPRPs a competitive advantage over apoA-I for adsorption to HA.  
The adsorption of aPRPs to the tooth surface is critically important for enamel 
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protection, and their replacement of weakly adsorbing proteins with less 
protective functions would be a significant benefit to the host. From a clinical 
perspective, shorter peptides from proteins with enamel protective properties 
such as statherin (Xiao et al., 2015) or casein (Reynolds, 1997) are actively 
being pursued to protect against tooth erosion and/or dental caries. Our results 
suggest that such peptides could rapidly replace other proteins already adsorbed 
to the tooth surface, e.g. serum proteins at the gingival margin. AEP 
displacement approaches represent a promising future direction to achieve AEP 
pellicles with high protective functions with the ultimate goal to diminish caries 
formation and gingival inflammation. 
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SUPPLEMENTAL DATA CHAPTER 2 




Supplemental Table 1. Proteins identified at specific gel spots from saliva  derived experimental pellicle.
Band (Molecular Weight)
Band  1 (6.92 kDa)
Unique Total reference Gene SymbolMWT(kDa) AVG Name Glycosilated Phosphorilated Theoretical pI
2 2 Q07020_RL18_HUMAN RPL18 21,62 2,6755 60S ribosomal protein L18 No Yes 11,73
Band  2 (9.74 kDa)
Unique Total reference Gene SymbolMWT(kDa) AVG Name Glycosilated Phosphorilated Theoretical pI
3 3 P01620_KV302_HUMAN N/A 11,77 3,249 Ig kappa chain V-III region SIE No No 8,7
3 3 P02760_AMBP_HUMAN AMBP 38,97 2,9461 Protein AMBP Yes No 6,13
2 3 P01834_IGKC_HUMAN IGKC 11,6 3,7187 Ig kappa chain C region No No 5,58
2 2 Q07020_RL18_HUMAN RPL18 21,62 2,9051 60S ribosomal protein L18 No Yes 11,73
2 2 P07355_ANXA2_HUMAN ANXA2 38,58 2,5533 Annexin A2 No Yes 7,56
Band  3 (12 kDa)
Unique Total reference Gene SymbolMWT(kDa) AVG Name Glycosilated Phosphorilated Theoretical pI
4 4 P10599_THIO_HUMAN TXN 11,73 2,8503 Thioredoxin No No 4,82
4 4 P12273_PIP_HUMAN PIP 16,56 2,6704 Prolactin-inducible protein Yes No 5,4
3 4 P01834_IGKC_HUMAN IGKC 11,6 3,3461 Ig kappa chain C region No No 5,58
3 4 P61769_B2MG_HUMAN B2M 13,71 1,4422 Beta-2-microglobulin Yes No 6,07
3 3 P01876_IGHA1_HUMAN IGHA1 37,63 2,7663 Ig alpha-1 chain C region Yes No 6,08
3 3 P07355_ANXA2_HUMAN ANXA2 38,58 2,6684 Annexin A2 No Yes 7,56
3 3 P02760_AMBP_HUMAN AMBP 38,97 2,5038 Protein AMBP Yes No 6,13
2 2 P01620_KV302_HUMAN N/A 11,77 3,6317 Ig kappa chain V-III region SIE No No 8,7
2 2 P62805_H4_HUMAN HIST1H4A 11,36 2,2418 Histone H4 No Yes 11,36
2 2 P01036_CYTS_HUMAN CST4 16,2 2,0031 Cystatin-S No Yes 4,83
Band  4 (16 kDa)
Unique Total reference Gene SymbolMWT(kDa) AVG Name Glycosilated Phosphorilated Theoretical pI
6 30 P01036_CYTS_HUMAN CST4 16,2 1,9757 Cystatin-S No Yes 4,83
3 4 P02760_AMBP_HUMAN AMBP 38,97 2,7929 Protein AMBP Yes No 6,13
3 3 P01620_KV302_HUMAN N/A 11,77 3,5984 Ig kappa chain V-III region SIE No No 8,7
3 3 P01037_CYTN_HUMAN CST1 16,38 2,528 Cystatin-SN No No 6,92
3 3 P12273_PIP_HUMAN PIP 16,56 2,5101 Prolactin-inducible protein Yes No 5,4
2 3 P01834_IGKC_HUMAN IGKC 11,6 3,0941 Ig kappa chain C region No No 5,58
2 2 P68871_HBB_HUMAN HBB 15,99 3,2763 Hemoglobin subunit beta Yes Yes 6,81
2 2 P04080_CYTB_HUMAN CSTB 11,13 2,9682 Cystatin-B No No 6,96
2 2 P07355_ANXA2_HUMAN ANXA2 38,58 2,4693 Annexin A2 No Yes 7,56
Band  5 (20.15 kDa)
Unique Total reference Gene SymbolMWT(kDa) AVG Name Glycosilated Phosphorilated Theoretical pI
4 12 P01036_CYTS_HUMAN CST4 16,2 1,917 Cystatin-S No Yes 4,83
4 4 P12273_PIP_HUMAN PIP 16,56 2,8032 Prolactin-inducible protein Yes No 5,4
4 4 P02808_STAT_HUMAN STHAT 06/jan 2,86 Statherin No Yes 6,25
3 4 P01834_IGKC_HUMAN IGKC 11,6 3,0441 Ig kappa chain C region No No 5,58
3 4 P07355_ANXA2_HUMAN ANXA2 38,58 2,8056 Annexin A2 No Yes 7,56
3 3 P01620_KV302_HUMAN N/A 11,77 3,7549 Ig kappa chain V-III region SIE No No 8,7
2 2 P68871_HBB_HUMAN HBB 15,99 3,5993 Hemoglobin subunit beta Yes Yes 6,81
2 2 P01876_IGHA1_HUMAN IGHA1 37,63 2,3471 Ig alpha-1 chain C region Yes No 6,08
2 2 P69905_HBA_HUMAN HBA1 15,25 2,1776 Hemoglobin subunit alpha Yes Yes 8,73
Band  6 (20.22 kDa)
Unique Total reference Gene SymbolMWT(kDa) AVG Name Glycosilated Phosphorilated Theoretical pI
4 4 P12273_PIP_HUMAN PIP 16,56 2,7052 Prolactin-inducible protein Yes No 5,4
3 4 P01834_IGKC_HUMAN IGKC 11,6 2,7418 Ig kappa chain C region No No 5,58
2 3 P02760_AMBP_HUMAN AMBP 38,97 2,9982 Protein AMBP Yes No 6,13
2 2 P01620_KV302_HUMAN N/A 11,77 3,4741 Ig kappa chain V-III region SIE No No 8,7
2 2 P23284_PPIB_HUMAN PPIB 23,73 2,7572 Peptidyl-prolyl cis-trans isomerase B Yes No 9,25
2 2 P07355_ANXA2_HUMAN ANXA2 38,58 2,6086 Annexin A2 No Yes 7,56
2 2 P41222_PTGDS_HUMAN PTGDS 21,02 2,5112 Prostaglandin-H2 D-isomerase Yes No 8,37
2 2 P02810_PRPC_HUMAN PRH1 24 2,1342 Salivary acidic proline-rich phosphoprotein 1/2 Yes Yes 4,14
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Band  7 (25-20 kDa)
Unique Total reference Gene SymbolMWT(kDa) AVG Name Glycosilated Phosphorilated Theoretical pI
8 12 P23284_PPIB_HUMAN PPIB 23,73 2,7753 Peptidyl-prolyl cis-trans isomerase B Yes No 9,25
6 8 P07951_TPM2_HUMAN TPM2 32,83 3,3639 Tropomyosin beta chain No Yes 4,66
6 7 P10916_MLRV_HUMAN MYL2 18,78 2,6921 Myosin regulatory light chain 2, ventricular/cardiac muscle isoformNo Yes 4,9
6 6 P32119_PRDX2_HUMAN PRDX2 21,88 2,369 Peroxiredoxin-2 No Yes 5,67
5 5 P04792_HSPB1_HUMAN HSPB1 22,77 2,759 Heat shock protein beta-1 No Yes 5,98
5 5 Q96DA0_ZG16B_HUMAN ZG16B 22,72 2,5188 Zymogen granule protein 16 homolog B Yes No 5,39
4 6 P62987_RL40_HUMAN UBA52 14,72 2,8927 Ubiquitin-60S ribosomal protein L40 No Yes 10,32
4 5 P62805_H4_HUMAN HIST1H4A 11,36 2,552 Histone H4 No Yes 11,36
4 4 P08590_MYL3_HUMAN MYL3 21,92 3,4313 Myosin light chain 3 No Yes 5,03
4 4 P02647_APOA1_HUMAN APOA1 30,76 3,1139 Apolipoprotein A-I Yes Yes 5,56
4 4 P31947_1433S_HUMAN SFN 27,76 2,5041 14-3-3 protein sigma No Yes 4,68
4 4 P00568_KAD1_HUMAN AK1 21,62 2,3255 Adenylate kinase isoenzyme 1 No Yes 8,73
3 8 P12273_PIP_HUMAN PIP 16,56 2,5542 Prolactin-inducible protein Yes No 5,4
3 4 P02585_TNNC2_HUMAN TNNC2 18,11 3,1248 Troponin C, skeletal muscle No No 4,06
3 4 P80188_NGAL_HUMAN LCN2 22,57 2,8852 Neutrophil gelatinase-associated lipocalin No No 9,02
3 3 O75223_GGCT_HUMAN GGCT 20,99 3,0282 Gamma-glutamylcyclotransferase No Yes 5,07
3 3 P01036_CYTS_HUMAN CST4 16,2 2,9623 Cystatin-S No Yes 4,83
3 3 P48788_TNNI2_HUMAN TNNI2 21,32 2,9376 Troponin I, fast skeletal muscle No Yes 8,88
3 3 P01620_KV302_HUMAN N/A 11,77 2,7338 Ig kappa chain V-III region SIE No No 8,7
3 3 P25311_ZA2G_HUMAN AZGP1 34,24 2,6996 Zinc-alpha-2-glycoprotein Yes No 5,58
3 3 Q06830_PRDX1_HUMAN PRDX1 22,1 2,6109 Peroxiredoxin-1 no Yes 8,27
3 3 P01876_IGHA1_HUMAN IGHA1 37,63 2,5476 Ig alpha-1 chain C region Yes No 6,08
3 3 Q13885_TBB2A_HUMAN TUBB2A 49,87 2,4326 Tubulin beta-2A chain No Yes 4,78
2 3 P05976_MYL1_HUMAN MYL1 21,13 3,3215 Myosin light chain 1/3, skeletal muscle isoform No Yes 4,97
2 3 P56537_IF6_HUMAN EIF6 26,58 3,213 Eukaryotic translation initiation factor 6 No Yes 4,56
2 2 P68871_HBB_HUMAN HBB 15,99 3,4821 Hemoglobin subunit beta Yes Yes 6,81
2 2 P06753_TPM3_HUMAN TPM3 32,93 3,2931 Tropomyosin alpha-3 chain No Yes 4,68
2 2 P45378_TNNT3_HUMAN TNNT3 31,81 3,0445 Troponin T, fast skeletal muscle No Yes 5,71
2 2 P63316_TNNC1_HUMAN TNNC1 18,39 3,0147 Troponin C, slow skeletal and cardiac muscles No Yes 4,02
2 2 P13805_TNNT1_HUMAN TNNT1 32,93 2,8918 Troponin T, slow skeletal muscle No Yes 5,86
2 2 P01834_IGKC_HUMAN IGKC 11,6 2,8886 Ig kappa chain C region No No 5,58
2 2 P62258_1433E_HUMAN YWHAE 29,16 2,8722 14-3-3 protein beta/alpha No Yes 4,63
2 2 O60911_CATL2_HUMAN CTSV 37,31 2,8416 Cathepsin L2 Yes No 8,59
2 2 Q99497_PARK7_HUMAN PARK7 19,88 2,6948 Protein deglycase DJ-1 No Yes 6,32
2 2 P52566_GDIR2_HUMAN ARHGDIB 22,97 2,6867 Rho GDP-dissociation inhibitor 2 No Yes 5,08
2 2 Q15828_CYTM_HUMAN CST6 16,5 2,639 Cystatin-M Yes No 7
2 2 P40926_MDHM_HUMAN MDH2 35,48 2,5646 Malate dehydrogenase, mitochondrial Yes No 8,54
2 2 Q14116_IL18_HUMAN IL18 22,31 2,5262 Interleukin-18 No No 5,01
2 2 P11021_GRP78_HUMAN HSPA5 72,29 2,4703 78 kDa glucose-regulated protein No Yes 5,01
2 2 H3BR70_H3BR70_HUMAN PKM 40,16 2,3785 Pyruvate kinase No No 7,96
2 2 P01857_IGHG1_HUMAN IGHG1 36,08 2,37 Ig gamma-1 chain C region Yes No 8,46
2 2 P69905_HBA_HUMAN HBA1 15,25 2,355 Hemoglobin subunit alpha Yes Yes 8,73
2 2 P31946_1433B_HUMAN YWHAB 28,06 2,157 14-3-3 protein beta/alpha No Yes 4,76
2 2 P20160_CAP7_HUMAN AZU1 26,87 2,1139 Azurocidin Yes No 9,53
2 2 P05090_APOD_HUMAN APOD 21,26 2,0716 Apolipoprotein D Yes No 5,2
2 2 Q8NCW5_NNRE_HUMAN APOA1BP 31,65 1,7342 NAD(P)H-hydrate epimerase No Yes 5,03
Band  8 (30.50 kDa)
Unique Total reference Gene SymbolMWT(kDa) AVG Name Glycosilated Phosphorilated Theoretical pI
6 6 Q96DR5_BPIA2_HUMAN BPIFA2 26,99 2,432 BPI fold-containing family A member 2 Yes No 5,19
4 5 P62736_ACTA_HUMAN ACTA2 41,98 2,7424 Actin, aortic smooth muscle No No 5,24
4 4 Q96DA0_ZG16B_HUMAN ZG16B 22,72 2,8194 Zymogen granule protein 16 homolog B Yes No 5,39
4 4 P13533_MYH6_HUMAN MYH6 223,6 2,7505 Myosin-6 No Yes 5,58
4 4 P07355_ANXA2_HUMAN ANXA2 38,58 2,3336 Annexin A2 No Yes 7,56
3 4 P52566_GDIR2_HUMAN ARHGDIB 22,97 2,6886 Rho GDP-dissociation inhibitor 2 No Yes 5,08
2 3 Q15517_CDSN_HUMAN CDSN 51,49 2,8761 Corneodesmosin Yes No 8,48
2 3 P31946_1433B_HUMAN YWHAB 28,06 2,1302 14-3-3 protein beta/alpha No Yes 4,76
2 2 P80188_NGAL_HUMAN LCN2 22,57 3,2376 Neutrophil gelatinase-associated lipocalin No No 9,02
2 2 P04406_G3P_HUMAN GAPDH 36,03 2,9714 Glyceraldehyde-3-phosphate dehydrogenase No Yes 8,58
2 2 P60709_ACTB_HUMAN ACTB 41,71 2,6952 Actin, cytoplasmic 1 No No 5,29
2 2 O00299_CLIC1_HUMAN CLIC1 26,91 2,4794 Chloride intracellular channel protein 1 No Yes 5,09
2 2 P20160_CAP7_HUMAN AZU1 26,87 2,4175 Azurocidin Yes No 9,53
2 2 P01857_IGHG1_HUMAN IGHG1 36,08 2,1222 Ig gamma-1 chain C region Yes No 8,46
2 2 P05090_APOD_HUMAN APOD 21,26 2,0413 Apolipoprotein D Yes No 5,2
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Band  9 (48.97-50.57 kDa)
Unique Total reference Gene SymbolMWT(kDa) AVG Name Glycosilated Phosphorilated Theoretical pI
5 7 P62736_ACTA_HUMAN ACTA2 41,98 3,3718 Actin, aortic smooth muscle No No 5,24
5 5 Q9UKX3_MYH13_HUMAN MYH13 223,47 2,3846 Myosin-13 No No 5,53
4 5 P25311_ZA2G_HUMAN AZGP1 34,24 2,8575 Zinc-alpha-2-glycoprotein Yes No 5,58
4 4 P07355_ANXA2_HUMAN ANXA2 38,58 2,9651 Annexin A2 No Yes 7,56
3 3 P04040_CATA_HUMAN CAT 59,72 2,7806 Catalase No Yes 6,9
3 3 P12273_PIP_HUMAN PIP 16,56 2,211 Prolactin-inducible protein Yes No 5,4
2 2 P30740_ILEU_HUMAN SERPINB1 42,71 3,3143 Leukocyte elastase inhibitor No No 5,9
2 2 Q96DA0_ZG16B_HUMAN ZG16B 22,72 3,1732 Zymogen granule protein 16 homolog B Yes No 5,39
2 2 P12882_MYH1_HUMAN MYH1 223,01 3,0082 Myosin-1 No Yes 5,58
2 2 P62987_RL40_HUMAN UBA52 14,72 3,001 Ubiquitin-60S ribosomal protein L40 No Yes 10,32
2 2 P01876_IGHA1_HUMAN IGHA1 37,63 2,8948 Ig alpha-1 chain C region Yes No 6,08
2 2 P04406_G3P_HUMAN GAPDH 36,03 2,8327 Glyceraldehyde-3-phosphate dehydrogenase No Yes 8,58
2 2 Q15517_CDSN_HUMAN CDSN 51,49 2,7821 Corneodesmosin Yes No 8,48
2 2 P23280_CAH6_HUMAN CA6 35,34 2,753 Carbonic anhydrase 6 Yes No 6,41
2 2 Q06830_PRDX1_HUMAN PRDX1 22,1 2,4998 Peroxiredoxin-1 no Yes 8,27
2 2 P01857_IGHG1_HUMAN IGHG1 36,08 2,4691 Ig gamma-1 chain C region Yes No 8,46
2 2 P14618_KPYM_HUMAN PKM 57,9 2,1844 Pyruvate kinase No No 7,96
Band  10 (60.37 kDa)
Unique Total reference Gene SymbolMWT(kDa) AVG Name Glycosilated Phosphorilated Theoretical pI
11 19 AMY1_HUMAN AMY1A 57,73 2,6976 Alpha-amylase 1 Yes Nos 6,34
4 4 P07355_ANXA2_HUMAN ANXA2 38,58 2,8973 Annexin A2 No Yes 7,56
4 4 P68104_EF1A1_HUMAN EEF1A1 50,11 2,2668 Elongation factor 1-alpha 1 No Yes 9,1
4 4 P01876_IGHA1_HUMAN IGHA1 37,63 1,9429 Ig alpha-1 chain C region Yes No 6,08
3 3 P05164_PERM_HUMAN MPO 83,81 2,711 Myeloperoxidase Yes No 9,22
3 3 Q06830_PRDX1_HUMAN PRDX1 22,1 2,2297 Peroxiredoxin-1 no Yes 8,27
2 2 P04040_CATA_HUMAN CAT 59,72 3,2154 Catalase No Yes 6,9
2 2 P14618_KPYM_HUMAN PKM 57,9 2,3632 Pyruvate kinase No No 7,96
2 2 P02788_TRFL_HUMAN LTF 78,13 2,2737 Lactotransferrin Yes Yes 8,47
2 2 P32119_PRDX2_HUMAN PRDX2 21,88 2,2221 Peroxiredoxin-2 No Yes 5,67
Band  11 (63.37 kDa)
Unique Total reference Gene SymbolMWT(kDa) AVG Name Glycosilated Phosphorilated Theoretical pI
9 27 AMY1_HUMAN AMY1A 57,73 2,5979 Alpha-amylase 1 Yes Nos 6,34
7 8 P01876_IGHA1_HUMAN IGHA1 37,63 2,268 Ig alpha-1 chain C region Yes No 6,08
5 5 P07237_PDIA1_HUMAN P4HB 57,08 2,5615 Protein disulfide-isomerase No Yes 4,69
5 5 P05164_PERM_HUMAN MPO 83,81 2,2484 Myeloperoxidase Yes No 9,22
3 3 P62736_ACTA_HUMAN ACTA2 41,98 2,4252 Actin, aortic smooth muscle No No 5,24
2 3 O75223_GGCT_HUMAN GGCT 20,99 2,2883 Gamma-glutamylcyclotransferase No Yes 5,07
2 2 P62987_RL40_HUMAN UBA52 14,72 3,1272 Ubiquitin-60S ribosomal protein L40 No Yes 10,32
2 2 P41222_PTGDS_HUMAN PTGDS 21,02 2,9883 Prostaglandin-H2 D-isomerase Yes No 8,37
2 2 P07355_ANXA2_HUMAN ANXA2 38,58 2,8777 Annexin A2 No Yes 7,56
2 2 P01011_AACT_HUMAN SERPINA3 47,62 2,7326 Alpha-1-antichymotrypsin Yes No 5,32
2 2 P01019_ANGT_HUMAN AGT 53,12 2,3319 Angiotensinogen Yes No 5,6
2 2 P04040_CATA_HUMAN CAT 59,72 2,2972 Catalase No Yes 6,9
2 2 P32119_PRDX2_HUMAN PRDX2 21,88 2,0823 Peroxiredoxin-2 No Yes 5,67
2 2 Q06830_PRDX1_HUMAN PRDX1 22,1 2,0337 Peroxiredoxin-1 No Yes 8,27
2 2 P07384_CAN1_HUMAN CAPN1 81,84 1,8104 Calpain-1 catalytic subunit No No 5,49
Band  12 (70.63 kDa)
Unique Total reference Gene SymbolMWT(kDa) AVG Name Glycosilated Phosphorilated Theoretical pI
23 38 ALBU_HUMAN ALB 69,32 2,5537 Serum albumin Yes Yes 5,67
6 6 P01876_IGHA1_HUMAN IGHA1 37,63 2,4782 Ig alpha-1 chain C region Yes No 6,08
3 3 P62736_ACTA_HUMAN ACTA2 41,98 2,9399 Actin, aortic smooth muscle No No 5,24
3 3 P07355_ANXA2_HUMAN ANXA2 38,58 2,7053 Annexin A2 No Yes 7,56
2 3 P25311_ZA2G_HUMAN AZGP1 34,24 2,3927 Zinc-alpha-2-glycoprotein Yes No 5,58
2 2 P62805_H4_HUMAN HIST1H4A 11,36 2,7537 Histone H4 No Yes 11,36
2 2 P60709_ACTB_HUMAN ACTB 41,71 2,4729 Actin, cytoplasmic 1 No No 5,29
2 2 P13796_PLSL_HUMAN LCP1 70,24 2,416 Plastin-2 No Yes 5,29
2 2 P14618_KPYM_HUMAN PKM 57,9 2,3558 Pyruvate kinase No No 7,96
2 2 Q06830_PRDX1_HUMAN PRDX1 22,1 2,2339 Peroxiredoxin-1 no Yes 8,27
Band  13 (100-75 kDa)
Unique Total reference Gene SymbolMWT(kDa) AVG Name Glycosilated Phosphorilated Theoretical pI
10 10 P02788_TRFL_HUMAN LTF 78,13 2,7313 Lactotransferrin Yes Yes 8,47
6 6 P11021_GRP78_HUMAN HSPA5 72,29 2,4819 78 kDa glucose-regulated protein No Yes 5,01
4 4 P07355_ANXA2_HUMAN ANXA2 38,58 2,8317 Annexin A2 No Yes 7,56
3 4 P02787_TRFE_HUMAN TF 77,01 2,1657 Serotransferrin Yes Yes 6,7
3 3 P62736_ACTA_HUMAN ACTA2 41,98 2,8451 Actin, aortic smooth muscle No No 5,24
3 3 P13667_PDIA4_HUMAN PDIA4 72,89 2,7092 Protein disulfide-isomerase A4 No No 4,89
3 3 P04040_CATA_HUMAN CAT 59,72 2,5995 Catalase No Yes 6,9
3 3 Q15517_CDSN_HUMAN CDSN 51,49 2,5591 Corneodesmosin Yes No 8,48
2 2 P60709_ACTB_HUMAN ACTB 41,71 2,9599 Actin, cytoplasmic 1 No No 5,29
2 2 Q06830_PRDX1_HUMAN PRDX1 22,1 2,6919 Peroxiredoxin-1 no Yes 8,27
2 2 P62987_RL40_HUMAN UBA52 14,72 2,6031 Ubiquitin-60S ribosomal protein L40 No Yes 10,32
2 2 P01871_IGHM_HUMAN IGHM 49,28 2,1661 Ig mu chain C region Yes No 6,35
2 2 P01857_IGHG1_HUMAN IGHG1 36,08 1,8562 Ig gamma-1 chain C region Yes No 8,46
2 2 P22079_PERL_HUMAN LPO 80,24 1,8432 Lactoperoxidase Yes Yes 8,22
Band  14 (419.90-100 kDa)
Unique Total reference Gene SymbolMWT(kDa) AVG Name Glycosilated Phosphorilated Theoretical pI
3 3 P32119_PRDX2_HUMAN PRDX2 21,88 2,5682 Peroxiredoxin-2 No Yes 5,67
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Band (Molecular Weight)
Band A (9.92 kDa)
Unique Total reference Gene Symbol MWT(kDa) AVG Name Glycosilated Phosphorilated Theoretical pI
5 5 P02652_APOA2_HUMAN APOA2 11,17 2,342 Apolipoprotein A-II Yes Yes 5,05
3 3 P62805_H4_HUMAN HIST1H4A 11,36 2,3264 Histone H4 No Yes 6,92
2 3 P25311_ZA2G_HUMAN AZGP1 34,24 2,4307 Zinc-alpha-2-glycoprotein Yes No 5,58
2 2 P02656_APOC3_HUMAN APOC3 10,85 3,6804 Apolipoprotein C-III Yes No 4,72
2 2 Q15517_CDSN_HUMAN CDSN 51,49 2,8408 Corneodesmosin Yes No 8,48
2 2 P62736_ACTA_HUMAN ACTA2 41,98 2,695 Actin, aortic smooth muscle No No 5,24
2 2 P07355_ANXA2_HUMAN ANXA2 38,58 2,5419 Annexin A2 No Yes 7,56
2 2 P04004_VTNC_HUMAN VTN 54,27 2,5036 Vitronectin Yes Yes 5,47
Band B (15-10 kDa)
Unique Total reference Gene Symbol MWT(kDa) AVG Name Glycosilated Phosphorilated Theoretical pI
4 5 P01876_IGHA1_HUMAN IGHA1 37,63 2,0073 Ig alpha-1 chain C region Yes No 6,08
4 4 P07355_ANXA2_HUMAN ANXA2 38,58 2,9015 Annexin A2 No Yes 7,56
3 4 P62805_H4_HUMAN HIST1H4A 11,36 2,4374 Histone H4 No Yes 6,92
3 3 Q06830_PRDX1_HUMAN PRDX1 22,1 2,4926 Peroxiredoxin-1 No Yes 8,27
2 3 P02656_APOC3_HUMAN APOC3 10,85 3,5658 Apolipoprotein C-III Yes No 4,72
2 2 P62736_ACTA_HUMAN ACTA2 41,98 3,125 Actin, aortic smooth muscle No No 5,24
2 2 P04040_CATA_HUMAN CAT 59,72 3,1038 Catalase No Yes 6,9
2 2 P68104_EF1A1_HUMAN EEF1A1 50,11 2,7454 Elongation factor 1-alpha 1 No Yes 9,1
2 2 Q15517_CDSN_HUMAN CDSN 51,49 2,6414 Corneodesmosin Yes No 8,48
2 2 P00739_HPTR_HUMAN HPR 39 2,0836 Haptoglobin-related protein No No 6,63
Band C (16.85 kDa)
Unique Total reference Gene Symbol MWT(kDa) AVG Name Glycosilated Phosphorilated Theoretical pI
3 3 P62805_H4_HUMAN HIST1H4A 11,36 2,4162 Histone H4 No Yes 6,92
2 3 P62736_ACTA_HUMAN ACTA2 41,98 2,4165 Actin, aortic smooth muscle No No 5,24
2 3 P25311_ZA2G_HUMAN AZGP1 34,24 2,2842 Zinc-alpha-2-glycoprotein Yes No 5,58
2 2 P07355_ANXA2_HUMAN ANXA2 38,58 3,047 Annexin A2 No Yes 7,56
2 2 P04040_CATA_HUMAN CAT 59,72 2,888 Catalase No Yes 6,9
2 2 P06727_APOA4_HUMAN APOA4 45,37 2,2023 Apolipoprotein A-IV No Yes 5,28
2 2 Q06830_PRDX1_HUMAN PRDX1 22,1 2,147 Peroxiredoxin-1 No Yes 8,27
2 2 P01876_IGHA1_HUMAN IGHA1 37,63 2,0894 Ig alpha-1 chain C region Yes No 6,08
Band D (25.75 kDa)
Unique Total reference Gene Symbol MWT(kDa) AVG Name Glycosilated Phosphorilated Theoretical pI
13 14 P02647_APOA1_HUMAN APOA1 30,76 2,3067 Apolipoprotein A-I Yes Yes 5,56
5 5 P02649_APOE_HUMAN APOE 36,13 2,3816 Apolipoprotein E Yes Yes 5,65
2 2 P25311_ZA2G_HUMAN AZGP1 34,24 2,6118 Zinc-alpha-2-glycoprotein Yes No 5,58
2 2 P0CG05_LAC2_HUMAN IGLC2 11,29 2,2751 Ig lambda-2 chain C regions No No 6,91
2 2 P02753_RET4_HUMAN RBP4 23 2,1966 Retinol-binding protein 4 No No 5,76
2 2 P02741_CRP_HUMAN CRP 25,02 1,9988 C-reactive protein No No 5,28
Band E (27.69 kDa)
Unique Total reference Gene Symbol MWT(kDa) AVG Name Glycosilated Phosphorilated Theoretical pI
6 8 P02647_APOA1_HUMAN APOA1 30,76 2,6051 Apolipoprotein A-I Yes Yes 5,56
3 11 P01620_KV302_HUMAN N/A 11,77 2,7422 Ig kappa chain V-III region SIE No No 8,7
3 8 P0CG05_LAC2_HUMAN IGLC2 11,29 2,4896 Ig lambda-2 chain C regions No No 6,91
3 5 P01834_IGKC_HUMAN IGKC 11,6 3,2471 Ig kappa chain C region No No 5,58
3 4 P05090_APOD_HUMAN APOD 21,26 2,3681 Apolipoprotein D Yes No 5,2
3 3 P02649_APOE_HUMAN APOE 36,13 2,9672 Apolipoprotein E Yes Yes 5,65
3 3 P01024_CO3_HUMAN C3 187,03 2,744 Complement C3 Yes Yes 6,02
2 5 P04433_KV309_HUMAN N/A 12,57 1,9892 Ig kappa chain V-III region VG No No 4,85
2 3 B9A064_IGLL5_HUMAN IGLL5 23,05 1,8031 Immunoglobulin lambda-like polypeptide 5No No 9,08
2 2 P80748_LV302_HUMAN N/A 11,93 3,2919 Ig lambda chain V-III region LOI No No 5,24
2 2 P62736_ACTA_HUMAN ACTA2 41,98 2,8344 Actin, aortic smooth muscle No No 5,24
2 2 P07355_ANXA2_HUMAN ANXA2 38,58 2,7889 Annexin A2 No Yes 7,56
2 2 A0A075B6I0_A0A075B6I0_HUMANIGLV8-61 12,81 2,4474  Protein IGLV8-61 No No 4,33
2 2 Q15517_CDSN_HUMAN CDSN 51,49 2,3662 Corneodesmosin Yes No 8,48
Band F (42.35 kDa)
Unique Total reference Gene Symbol MWT(kDa) AVG Name Glycosilated Phosphorilated Theoretical pI
7 7 P01024_CO3_HUMAN C3 187,03 2,8446 Complement C3 Yes Yes 6,02
5 5 P07355_ANXA2_HUMAN ANXA2 38,58 2,9226 Annexin A2 No Yes 7,56
5 5 P62736_ACTA_HUMAN ACTA2 41,98 2,7345 Actin, aortic smooth muscle No No 5,24
5 5 P58107_EPIPL_HUMAN EPPK1 555,28 2,0454 Epiplakin No Yes 5,44
4 4 P06727_APOA4_HUMAN APOA4 45,37 2,6279 Apolipoprotein A-IV No Yes 5,28
4 4 P14618_KPYM_HUMAN PKM 57,9 2,2933 Pyruvate kinase PKM No Yes 7,96
3 3 P11142_HSP7C_HUMAN HSPA8 70,85 3,1422 Heat shock cognate 71 kDa protein No Yes 5,37
3 3 P10909_CLUS_HUMAN CLU 52,46 2,5307 Clusterin Yes Yes 5,89
3 3 P05090_APOD_HUMAN APOD 21,26 2,0713 Apolipoprotein D Yes No 5,2
2 3 P05120_PAI2_HUMAN SERPINB2 46,57 2,5033 Plasminogen activator inhibitor 2 Yes No 5,46
2 2 P02649_APOE_HUMAN APOE 36,13 3,0765 Apolipoprotein E Yes Yes 5,65
2 2 P60709_ACTB_HUMAN ACTB 41,71 2,8731 Actin, cytoplasmic 1 No No 5,29
2 2 P01834_IGKC_HUMAN IGKC 11,6 2,7535 Ig kappa chain C region No No 5,58
2 2 Q15517_CDSN_HUMAN CDSN 51,49 2,7387 Corneodesmosin Yes No 8,48
2 2 P02545_LMNA_HUMAN LMNA 74,09 2,6122 Prelamin-A/C No Yes 6,57
2 2 P25311_ZA2G_HUMAN AZGP1 34,24 2,513 Zinc-alpha-2-glycoprotein Yes No 5,58
2 2 Q01469_FABP5_HUMAN FABP5 15,15 2,4244 Fatty acid-binding protein, epidermal No Yes 6,82
2 2 Q06830_PRDX1_HUMAN PRDX1 22,1 2,3386 Peroxiredoxin-1 No Yes 8,27
2 2 P01857_IGHG1_HUMAN IGHG1 36,08 1,9261 Ig gamma-1 chain C region Yes No 8,46






Band G (37 kDa)
Unique Total reference Gene Symbol MWT(kDa) AVG Name Glycosilated Phosphorilated Theoretical pI
26 29 P06727_APOA4_HUMAN APOA4 45,37 2,6267 Apolipoprotein A-IV No Yes 5,28
7 8 P36955_PEDF_HUMAN SERPINF1 46,28 2,8146 Pigment epithelium-derived factor No Yes 5,9
5 5 P01024_CO3_HUMAN C3 187,03 2,283 Complement C3 Yes Yes 6,02
4 5 P25311_ZA2G_HUMAN AZGP1 34,24 2,1489 Zinc-alpha-2-glycoprotein Yes No 5,58
2 3 P62736_ACTA_HUMAN ACTA2 41,98 2,4681 Actin, aortic smooth muscle No No 5,24
2 2 P00738_HPT_HUMAN HP 45,18 3,4321 Haptoglobin Yes No 6,13
2 2 P01876_IGHA1_HUMAN IGHA1 37,63 2,4741 Ig alpha-1 chain C region Yes No 6,08
2 2 P62805_H4_HUMAN HIST1H4A 11,36 2,4341 Histone H4 No Yes 6,92
2 2 P01834_IGKC_HUMAN IGKC 11,6 2,3628 Ig kappa chain C region No No 5,58
2 2 P00739_HPTR_HUMAN HPR 39 2,3098 Haptoglobin-related protein No No 6,63
2 2 P07355_ANXA2_HUMAN ANXA2 38,58 2,2252 Annexin A2 No Yes 7,56
2 2 P0C0L4_CO4A_HUMAN C4A 192,66 2,2184 Complement C4-A Yes Yes 8,69
Band H (60.33-57.29 kDa)
Unique Total reference Gene Symbol MWT(kDa) AVG Name Glycosilated Phosphorilated Theoretical pI
6 13 P01857_IGHG1_HUMAN IGHG1 36,08 2,3199 Ig gamma-1 chain C region Yes No 8,46
5 5 P02774_VTDB_HUMAN GC 52,93 2,4576 Vitamin D-binding protein Yes No 5,22
5 5 P07355_ANXA2_HUMAN ANXA2 38,58 2,2551 Annexin A2 No Yes 7,56
4 4 P02750_A2GL_HUMAN LRG1 38,15 2,4623 Leucine-rich alpha-2-glycoprotein Yes No 5,66
3 3 P04083_ANXA1_HUMAN ANXA1 38,69 2,8449 Annexin A1 No Yes 6,64
3 3 Q15517_CDSN_HUMAN CDSN 51,49 2,2889 Corneodesmosin Yes No 8,48
3 3 P62736_ACTA_HUMAN ACTA2 41,98 2,1589 Actin, aortic smooth muscle No No 5,24
2 3 D6RF35_D6RF35_HUMAN GC 52,99 3,0592 Vitamin D-binding protein Yes No 5,22
2 2 P01009_A1AT_HUMAN SERPINA1 46,71 2,6654 Alpha-1-antitrypsin Yes Yes 5,37
2 2 P14618_KPYM_HUMAN PKM 57,9 2,5448 Pyruvate kinase PKM No Yes 7,96
2 2 P01008_ANT3_HUMAN SERPINC1 52,57 2,4676 Antithrombin-III Yes Yes 5,95
2 2 P62805_H4_HUMAN HIST1H4A 11,36 2,4642 Histone H4 No Yes 6,92
2 2 Q06830_PRDX1_HUMAN PRDX1 22,1 2,4474 Peroxiredoxin-1 No Yes 8,27
2 2 P00338_LDHA_HUMAN LDHA 36,67 2,2085 L-lactate dehydrogenase A chain No Yes 8,46
2 2 Q09666_AHNK_HUMAN AHNAK 628,7 1,7873 Neuroblast differentiation-associated protein AHNAKNo Yes 5,8
Band I (64.22 kDa)
Unique Total reference Gene Symbol MWT(kDa) AVG Name Glycosilated Phosphorilated Theoretical pI
8 15 P01857_IGHG1_HUMAN IGHG1 36,08 2,167 Ig gamma-1 chain C region Yes No 8,46
7 11 P01009_A1AT_HUMAN SERPINA1 46,71 2,5217 Alpha-1-antitrypsin Yes Yes 5,37
7 7 P01008_ANT3_HUMAN SERPINC1 52,57 2,4192 Antithrombin-III Yes Yes 5,95
6 6 P01042_KNG1_HUMAN KNG1 71,91 2,4042 Kininogen-1 Yes Yes 6,23
3 3 P01011_AACT_HUMAN SERPINA3 47,62 2,7549 Alpha-1-antichymotrypsin Yes No 5,32
3 3 P07355_ANXA2_HUMAN ANXA2 38,58 2,4555 Annexin A2 No Yes 7,56
3 3 P02774_VTDB_HUMAN GC 52,93 1,8523 Vitamin D-binding protein Yes No 5,22
2 2 P04040_CATA_HUMAN CAT 59,72 2,8906 Catalase No Yes 6,9
2 2 P01859_IGHG2_HUMAN IGHG2 35,88 2,6413 Ig gamma-2 chain C region Yes No 7,66
2 2 P01019_ANGT_HUMAN AGT 53,12 2,3912 Angiotensinogen Yes No 5,6
2 2 Q8WVV4_POF1B_HUMAN POF1B 68,02 2,285 Protein POF1B No No 5,89
2 2 P29622_KAIN_HUMAN SERPINA4 48,51 2,1073 Kallistatin Yes No 7,88
Band J (68.56 kDa)
Unique Total reference Gene Symbol MWT(kDa) AVG Name Glycosilated Phosphorilated Theoretical pI
42 205 ALBU_HUMAN ALB 69,32 2,5806 Serum albumin Yes Yes 5,67
25 38 P01024_CO3_HUMAN C3 187,03 3,2073 Complement C3 Yes Yes 6,02
7 8 P01876_IGHA1_HUMAN IGHA1 37,63 2,7968 Ig alpha-1 chain C region Yes No 6,08
7 7 P01011_AACT_HUMAN SERPINA3 47,62 2,5328 Alpha-1-antichymotrypsin Yes No 5,32
6 6 P01042_KNG1_HUMAN KNG1 71,91 2,3081 Kininogen-1 Yes Yes 6,23
4 4 P01009_A1AT_HUMAN SERPINA1 46,71 2,4943 Alpha-1-antitrypsin Yes Yes 5,37
3 5 P04004_VTNC_HUMAN VTN 54,27 3,1993 Vitronectin Yes Yes 5,47
3 4 Q9UK55_ZPI_HUMAN SERPINA10 50,67 1,9784 Protein Z-dependent protease inhibitorYes Yes 7,86
3 3 P07357_CO8A_HUMAN C8A 65,12 2,7801 Complement component C8 alpha chainYes No 5,74
3 3 P05546_HEP2_HUMAN SERPIND1 57,03 2,7666 Heparin cofactor 2 Yes Yes 6,26
3 3 P00751_CFAB_HUMAN CFB 85,48 2,6298 Complement factor B Yes Yes 6,66
3 3 P01019_ANGT_HUMAN AGT 53,12 2,4928 Angiotensinogen Yes No 5,6
3 3 P01008_ANT3_HUMAN SERPINC1 52,57 2,4026 Antithrombin-III Yes Yes 5,95
2 3 P02790_HEMO_HUMAN HPX 51,64 2,8289 Hemopexin Yes No 6,43
2 3 P01857_IGHG1_HUMAN IGHG1 36,08 2,2547 Ig gamma-1 chain C region Yes No 8,46
2 2 P04217_A1BG_HUMAN A1BG 54,22 3,0856 Alpha-1B-glycoprotein Yes No 5,63
2 2 P08697_A2AP_HUMAN SERPINF2 54,53 2,8708 Alpha-2-antiplasmin Yes No 5,87
2 2 P02748_CO9_HUMAN C9 63,13 2,4503 Complement component C9 Yes Yes 5,42
Band K (80.59 kDa)
Unique Total reference Gene Symbol MWT(kDa) AVG Name Glycosilated Phosphorilated Theoretical pI
22 28 ALBU_HUMAN ALB 69,32 2,8339 Serum albumin Yes Yes 5,67
12 17 P02787_TRFE_HUMAN TF 77,01 2,6687 Serotransferrin Yes Yes 6,7
5 5 P0C0L4_CO4A_HUMAN C4A 192,66 2,5952 Complement C4-A Yes Yes 8,69
5 5 P01024_CO3_HUMAN C3 187,03 2,1133 Complement C3 Yes Yes 6,02
4 4 P07355_ANXA2_HUMAN ANXA2 38,58 3,0065 Annexin A2 No Yes 7,56
4 4 P01871_IGHM_HUMAN IGHM 49,28 2,7208 Ig mu chain C region Yes No 6,35
4 4 Q06830_PRDX1_HUMAN PRDX1 22,1 2,1254 Peroxiredoxin-1 No Yes 8,27
3 4 P19827_ITIH1_HUMAN ITIH1 101,33 2,8163 Inter-alpha-trypsin inhibitor heavy chain H1Yes Yes 6,33
3 3 P04040_CATA_HUMAN CAT 59,72 2,8886 Catalase No Yes 6,9
3 3 P11021_GRP78_HUMAN HSPA5 72,29 2,6456 78 kDa glucose-regulated protein No Yes 5,01
3 3 P14618_KPYM_HUMAN PKM 57,9 2,5963 Pyruvate kinase PKM No Yes 7,96
3 3 P62736_ACTA_HUMAN ACTA2 41,98 2,4646 Actin, aortic smooth muscle No No 5,24
3 3 P35858_ALS_HUMAN IGFALS 65,99 2,381 Insulin-like growth factor-binding protein complex acid labile subunitYes No 6,13
2 3 P0CG05_LAC2_HUMAN IGLC2 11,29 2,6202 Ig lambda-2 chain C regions No No 6,91
2 3 P01857_IGHG1_HUMAN IGHG1 36,08 2,4045 Ig gamma-1 chain C region Yes No 8,46
2 2 P04406_G3P_HUMAN GAPDH 36,03 2,8102 Glyceraldehyde-3-phosphate dehydrogenaseNo Yes 8,58
2 2 P62805_H4_HUMAN HIST1H4A 11,36 2,5488 Histone H4 No Yes 6,92
2 2 P60709_ACTB_HUMAN ACTB 41,71 2,548 Actin, cytoplasmic 1 No No 5,29
2 2 P04217_A1BG_HUMAN A1BG 54,22 2,3784 Alpha-1B-glycoprotein Yes No 5,63
2 2 P00748_FA12_HUMAN F12 67,75 2,3583 Coagulation factor XII Yes No 9
2 2 P32119_PRDX2_HUMAN PRDX2 21,88 2,3523 Peroxiredoxin-2 No Yes 5,67







Band L (97. 78 kDa)
Unique Total reference Gene Symbol MWT(kDa) AVG Name Glycosilated Phosphorilated Theoretical pI
19 26 P00751_CFAB_HUMAN CFB 85,48 2,7159 Complement factor B Yes Yes 6,66
18 21 P06396_GELS_HUMAN GSN 85,64 3,0827 Gelsolin No Yes 5,72
12 13 P02787_TRFE_HUMAN TF 77,01 2,7462 Serotransferrin Yes Yes 6,7
8 8 P10643_CO7_HUMAN C7 93,46 3,2664 Complement component C7 Yes No 6,09
8 8 P01024_CO3_HUMAN C3 187,03 2,7986 Complement C3 Yes Yes 6,02
7 7 P02647_APOA1_HUMAN APOA1 30,76 2,6728 Apolipoprotein A-I Yes Yes 5,56
5 5 P00747_PLMN_HUMAN PLG 90,51 2,5247 Plasminogen Yes Yes 7,08
4 4 P05155_IC1_HUMAN SERPING1 55,12 2,9395 Plasma protease C1 inhibitor Yes No 5,97
4 4 P01876_IGHA1_HUMAN IGHA1 37,63 2,9392 Ig alpha-1 chain C region Yes No 6,08
4 4 P04196_HRG_HUMAN HRG 59,54 2,6948 Histidine-rich glycoprotein Yes No 7,03
4 4 P62987_RL40_HUMAN UBA52 14,72 2,6069 Ubiquitin-60S ribosomal protein L40 No Yes 10,32
3 3 P0C0L4_CO4A_HUMAN C4A 192,66 3,7044 Complement C4-A Yes Yes 8,69
3 3 P07355_ANXA2_HUMAN ANXA2 38,58 3,1485 Annexin A2 No Yes 7,56
3 3 P01008_ANT3_HUMAN SERPINC1 52,57 3,0063 Antithrombin-III Yes Yes 5,95
3 3 P01009_A1AT_HUMAN SERPINA1 46,71 2,7982 Alpha-1-antitrypsin Yes Yes 5,37
3 3 P35858_ALS_HUMAN IGFALS 65,99 2,3455 Insulin-like growth factor-binding protein complex acid labile subunitYes No 6,13
2 3 P62736_ACTA_HUMAN ACTA2 41,98 2,9927 Actin, aortic smooth muscle No No 5,24
2 2 P32119_PRDX2_HUMAN PRDX2 21,88 3,3941 Peroxiredoxin-2 No Yes 5,67
2 2 P04406_G3P_HUMAN GAPDH 36,03 3,192 Glyceraldehyde-3-phosphate dehydrogenaseNo Yes 8,58
2 2 Q14624_ITIH4_HUMAN ITIH4 103,29 3,0969 Inter-alpha-trypsin inhibitor heavy chain H4Yes No 5,92
2 2 P01834_IGKC_HUMAN IGKC 11,6 2,8158 Ig kappa chain C region No No 5,58
2 2 P01857_IGHG1_HUMAN IGHG1 36,08 2,7294 Ig gamma-1 chain C region Yes No 8,46
2 2 Q15517_CDSN_HUMAN CDSN 51,49 2,61 Corneodesmosin Yes No 8,48
2 2 P68104_EF1A1_HUMAN EEF1A1 50,11 2,5645 Elongation factor 1-alpha 1 No Yes 9,1
2 2 Q06830_PRDX1_HUMAN PRDX1 22,1 2,3286 Peroxiredoxin-1 No Yes 8,27
2 2 P25311_ZA2G_HUMAN AZGP1 34,24 2,3194 Zinc-alpha-2-glycoprotein Yes No 5,58
2 2 P01042_KNG1_HUMAN KNG1 71,91 2,2734 Kininogen-1 Yes Yes 6,23
2 2 O95969_SG1D2_HUMAN SCGB1D2 9,92 2,1734 Secretoglobin family 1D member 2 No No 8,58
2 2 P05546_HEP2_HUMAN SERPIND1 57,03 2,1458 Heparin cofactor 2 Yes Yes 6,26
Band M (121.17 kDa)
Unique Total reference Gene Symbol MWT(kDa) AVG Name Glycosilated Phosphorilated Theoretical pI
14 17 P01024_CO3_HUMAN C3 187,03 2,5075 Complement C3 Yes Yes 6,02
4 7 P08123_CO1A2_HUMAN COL1A2 129,24 1,772 Collagen alpha-2(I) chain Yes No 10,05
4 4 P00751_CFAB_HUMAN CFB 85,48 2,5645 Complement factor B Yes Yes 6,66
3 3 P07355_ANXA2_HUMAN ANXA2 38,58 2,9254 Annexin A2 No Yes 7,56
3 3 P62736_ACTA_HUMAN ACTA2 41,98 2,7457 Actin, aortic smooth muscle No No 5,24
3 3 P04040_CATA_HUMAN CAT 59,72 2,4404 Catalase No Yes 6,9
3 3 P19823_ITIH2_HUMAN ITIH2 106,4 2,3018 Inter-alpha-trypsin inhibitor heavy chain H2Yes Yes 5,75
3 3 P06396_GELS_HUMAN GSN 85,64 1,7724 Gelsolin No Yes 5,72
2 3 P19827_ITIH1_HUMAN ITIH1 101,33 3,1176 Inter-alpha-trypsin inhibitor heavy chain H1Yes Yes 6,33
2 3 Q15517_CDSN_HUMAN CDSN 51,49 2,8024 Corneodesmosin Yes No 8,48
2 2 P60709_ACTB_HUMAN ACTB 41,71 2,654 Actin, cytoplasmic 1 No No 5,29
2 2 P14618_KPYM_HUMAN PKM 57,9 2,4082 Pyruvate kinase PKM No Yes 7,96
2 2 P04083_ANXA1_HUMAN ANXA1 38,69 2,1776 Annexin A1 No Yes 10,05
2 2 P02452_CO1A1_HUMAN COL1A1 138,86 2,0353 Collagen alpha-1(I) chain Yes Yes 9,29
Band N ( 139.95-250 kDa)
Unique Total reference Gene Symbol MWT(kDa) AVG Name Glycosilated Phosphorilated Theoretical pI
2 3 P19827_ITIH1_HUMAN ITIH1 101,33 2,8192 Inter-alpha-trypsin inhibitor heavy chain H1Yes Yes 6,33
2 3 Q6UWP8_SBSN_HUMAN SBSN 60,5 2,4999 Suprabasin No No 6,45






Supplemental Figure 1. Overlay of the gels visualizing the Cy3 and Cy5 labeled 
WSS and HS proteins, resp., adsorbed to HA. Lane 1, MW standard (after silver 
staining of the same gel); lane 2, WSS; lane 3, HS; lanes 4-6: WSS:HS at 1:1, 9:1 and 







Supplemental Figure 2. Black and white versions of the Cy3 and Cy5 labeled WSS 
and HS protein gels shown in Supplemental Fig. 1. The boxed proteins were 
selected for densitometric analysis. Proteins identified in the boxed are indicated. * 
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ABSTRACT 
Although the mature dental biofilm composition is well studied, there is very little 
information on the earliest phase of in vivo tooth colonization. Progress in dental 
biofilm collection methodologies and techniques of large-scale microbial 
identification have made new studies in this field of oral biology feasible. The aim 
of this study was to characterize the temporal changes and diversity of the 
cultivable and non-cultivable microbes in the early dental biofilm. Samples of 
early dental biofilm were collected from 11 healthy subjects at 0, 2, 4 and 6 hours 
after removal of plaque and pellicle from tooth surfaces. With the semi-
quantitative HOMIM technique, which is based on 16S rRNA sequence 
hybridizations, plaque samples were analyzed with the currently available 407 
HOMIM microbial probes. This led to the identification of at least 92 species with 
streptococci being the most abundant bacteria across all time points in all 
subjects. High frequency detection was furthermore made with Haemophilus 
parainfluenzae, Gemella haemolysans, Slackia exigua and Rothia species. 
Abundance changes over time were noted for S. anginosus or S. intermedius 
(p=0.02), S. mitis bv2 (p=0.0002), S. oralis (p=0.0002) and Streptococcus Cluster 
I (p=0.003) and G. haemolysans (p=0.0005) and S. maltophilia (p=0.02). Among 
the currently uncultivable microbiota, eight phylotypes were detected in the early 
stages of biofilm formation, one belonging to the TM7 division, which has 
attracted attention due to its potential association with periodontal disease.  
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INTRODUCTION 
 The microbial diversity in the oral cavity is among the largest so far 
characterized in the human body (Human Microbiome Project, 2012). Of specific 
interest is the dental biofilm which forms first by selective adsorption of bacteria 
from saliva onto the tooth surface followed by bacterial growth. It is well known 
that biofilm microbes interact with each other and thus showing significant 
different characteristics from their planktonic counterparts (Marsh and Bradshaw, 
1995). While the biofilm contains beneficial as well as harmful bacteria, their 
relative proportions have a tendency to change as dental plaque matures 
(Haffajee et al., 2009). These changes depend on bacterial interactions as well 
as host-derived factors, which are all responsible for the ensuing development 
and biological effects of this structure (Rosan and Lamont, 2000). The very first 
microbial settlers of tooth surfaces are critical for the maturation process of 
dental plaque. As such, they are likely to play an unanticipated role in 
pathological conditions associated with oral biofilm formation such as caries and 
periodontal disease. Understanding the earliest but most critical steps in the 
progression of disease involves identification, timing and quantitation of the total 
dental microbiome, an important goal yet to be achieved.  
 It has been well established that enamel tooth surfaces are immediately 
covered with a layer of salivary proteins upon exposure to the oral environment. 
This layer, which is called the acquired enamel pellicle, is several microns in 
thickness (Meckel, 1965; Meckel et al., 1965; Armstrong, 1968). It is formed by 
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the selective adsorption of mostly phosphorylated salivary proteins (Oppenheim 
et al., 1971; Hay, 1973a; b). The earliest phase of bacterial biofilm formation is 
the attachment of oral bacteria, via specific molecular interactions, to the 
acquired enamel pellicle (Gibbons et al., 1976; Gibbons et al., 1983; 
Scannapieco, 1994). This permits the attached bacteria to remain attached on 
tooth surfaces despite the mechanical forces of salivary flow, tongue movements 
and rinsing with water. The first insights into the early biofilm composition, 
obtained with culture-based techniques, have shown that streptococci, as well as 
Neisseria, and Rothia species are the predominant early colonizers. Streptococci 
express adhesins, specifically α-amylase-binding protein A, Antigen I/II, 
SspA/SspB and surface lectins that recognize receptors on proteins in the 
acquired enamel pellicle (Nobbs et al., 2009). As plaque matures, the proportions 
of facultative and anaerobic filamentous genera, such as Actinomyces, 
Corynebacterium, Fusobacterium, and Veillonella, increase gradually (Ritz, 1967; 
Socransky et al., 1977; Syed and Loesche, 1978; Theilade et al., 1982; Nyvad 
and Kilian, 1987; 1990). Streptococci coaggregate within and between species 
involving e.g. receptor polysaccharides and type 2 fimbriae expressed by 
Actinomyces (Palmer et al., 2003; Kolenbrander et al., 2006; Ruhl et al., 2014). 
The multiple affinity properties of streptococci confer advantageous 
characteristics to this genus and explain their dominance as the initial colonizing 
bacteria of the tooth surface (Kolenbrander et al., 1993; Li et al., 2004a).  
While valuable insights were obtained with the relatively few biofilm bacteria 
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which could be cultured at that time, inevitably the true microbial complexity of 
the biofilm structure could not be fully established. More recently developed 
molecular techniques have not only expanded our ability to uncover the 
complexity of colonizing microbial communities, but also to identify the non-
cultivable species (Diaz et al., 2006; Langfeldt et al., 2014). We have previously 
used the “checkerboard assay” employing whole genomic probes, limited to 
detecting cultivable bacteria (Li et al., 2004a). The successive adhesion pattern 
of 40 species was characterized and the different species contributions were 
quantitated.  Porphyromonas gingivalis and Treponema denticola were found to 
be among the early colonizers but were rapidly superseded by streptococci and 
Actinomyces sp. The microbial complexity of oral biofilm has also been studied in 
plaque formed in situ on retrievable enamel chips using a 16S rDNA-based 
pyrosequencing approach, identifying at least 97 different species and some 
phylotypes. Of special note is the fact that non-cultivable species were found for 
the first time in this study and they were tentatively assigned to Clostridia and 
Flavobacteria (Diaz et al., 2006).  
The knowledge gained on mature in vivo formed oral biofilm, using cultivation 
and DNA-based approaches, is considerable (Teles et al., 2012; Langfeldt et al., 
2014; Takeshita et al., 2015). Much less information, however, is available on the 
earliest phases of biofilm formation and its non-cultivable bacterial fraction. In the 
present study we harvested in vivo biofilms formed during the very early phases 
(< 6 hr) of microbial attachment to the tooth surfaces. Bacterial growth during this 
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time interval is limited and the focus of this study is on the very first bacteria that 
interact with the pellicle proteins. The Human Oral Microbiome Identification 
Microarray (HOMIM) was employed, using 407 microbial probes distinguishing 
over 300 cultivable as well as non-cultivable species. The data obtained reveal 
the microbial composition of the very early stage of biofilm formation and 
provided in depth information regarding its temporal development.  
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MATERIAL AND METHODS 
Subject Population  
Early dental biofilms were collected from 11 healthy subjects. All subjects 
provided informed consent prior to their participation. The study was conducted 
according to the principles outlined in the Declaration of Helsinki on 
experimentation involving human subjects. The study protocol was approved by 
the Institutional Review Board of Boston University Medical Center. The subjects 
were screened using oral and systemic health histories. Exclusion criteria were: 
a) overt signs of gingivitis, periodontal disease, active dental caries, or any other 
oral condition that could affect oral fluid/biofilm composition; b) fewer than 14 
teeth, c) history of antibiotics use in the past 3 months; d) long term use of anti-
inflammatory medication; e) current smokers; f) pregnancy; g) presence of 
systemic diseases that could affect oral health; and h) systemic medications and 
treatments that could affect salivary function. Clinical examinations took place on 
different days of the same week at the Clinical Research Center at the School of 
Dental Medicine of Boston University. All clinical exams were performed once at 
baseline by the same trained and calibrated periodontist. Measurements were 
taken at 6 sites per tooth (mesio-buccal, buccal, disto-buccal, mesio-lingual, 
lingual and disto-lingual) for all teeth, except third molars, and included: probing 
depth (PD) and clinical attachment level (CAL), measured to the nearest 
millimeter with a periodontal probe (UNC-15, Hu-Friedy, Chicago, IL, USA), and 
presence or absence of bleeding on probing (BOP), supragingival visible plaque 
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(PL), gingival marginal bleeding (GI), and suppuration. Clinical diagnosis of 
periodontal health (PH) was established for all subjects based on the following 
criteria: ≤ 10% of sites with BOP, and no PD or CAL > 3 mm, although PD or 
CAL = 4 mm in not more than 5% of the sites without BOP were allowed.  
 
Sample Collection and Processing 
 The buccal tooth surfaces in both arches, excluding second and third 
molars, were thoroughly cleaned to remove the acquired enamel pellicle and 
dental plaque using a prophylaxis hand piece with rubber cup and dental pumice 
containing no additives (Preppies, Whip Mix, Louisville, KY) (Yao et al., 2001). 
This was followed by in vivo exposure to the oral environment for either 0, 2, 4 or 
6 hours. At each of these four time points biofilm was collected. The samples 
were acquired on two different days within the same week. The 0 and 6 hour 
samples were collected on day 1, and the 2 and 4 hour samples were collected 
on day 2. During the biofilm formation phase, subjects were asked to refrain from 
eating, drinking (except water) or oral hygiene. For harvesting biofilm, teeth were 
isolated from the buccal/labial mucosa with cotton rolls to avoid contact between 
tooth surfaces and the oral mucosa. The collection area was rinsed twice with 
distilled water and dried with air. Polyvinylidene fluoride (PVDF) membranes (45 
µm pore size, 13 mm diameter; Durapore; Millipore, Bedford, MA, USA) soaked 
in 0.5 mol/L sodium bicarbonate, pH 8.4 were used to swab the coronal two-
thirds of buccal dental surfaces of incisors, canines, pre-molars and first molars 
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of both arches while applying mild pressure (Figure 1). Sodium bicarbonate has 
previously been shown to be effective in releasing proteinaceous materials 
adsorbed onto tooth surfaces (Li et al., 2004a). The pooled membranes (four 
membranes per time point per subject) were placed into 300 µl of TE buffer (50 
mM Tris-HCl, 0.1 mM EDTA, pH 7.6), followed by vortexing for 30 sec and 
sonication for 5 min. DNA isolation was performed using the Ready-Lyse™ 
Lysozyme Solution and the MasterPure DNA Purification Kit (both from 
Epicentre, Madison, WI) following the manufacturers’ instructions. The samples 




Figure 1. Dental biofilm collection procedure. For biofilm collection one folded 
Polyvinylidene fluoride (PVDF) membrane pre-soaked in 0.5 mol/L sodium bicarbonate, 
pH 8.4 was used to swab the coronal two-thirds of buccal dental surfaces of incisors, 
canines, pre-molars and first molars of both arches while applying mild pressure.  For 
each quadrant 1 fresh membrane was used. . 
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Microbiological Assessment and Quantitation 
Purified DNA samples were analyzed using the Human Oral Microbe 
Identification Microarray (HOMIM) (Colombo et al., 2009). For microbial 
identification a library of 407 probes was used recognizing the most prevalent 
oral bacterial species. Briefly, 16S rRNA-based, reverse-capture oligonucleotide 
probes (typically 18 to 20 bases) were printed on aldehyde-coated glass slides. 
The 16S rRNA genes were PCR-amplified from DNA extracts using 16S rRNA 
universal forward and reverse primers and labeled via incorporation of Cy3-dCTP 
in a second PCR amplification. The labeled 16S rRNA amplicons were hybridized 
for 16 h with probes on the custom made arrays. After washing, the microarray 
slides were scanned using an Axon 4000B scanner and the raw data were 
extracted using the GenePix Pro software (GenePix, MDS Analytical 
Technologies, Sunnyvale, CA). The abundance of each species/phylotypes 
interrogated by the array was then assigned an ordinal, non-linear HOMIM score 
from 0 to 5 using an online analysis tool (http://bioinformatics.forsyth.org/homim), 
where a score of 0 indicates a fluorescent signal that is less than two times the 
background level and a score of 5 corresponds to the average maximum 
intensity of a set of universal positive control probes.  
 
Statistical Analyses  
Statistical analyses were performed using the R software program for 
statistical computing (version 2.15.1). The Wilcoxon's signed-rank test (as 
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defined in the 'wilcox.test' R function) was used to determine across all subjects 
whether the abundance of a given species/phylotype was significantly different 
between two time points. Spearman's correlation coefficient (rho) and its 
associated p value (as computed using the 'cor.test' R function) were used to 
identify species whose abundance was significantly associated with specific time 
points, both within each subject and across all subjects. The rho value measures 
how well the amount of a given species in a given subject correlates with the 
amount of time that has elapsed, e.g., a rho value of +1 or -1 means that the 
HOMIM scores increased or decreased, respectively, at each and every time 
point, during the 6 h biofilm development time. A species with a rho of 0 (no 
correlation) would have discrete HOMIM scores that show high levels of variation 
over time, whereas a species with an undefined rho would have HOMIM scores 
that are unchanged over time (e.g., always 0, always 1, etc.). Correction for 
multiple hypothesis testing was accomplished using the Benjamini-Hochberg 
false discovery rate (FDR). The level of significance for each test was set at 5%. 
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RESULTS 
Demographic and clinical parameters 
The demographics and clinical parameters determined for the enrolled 
subjects are shown in Supplemental Table 1. The periodontal measures 
obtained, CAL, PD and BOP, were consistent with periodontal health according 
to reported criteria (Armitage, 1999).  
 
Microbial characterization and prevalence 
Early biofilms from the 11 subjects were obtained after 0, 2, 4 and 6 hours 
biofilm maturation times, and evaluated by HOMIM. Of the possible 407 target 
probes, 124 hybridized with PCR products from the DNA samples obtained 
(HOMIM score ≥ 1; Supplemental Table 2). In view of the multi-targeting by some 
probes it was established that the 124 probes represented at least 92 different 
oral species. Among the 124 probes 47 showed a HOMIM score of >2 in at least 
one of the 11 subjects (Figure 2). The identified bacteria primarily belonged to 
the phyla Firmicutes (42.2%), followed by Protobacteria (25.6%) and 
Actinobacteria (16.5%). Less prevalent bacteria belonged to the phyla 
Bacteroidetes (8.26%), Fusobacteria (4.96%), Synergistetes (0.83%) and TM7 
(0.83%). As expected, streptococci (S. oralis, S. anginosus/intermedius and S. 
mitis) were the most abundant across all time points in all subjects. Together with 
the streptococci, species of Gemella haemolysans, Haemophilus parainfluenzae, 
Actinomyces cluster I (A. meyeri, A. viscosus, A. odontolyticus, A. oricola), 
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Rothia dentocariosa/mucilaginosa, Neisseria cluster II (Neisseria oralis, Neisseria 
flava, Neisseria mucosa, Neisseria sicca), Kingella oralis, Slackia exigua and 
Veillonella atypica/parvula were the fifteen predominant bacteria identified in 
dental biofilm formed during the first 6 hours (Figure 2; Supplemental Table 2). 
 Species belonging to the “orange complex“ (Socransky et al., 1998) 
comprising Fusobacterium nucleatum, F. periodontium and Parvimonas micra 
were also found to be present in the early dental biofilm. This is consistent with 
previous studies (Li et al., 2004a), although we could not confirm the presence of 
well-established periodontal pathogens such as Porphyromonas gingivalis and 
Aggregatibacter actinomycetemcomitans. Fastidious and not-yet-cultivated 
species, more recently associated with periodontal disease, Filifactor alocis, 
Dialister invisus and TM7 [G-1] OT 347 (Kumar et al., 2003; Perez-Chaparro et 
al., 2014), were present in low numbers. The typical cariogenic bacterium S. 
mutans was detected in the early biofilm of two of the 11 individuals. 







Figure 2. Intensity map of the distribution of bacterial species in each subject, and 
the mean across all subjects, after 0, 2, 4 and 6 hours of biofilm formation. The 
image shows the intensity of the 47 probes (rows) with a maximum HOMIM score >2 in 
at least one sample. Species are sorted in descending order by mean HOMIM score. 
The different intensities of green correspond to signal intensities of the arrays, 
quantitated by HOMIM scores 0–5. Gray indicates missing data for the 6 hr samples in 2 
subjects. Probes are labeled with species descriptors, followed by HOMD oral taxa in 
parentheses. F. = Fusobacterium, L. = Leptotrichia, S. sanguinegens = Sneathia 
sanguinegens, all other S. = Streptococcus. 
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Changes in abundance over time 
 
Temporal changes of bacterial prevalence and proportions during the first 
six hours of biofilm formation were assessed by computing the Spearman 
correlation coefficient (rho), which measures how well the amount of a given 
species correlates with the time of enamel exposure to the oral environment 
(Supplemental Table 3). Among these species, significant increases in rho 
values over time were noted for G. haemolysans (p=0.0005), S. anginosus or S. 
intermedius (p=0.02), S. mitis bv2 (p=0.0002), S. oralis (p=0.0002) and 
Streptococcus Cluster I (p=0.003). Significant decreases over time were 
observed for Stenotrophomonas maltophilia (p=0.02). When corrected for 
multiple hypothesis testing across all probes (Supplemental Table 3) the rho 
values of G. haemolysans and S. oralis remained strongly significant (FDR q < 
0.25), indicating that these species are likely to play important roles during dental 
biofilm maturation and possibly microbial coaggregation. A heat map of the Rho 
values of the 47 most abundant species is shown in Figure 3, and values are 
shown in Supplemental Table 3. While trends of increases and decreases could 
clearly be observed for some of the bacteria listed, they were only significant for 
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Figure 3. Heat map showing changes in bacterial intensities in the early biofilm 
over time. Shown are the results for the 47 probes with the highest level of abundance 
(maximum HOMIM score >2 across all samples). Each column represents one subject, 
and each cell indicates Spearman's correlation coefficient (rho) of the HOMIM scores for 
a given species in a given subject with the four time points of biofilm formation. Red and 
blue indicate rho values of +1 and -1, respectively, indicating that the proportion of a 
given species continuously increased or decreased, respectively. White indicates a rho 
value of 0, indicating that the scores showed no pattern of increase or decrease over 
time. Gray indicates that all HOMIM scores for a given species in a given subject were 
identical and rho is undefined. All of the available timepoints for each subject (3 or 4) 
were used to compute the correlation coefficient within that subject. Probes are labeled 
with species descriptors, followed by HOMD oral taxa in parentheses. F. = 
Fusobacterium, L. = Leptotrichia, S. sanguinegens = Sneathia sanguinegens, all other S. 
= Streptococcus. Spearman's correlation coefficients were also computed for each 
species with respect to time points across all samples in each row, and probes with 
across subject rho values significantly different from zero (p < 0.05) are indicated with an 
asterisk. 
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Identification of not-yet-cultivated phylotypes 
The HOMIM technology offers the opportunity to detect not only those 
species that can be cultured, but also those that have escaped identification so 
far by in vitro culturing approaches. Table 1 shows the prevalence of uncultivable 
species found among the 11 subjects (HOMIM score of ≥ 1). Eight not-yet-
cultivated phylotypes were detected, including species belonging to the 
candidate bacterial division TM7. All non-cultivable phylotypes detected exhibited 
low HOMIM score (≤ 2), except for Actinomyces sp. OT 177 which showed a 
HOMIM score of 3 at one time-point (Supplemental Table 2). It was also the most 
prevalent since it was detected at all time points, in at least half of the subjects 
(Table 1). The other phylotypes were detected in less than 25% of the subjects, 
at all time points examined. Overall, the data reveal that these non-cultivable 
species constitute a small but integral part of the early biofilm. 
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Table 1. Not yet cultivated species identified in the dental biofilm samples1 
 
  
  89 
DISCUSSION 
 The results obtained show that the early in vivo dental biofilm exhibits 
considerable bacterial diversity. A total of 124 probes reacted positively, giving 
evidence for the presence of a minimum of 92 bacterial species, belonging to 40 
genera and 7 phyla. Furthermore, for the first time, we report on the presence of 
non-cultivable species in this native tooth surface biofilm. 
Overall, a very good consistency was observed in oral colonization among 
subjects, whether the species were prevalent or not, as evidenced by the 
abundancy gradient of the mean values among subjects (right column, Figure 2). 
As expected, the streptococci were the most abundant at all time points. Within 
the bacteria that showed significant increases over time were the well-known 
early colonizers S. oralis, S. anginosus and S. intermedius (Figure 3). For these 
streptococci the attachment mechanisms to the acquired enamel pellicle has 
been related to acidic proline-rich proteins, α-amylase, and various glycoproteins 
(Abeygunawardana et al., 1991; Gibbons et al., 1991; Murray et al., 1992; 
Scannapieco et al., 1995; Ruhl et al., 2004). Importantly, these streptococci are 
able to proliferate in the presence of oxygen, a characteristic only of the early 
biofilm environment.  
At the 2h time point, and in subsequent time points, Gemella haemolysans was 
among the ten most prevalent bacteria. What sets this species apart from most of 
the other prevalent early colonizers is that its rho value for increase over time 
was highly significant (FDR q < 0.25). Gemella haemolysans has previously been 
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identified by classic cultivation methods (Nyvad and Kilian, 1987) and is 
considered to be among the core healthy microbial colonizers of in situ dental 
biofilm (Diaz et al., 2006). In this study we identified this species in in vivo biofilm, 
and already in the very earliest phases of biofilm formation. The potential role 
that Gemella plays in biofilm processes such as coaggregation and symbiosis, or 
even in disease promotion, remains to be established.  
At the 4h time point, Haemophilus parainfluenzae was among the first non-
streptococcal species to appear, with a high mean HOMIM score of 3 (Figure 2 
and supplemental Table 2). The early appearance of H. parainfluenzae can be 
explained by its adherence characteristics (Liljemark, 1985; Whittaker et al., 
1996) since it displays a high affinity for salivary mucin MG1 (Veerman et al., 
1995) present in the acquired enamel pellicle (Al-Hashimi and Levine, 1989). 
Furthermore H. parainfluenzae has been shown to coaggregate with S. sanguis 
and S. oralis, due to its outer membrane adhesin that recognizes specific 
receptor polysaccharides (Liljemark et al., 1988; Lai et al., 1990; Liljemark et al., 
1992; Kolenbrander et al., 2002). 
The 6 h samples revealed what could be considered the key colonizers of early 
in vivo formed biofilm. In order of abundance these colonizers are Streptococcus 
oralis, Haemophilus parainfluenzae, Gemella haemolysans, Streptococcus 
sanguinis, Streptococcus anginosus/ intermedius, Slackia exigua, Streptococcus 
gordonii and Rothia dentocariosa/mucilaginosa. Surprisingly, the not much 
studied Slackia exigua was found to be among the most abundant colonizers of 
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all subjects at all time points, with a mean HOMIM score across time points of 1.9 
(Supplemental Table 2). Typically associated with endodontic (Hashimura et al., 
2001) and periodontal lesions (Moore et al., 1983) this species is fastidious and 
grows poorly (Kim et al., 2010) and may therefore have been easily overlooked in 
previous culture-based studies. The key colonizers identified here form the 
substratum for the developing biofilm architecture. This structure has been 
shown to form in an orchestrated fashion (Kolenbrander et al., 2002) and is 
capable to impact oral health adversely.  
 It has been estimated that at least 35% of the 700 bacterial species in the 
oral cavity cannot be grown in culture at this time (Aas et al., 2005; Dewhirst et 
al., 2010). The identification of both cultivable and not-yet-cultivable bacterial 
species in biofilm structures is equally important and critical for understanding the 
complete bacterial “interactome” of dental colonizers. The elegant work of Diaz 
and coworkers, although not using an in vivo but an in situ approach, provided 
evidence for uncultivable species in the early biofilm belonging to Firmicutes and 
Bacteroidetes phyla, with tentative class assignments to Clostridia and 
Flavobacteria, respectively (Diaz et al., 2006). In our in vivo investigation we 
found eight uncultivable phylotypes, and were able to make a more definitive 
genus level assignment (Table 2). They are Bergeyella sp., Haemophilus sp., 
Fretibacterium sp., TM7 sp., Actinomyces sp., Megasphaera sp. and 
Stomatobaculum sp.  
It is well recognized that there are many qualities of oral biofilm that can lead to 
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the development or suppression of biofilm-induced pathogenicity (Heller et al., 
2012; Lourenco et al., 2014; Whitmore and Lamont, 2011). The presence of a 
few uncultivable species such as TM7, could be highly significant for the 
manifestation of oral diseases, particularly periodontal disease (Camelo-Castillo 
et al., 2015). In the recently proposed polymicrobial synergy and dysbiosis model 
for periodontitis, the disease is caused ultimately by a dysbiotic change in the 
biofilm microbiota that triggers an inflammatory host response (Hajishengallis 
and Lamont, 2012). This model contends that commensal oral microbes can be 
“accessory pathogens” (Whitmore and Lamont, 2011), since such non-
pathogenic species can provide biofilm conditions favoring an increase of 
periodontal pathogens leading to disease manifestation. Uncultivable dental 
biofilm microbes such as Actinomyces sp OT 177 identified here and shown to 
be present at all time points, may play hitherto unappreciated roles by 
contributing to disease initiation, serving as triggers, or suppression by similar 
dysbiotic mechanisms. 
While the HOMIM approach has significantly expanded our knowledge on 
the temporal relationship of bacterial attachment, it doesn’t allow us to decipher 
directly the spatial relationships among the bacterial species investigated. Some 
insight on the spatial relationships of mature biofilm structures have been 
obtained using electron microscopy techniques and more recently confocal laser 
scanning microscopy (CLSM), fluorescence in vitro hybridization and the recent 
state-of-the-art combinatorial labeling and spectral imaging methodology 
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(CLASI)-FISH (Dige et al., 2007; Zijnge et al., 2010;Valm et al., 2011). The use of 
such techniques will be necessary in order to gain insight into the 3-dimensional 
architecture of the biofilm.  
In summary, this study has provided an in-depth microbial characterization 
of the in vivo dental biofilm formed over the first 6 hours of development. It has 
yielded the first microbial identifications at the genus-level of the not yet 
cultivable microbes and has provided semi-quantitative insights into their 
abundance in the incipient oral biofilm. It is obvious that the functional properties 
of these microorganisms in the oral biofilm environment are of high interest from 
a clinical and disease preventive perspective. While one strategy would be to 
prevent growth conditions favoring detrimental bacteria, other pursuits will require 
a more detailed knowledge pertaining to the cultivating and co-cultivating of all 
biofilm inhabitants (Jenkinson and Lamont, 2005; Soro et al., 2014; Oberhardt et 
al., 2015; Thompson et al., 2015). Such insights will be helpful to design target-
specific approaches for the prevention and/or intervention of diseases exhibiting 
an oral biofilm-based etiology.  
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Supplemental Table 2. Distribution of bacterial species in each subject at 0, 2, 4 and 6 hours of biofilm formation. The 
table shows the intensity of the 124 probes (rows) that were assigned a non-zero HOMIM score in at least one DNA sample 
(columns).  The genus and phylum of each probe are shown on the left. The mean HOMIM score and the maximum HOMIM 



























































































































































1 Bacteroidetes Bacteroidetes Bacteroidetes[G-2] sp clone AU126_ot274_X57 0,18 0,00 0,00 0,00 0,05 2 -0,21 0,19 0,69 0 0 0 NA 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
2 Bacteroidetes Bergeyella Bergeyella sp clone AK152_ot322_AD84 0,09 0,00 0,09 0,00 0,05 1 -0,09 0,59 0,87 1 0 1 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
3 Bacteroidetes Capnocytophaga Capnocytophaga granulosa and sp clone BB167_ot325_326_AA89 0,55 1,18 0,64 0,44 0,71 4 -0,04 0,78 0,89 4 3 1 NA 2 4 2 0 0 0 0 0 0 4 2 0 0 2 0 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 4 0 0 0 0 0 0 0 0
4 Bacteroidetes Capnocytophaga Capnocytophaga ochracea and sp clones A47ROY and BB167_ot323_326_700_Y83 0,00 0,00 0,18 0,00 0,05 1 0,12 0,43 0,87 0 0 1 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0
5 Bacteroidetes Capnocytophaga Capnocytophaga sputigena_ot775_W46 0,09 0,64 0,36 0,22 0,33 2 0,00 0,99 0,99 1 0 0 NA 0 2 2 0 0 0 0 0 0 2 2 0 0 2 0 NA 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0
6 Bacteroidetes Sphaerocytophaga Sphaerocytophaga S3_ot337_O04 0,09 0,00 0,00 0,22 0,07 2 0,02 0,92 0,93 0 0 0 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 NA 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0
7 Bacteroidetes Prevotella Prevotella Cluster II_ot291_685_782_X13 0,09 0,27 0,64 0,33 0,33 2 0,21 0,18 0,69 1 1 1 NA 0 0 0 0 0 0 1 0 0 0 0 0 0 1 2 NA 0 1 0 1 0 0 1 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 2
8 Bacteroidetes Prevotella Prevotella Cluster III_ot306_310_313_AB01 0,00 0,09 0,18 0,00 0,07 1 0,07 0,67 0,87 0 0 0 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 NA 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0
9 Proteobacteria Cardiobacterium Cardiobacterium hominis_ot633_O97 0,27 0,73 0,55 0,33 0,48 3 0,06 0,71 0,87 1 1 0 NA 2 3 2 1 0 0 0 0 0 2 2 1 0 2 2 NA 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
10 Proteobacteria Cardiobacterium Cardiobacterium hominis_ot633_AD16 0,00 0,18 0,00 0,00 0,05 2 -0,06 0,71 0,87 0 0 0 NA 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
11 Proteobacteria Haemophilus Haemophilus parainfluenzae_ot718_W79 2,64 2,91 3,45 3,00 3,00 5 0,11 0,47 0,87 5 4 5 NA 0 2 3 1 0 3 1 0 1 2 3 2 0 3 1 NA 2 3 2 2 5 2 4 3 4 3 4 4 3 4 5 5 4 4 5 5 5 2 5 5
12 Proteobacteria Haemophilus Haemophilus sp clone BJ021_ot035_P07 0,00 0,18 0,18 0,00 0,10 2 0,02 0,90 0,93 0 2 2 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
13 Proteobacteria Haemophilus Haemophilus sp clone BJ095_ot036_AA97 0,64 0,27 1,00 1,11 0,74 4 0,25 0,12 0,69 4 0 2 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 NA 0 2 1 0 2 0 1 0 0 0 2 2 0 0 2 2 0 0 1 2 1 0 2 4
14 Proteobacteria Pseudomonas Pseudomonas Cluster I_ot536_612_740_834_O96 0,00 0,09 0,36 0,33 0,19 3 0,18 0,25 0,70 0 0 0 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 1 2 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 3
15 Proteobacteria Stenotrophomonas Stenotrophomonas maltophilia_ot663_AB85 0,27 0,00 0,00 0,00 0,07 2 -0,30 0,06 0,69 1 0 0 NA 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
16 Proteobacteria Stenotrophomonas Stenotrophomonas maltophilia_ot663_AB86 0,55 0,00 0,00 0,00 0,14 3 -0,37 0,02 0,42 1 0 0 NA 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 NA 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0
17 Proteobacteria Ochrobactrum Ochrobactrum anthropi_ot544_AB24 0,09 0,00 0,00 0,00 0,02 1 -0,21 0,19 0,69 0 0 0 NA 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
18 Proteobacteria Campylobacter Campylobacter gracilis_ot623_Q04 0,00 0,27 0,00 0,00 0,07 2 -0,09 0,59 0,87 0 1 0 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0
19 Proteobacteria Campylobacter Campylobacter gracilis_ot623_X34 0,64 1,09 1,00 0,67 0,86 3 0,03 0,86 0,93 0 1 0 NA 1 2 0 2 0 0 0 1 2 1 2 1 1 2 2 NA 2 2 2 1 0 0 0 0 1 0 2 0 0 0 0 0 0 1 2 0 0 3 1 1
20 Proteobacteria Campylobacter Campylobacter concisus and rectus_ot575_748_T86 0,09 0,00 0,18 0,22 0,12 2 0,07 0,66 0,87 0 0 0 NA 0 0 0 2 0 0 0 0 0 0 0 0 1 0 0 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0
21 Proteobacteria Campylobacter Campylobacter concisus and rectus_ot575_748_X36 0,09 0,00 0,09 0,00 0,05 1 -0,09 0,59 0,87 1 0 0 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0
22 Proteobacteria Campylobacter Campylobacter showae_ot763_W36 0,18 0,18 0,18 0,00 0,14 2 -0,12 0,43 0,87 2 1 0 NA 0 0 0 0 0 0 0 0 0 1 2 0 0 0 0 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
23 Proteobacteria Campylobacter Campylobacter showae_ot763_X35 0,27 0,45 0,18 0,00 0,24 2 -0,21 0,17 0,69 2 1 0 NA 1 2 0 0 0 0 0 0 0 2 2 0 0 0 0 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
24 Proteobacteria Campylobacter Campylobacter Cluster I_ot580_748_763_T87 0,09 0,00 0,18 0,00 0,07 2 -0,08 0,61 0,87 1 0 0 NA 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
25 Proteobacteria Burkholderia Burkholderia cepacia_ot571_AB64 0,27 0,18 0,00 0,22 0,17 3 -0,06 0,72 0,87 0 0 0 NA 0 0 0 0 3 0 0 2 0 0 0 0 0 0 0 NA 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0
26 Proteobacteria Burkholderia Burkholderia cepacia_ot571_AB65 0,45 0,36 0,00 0,22 0,26 4 -0,15 0,35 0,83 0 0 0 NA 0 0 0 0 4 0 0 2 0 0 0 0 0 0 0 NA 0 2 0 0 0 0 0 0 0 0 0 0 1 2 0 0 0 0 0 0 0 0 0 0
27 Proteobacteria Burkholderia Burkholderia cepacia_ot571_AC05 0,73 0,36 0,09 0,56 0,43 5 0,05 0,78 0,89 0 0 0 NA 0 0 0 0 5 0 0 3 0 0 0 1 0 0 0 NA 0 2 0 0 0 0 0 0 0 0 0 0 3 2 1 0 0 0 0 0 0 0 0 1
28 Proteobacteria Eikenella Eikenella corrodens and Kingella denitrificans and sp clone DE012_ot012_577_582_AD97 0,00 0,09 0,18 0,00 0,07 2 0,02 0,89 0,93 0 0 0 NA 0 0 0 0 0 0 0 0 0 1 2 0 0 0 0 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
29 Proteobacteria Eikenella Eikenella corrodens and Kingella denitrificans and sp clone DE012_ot012_577_582_AD98 0,00 0,18 0,27 0,22 0,17 2 0,17 0,27 0,74 0 0 0 NA 0 0 0 0 0 0 0 0 0 2 2 0 0 0 0 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 2 0 0 0 0
30 Proteobacteria Kingella Kingella denitrificans_ot582_X41 0,00 0,00 0,09 0,22 0,07 2 0,22 0,16 0,69 0 0 0 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 2 0 0 0 0
31 Proteobacteria Kingella Kingella oralis_ot706_AA77 0,45 1,18 0,91 0,89 0,86 3 0,16 0,31 0,79 1 2 1 NA 1 3 2 1 0 0 0 0 0 0 0 0 1 2 2 NA 0 3 0 1 2 2 2 2 0 0 1 2 0 0 0 0 0 1 0 1 0 0 2 1
32 Proteobacteria Kingella Kingella oralis and Neisseria sp clone BM052_ot009_706_O86 0,82 1,36 1,27 1,33 1,19 3 0,15 0,33 0,81 1 3 2 NA 2 3 3 2 0 0 0 0 0 0 0 0 1 2 2 NA 1 3 0 2 2 2 3 2 1 0 1 2 0 0 1 0 1 2 0 2 0 0 2 2
33 Proteobacteria Lautropia Lautropia mirabilis_ot022_O88 0,09 0,00 0,00 0,00 0,02 1 -0,21 0,19 0,69 0 0 0 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 NA 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
34 Proteobacteria Lautropia Lautropia mirabilis_ot022_X44 0,73 0,36 0,36 0,33 0,45 2 -0,18 0,24 0,70 0 0 0 NA 1 0 0 0 1 0 0 0 1 1 0 1 2 2 2 NA 0 0 0 0 2 0 0 1 0 0 0 0 0 0 0 0 1 1 1 1 0 0 1 0
35 Proteobacteria Neisseria Neisseria elongata_ot598_AA75 0,45 1,00 1,09 0,56 0,79 3 0,07 0,64 0,87 3 2 1 NA 0 2 2 1 0 0 0 0 1 3 3 2 0 2 0 NA 0 0 0 0 0 0 0 0 0 0 2 0 1 2 3 2 0 0 0 0 0 0 1 0
36 Proteobacteria Neisseria Neisseria flavescens_ot610_AA76 0,27 0,27 0,27 0,22 0,26 2 -0,05 0,76 0,89 2 1 0 NA 0 0 0 0 0 0 0 0 1 2 2 2 0 0 0 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0
37 Proteobacteria Neisseria Neisseria gonorrhoeae and polysaccharea_ot621_737_O76 0,27 0,27 0,73 0,22 0,38 2 0,12 0,45 0,87 2 2 1 NA 0 0 0 0 0 0 2 0 0 0 0 0 0 0 1 NA 0 1 0 0 1 0 2 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 1
38 Proteobacteria Neisseria Neisseria Cluster II_ot014_609_682_764_O45 1,18 1,27 1,36 1,22 1,26 4 0,04 0,79 0,89 1 2 2 NA 2 3 2 0 0 0 0 0 3 2 2 3 2 2 1 NA 1 3 3 1 4 0 2 2 0 2 1 3 0 0 0 0 0 0 0 0 0 0 2 2
39 Proteobacteria Neisseria Neisseria Cluster IV_ot009_014_015_016_Y58 0,09 0,09 0,00 0,00 0,05 1 -0,19 0,23 0,69 0 0 0 NA 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
40 Firmicutes Anaeroglobus Anaeroglobus geminatus_ot121_AA56 0,09 0,00 0,00 0,00 0,02 1 -0,21 0,19 0,69 1 0 0 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
41 Firmicutes Dialister Dialister invisus_ot118_P73 0,09 0,00 0,00 0,00 0,02 1 -0,21 0,19 0,69 1 0 0 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
42 Firmicutes Megasphaera Megasphaera sp clone CS025_ot123_AD11 0,09 0,00 0,00 0,00 0,02 1 -0,21 0,19 0,69 1 0 0 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
43 Firmicutes Selenomonas Selenomonas sp clones DS071 and EW084_ot138_146_Q52 0,09 0,00 0,00 0,00 0,02 1 -0,21 0,19 0,69 1 0 0 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
44 Firmicutes Veillonella Veillonella atypica_ot524_W88 0,09 0,18 0,00 0,11 0,10 2 -0,03 0,85 0,93 0 0 0 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 NA 1 2 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
45 Firmicutes Veillonella Veillonella parvula_ot161_AC37 1,00 0,64 0,64 0,56 0,71 3 -0,16 0,33 0,81 1 1 1 NA 0 0 0 0 0 0 0 0 2 1 1 0 2 0 2 NA 1 2 0 2 0 0 0 0 3 1 1 1 0 0 0 0 2 2 2 2 0 0 0 0
46 Firmicutes Veillonella Veillonella parvula_ot161_M04 0,73 0,36 0,27 0,44 0,45 2 -0,17 0,28 0,75 0 0 0 NA 0 0 0 0 0 0 0 0 1 0 0 0 2 0 1 NA 1 2 0 2 0 0 0 0 2 0 0 0 0 0 0 0 2 2 2 2 0 0 0 0
47 Firmicutes Veillonella Veillonella sp clones FO009 and HB016_ot780_AD02 0,00 0,09 0,00 0,00 0,02 1 -0,06 0,71 0,87 0 0 0 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
48 Firmicutes Veillonella Veillonella atypica and parvula_ot161_524_Q67 1,55 0,91 0,82 1,22 1,12 4 -0,10 0,51 0,87 1 1 2 NA 0 0 0 0 2 0 0 1 2 0 1 0 3 1 2 NA 2 4 0 4 0 0 0 0 4 2 2 2 0 0 0 0 3 2 2 3 0 0 0 1
49 Firmicutes Solobacterium Solobacterium moorei_ot678_AC01 0,00 0,09 0,00 0,00 0,02 1 -0,06 0,71 0,87 0 1 0 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
50 Firmicutes Solobacterium Solobacterium moorei_ot678_AC02 0,09 0,09 0,00 0,00 0,05 1 -0,19 0,23 0,69 1 1 0 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
51 Firmicutes Parvimonas Parvimonas micra_ot111_L97 0,18 0,18 0,27 0,22 0,21 2 0,06 0,72 0,87 2 2 2 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 2
52 Firmicutes Parvimonas Parvimonas micra_ot111_V05 0,18 0,18 0,27 0,11 0,19 2 0,05 0,78 0,89 2 2 2 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1
53 Firmicutes Lachnospiraceae Lachnospiraceae[G-4] sp clone DO016_ot097_R64 0,09 0,00 0,00 0,00 0,02 1 -0,21 0,19 0,69 0 0 0 NA 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
54 Firmicutes Eubacterium Eubacterium[11][G-3] brachy_ot557_AC03 0,09 0,09 0,00 0,00 0,05 1 -0,19 0,23 0,69 1 0 0 NA 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
55 Firmicutes Eubacterium Eubacterium[11][G-7] yurii_ot377_W84 0,18 0,09 0,09 0,11 0,12 1 -0,08 0,62 0,87 1 1 0 NA 1 0 0 1 0 0 0 0 0 0 0 0 0 0 1 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
56 Firmicutes Eubacterium Eubacterium[14][G-1] saburreum_ot494_W21 0,00 0,00 0,09 0,00 0,02 1 0,09 0,59 0,87 0 0 0 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0
57 Firmicutes Filifactor Filifactor alocis_ot539_AB94 0,00 0,00 0,09 0,22 0,07 2 0,22 0,16 0,69 0 0 0 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 2
58 Firmicutes Filifactor Filifactor alocis_ot539_AB95 0,00 0,00 0,09 0,22 0,07 2 0,22 0,16 0,69 0 0 0 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 2








59 Firmicutes Gemella Gemella haemolysans_ot626_K63 0,91 2,18 2,82 3,00 2,19 5 0,56 0,00 0,01 2 5 5 NA 2 2 2 3 0 0 2 4 0 1 3 3 1 4 2 NA 1 4 4 3 0 2 3 1 0 1 2 3 0 0 1 2 2 2 3 4 2 3 4 4
60 Firmicutes Gemella Gemella morbillorum_ot046_AB09 0,36 0,36 0,36 0,00 0,29 3 -0,12 0,44 0,87 3 2 1 NA 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 NA 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
61 Firmicutes Gemella Gemella morbillorum_ot046_K64 0,91 1,55 1,55 1,00 1,26 4 0,07 0,65 0,87 4 3 2 NA 2 2 1 2 0 0 1 0 1 3 2 1 2 3 3 NA 0 0 0 0 0 2 2 2 0 0 1 0 0 2 2 1 0 0 0 0 1 2 3 3
62 Firmicutes Gemella Gemella sanguinis_ot757_AB17 0,27 0,18 0,00 0,11 0,14 1 -0,23 0,15 0,69 1 0 0 NA 1 0 0 0 1 0 0 0 0 0 0 0 0 0 0 NA 0 0 0 0 0 0 0 0 0 1 0 1 0 1 0 0 0 0 0 0 0 0 0 0
63 Firmicutes Staphylococcus Staphylococcus caprae and epidermidis_ot567_601_AC14 0,18 0,09 0,00 0,00 0,07 2 -0,19 0,22 0,69 0 0 0 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 NA 0 0 0 0 0 0 0 0 0 0 0 0 2 1 0 0 0 0 0 0 0 0 0 0
64 Firmicutes Granulicatella Granulicatella adiacens_ot534_AB30 0,18 0,18 0,27 0,11 0,19 2 0,05 0,77 0,89 2 1 1 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 NA 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 1 0
65 Firmicutes Granulicatella Granulicatella adiacens and elegans_ot534_596_W81 0,27 0,55 0,82 0,67 0,57 4 0,24 0,13 0,69 2 4 4 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 2 1 NA 0 0 0 0 0 0 2 1 0 0 1 1 0 0 0 0 1 0 0 2 0 0 1 2
66 Firmicutes Granulicatella Granulicatella elegans_ot596_AB28 0,18 0,45 0,45 0,56 0,40 3 0,20 0,20 0,69 0 3 3 NA 2 0 0 1 0 0 0 0 0 0 1 0 0 2 0 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 1 2
67 Firmicutes Granulicatella Granulicatella elegans_ot596_AB29 0,36 0,64 0,73 0,78 0,62 5 0,10 0,55 0,87 1 5 5 NA 2 0 0 2 0 0 0 0 0 0 1 0 0 2 0 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 2 0 0 2 3
68 Firmicutes Lactobacillus Lactobacillus acidophilus_ot529_AC30 0,00 0,00 0,09 0,00 0,02 1 0,09 0,59 0,87 0 0 0 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
69 Firmicutes Streptococcus Streptococcus anginosus_ot543_AB84 0,00 0,09 0,09 0,00 0,05 1 0,02 0,90 0,93 0 1 1 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
70 Firmicutes Streptococcus Streptococcus anginosus and gordonii_ot543_622_F49 1,45 2,09 2,45 1,67 1,93 5 0,13 0,41 0,87 1 3 1 NA 2 2 3 2 0 3 5 2 1 1 1 2 4 3 4 NA 4 4 4 3 0 0 0 0 2 1 1 0 0 1 2 2 1 3 4 2 1 2 2 2
71 Firmicutes Streptococcus Streptococcus anginosus and intermedius_ot543_644_AB82 0,18 0,55 0,09 0,22 0,26 2 -0,10 0,52 0,87 1 2 0 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 NA 1 2 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0
72 Firmicutes Streptococcus Streptococcus australis and sp clone FN042_ot065_073_AB83 0,18 0,55 0,73 0,22 0,43 4 0,16 0,31 0,79 2 4 3 NA 0 0 0 0 0 0 1 0 0 0 0 0 0 2 2 NA 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 1 1
73 Firmicutes Streptococcus Streptococcus australis and sp clone FN042_ot065_073_U50 0,18 0,55 0,55 0,56 0,45 2 0,18 0,25 0,70 1 1 0 NA 0 1 1 0 0 2 0 0 1 1 2 1 0 1 0 NA 0 0 0 0 0 0 0 0 0 0 0 2 0 0 2 1 0 0 0 0 0 0 1 1
74 Firmicutes Streptococcus Streptococcus cristatus and sp clone BM035_ot058_578_AD88 0,00 0,18 0,18 0,00 0,10 2 -0,02 0,92 0,93 0 0 0 NA 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 NA 0 0 0 0 0 0 0 0 0 1 2 0 0 0 0 0 0 0 0 0 0 0 0 0
75 Firmicutes Streptococcus Streptococcus cristatus and sp clone BM035_ot058_578_AD89 0,00 0,09 0,18 0,00 0,07 2 0,02 0,89 0,93 0 0 0 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 NA 0 0 0 0 0 0 0 0 0 1 2 0 0 0 0 0 0 0 0 0 0 0 0 0
76 Firmicutes Streptococcus Streptococcus cristatus and sp clone BM035_ot058_578_AA47 0,82 1,55 1,55 1,44 1,33 3 0,22 0,16 0,69 1 0 0 NA 2 3 2 3 0 0 2 0 2 3 2 2 1 2 2 NA 0 1 0 1 0 0 1 0 2 3 3 2 0 2 2 1 1 1 1 2 0 2 2 2
77 Firmicutes Streptococcus Streptococcus anginosus and gordonii_ot543_622_X11 0,18 0,00 0,27 0,00 0,12 2 -0,12 0,46 0,87 0 0 0 NA 0 0 0 0 0 0 2 0 0 0 0 0 1 0 1 NA 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
78 Firmicutes Streptococcus Streptococcus infantis and sp clone FN042_ot065_638_Y74 0,27 0,82 0,73 0,44 0,57 2 0,11 0,49 0,87 2 2 1 NA 0 1 1 0 0 2 0 0 1 1 2 1 0 1 1 NA 0 0 0 0 0 0 0 0 0 1 1 2 0 1 1 1 0 0 0 0 0 0 1 0
79 Firmicutes Streptococcus Streptococcus anginosus and intermedius_ot543_644_Q62 2,00 2,91 3,27 2,89 2,76 5 0,32 0,04 0,69 4 5 4 NA 2 3 2 3 0 2 4 2 2 2 3 2 2 4 4 NA 3 3 3 4 2 2 3 2 1 2 3 3 0 3 3 3 3 4 3 3 3 2 4 4
80 Firmicutes Streptococcus Streptococcus constellatus and intermedius_ot576_644_AB77 1,00 0,91 0,55 0,56 0,76 3 -0,19 0,23 0,69 2 3 2 NA 0 0 0 0 0 0 0 0 1 0 0 0 2 1 2 NA 2 2 0 2 0 0 0 1 0 0 0 0 0 1 0 0 2 3 1 0 2 0 1 2
81 Firmicutes Streptococcus Streptococcus constellatus and intermedius_ot576_644_F48 1,00 1,36 0,64 0,78 0,95 4 -0,14 0,39 0,87 2 4 2 NA 0 0 0 0 0 0 0 0 1 0 0 0 2 1 2 NA 2 2 1 2 0 1 0 2 0 0 0 0 0 2 0 0 2 4 1 1 2 1 1 2
82 Firmicutes Streptococcus Streptococcus mitis bv2 and sp clone FP064_ot069_398_Q64 0,18 0,45 0,73 1,11 0,60 2 0,45 0,00 0,12 2 2 0 NA 0 0 2 1 0 0 0 1 0 1 1 2 0 1 0 NA 0 1 1 2 0 0 0 0 0 0 0 1 0 0 2 2 0 0 0 0 0 0 2 1
83 Firmicutes Streptococcus Streptococcus mutans_ot686_X04 0,55 0,73 0,18 0,44 0,48 4 -0,11 0,48 0,87 0 0 0 NA 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 NA 2 3 0 4 0 0 0 0 4 4 2 0 0 0 0 0 0 0 0 0 0 0 0 0
84 Firmicutes Streptococcus Streptococcus mutans_ot686_AC57 0,27 0,27 0,00 0,22 0,19 2 -0,14 0,38 0,87 0 0 0 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 NA 1 1 0 2 0 0 0 0 2 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0
85 Firmicutes Streptococcus Streptococcus oralis and sp clones C5MLM037 and EK048_ot064_707_F46 3,45 4,36 5,00 4,67 4,36 5 0,50 0,00 0,05 5 5 5 NA 3 4 5 5 2 3 5 4 2 2 5 4 4 5 5 NA 4 5 5 5 2 5 5 4 4 4 5 5 3 5 5 5 4 5 5 5 5 5 5 5
86 Firmicutes Streptococcus Streptococcus parasanguis I and II and sp clone BE024_ot057_411_721_V77 0,00 0,55 0,45 0,56 0,38 2 0,27 0,09 0,69 0 1 0 NA 0 0 0 0 0 2 2 1 0 0 0 0 0 0 0 NA 0 2 1 2 0 0 0 0 0 1 1 2 0 0 0 0 0 0 0 0 0 0 1 0
87 Firmicutes Streptococcus Streptococcus parasanguis I and II_ot411_721_AB05 1,00 1,45 1,55 1,11 1,29 3 0,12 0,47 0,87 2 2 1 NA 1 1 1 1 1 2 2 1 0 1 1 0 1 2 2 NA 2 3 2 2 1 1 1 0 1 2 2 2 0 1 1 1 1 1 2 1 1 0 2 2
88 Firmicutes Streptococcus Streptococcus salivarius and sp clone FO042_ot067_755_E34 1,36 1,45 1,09 1,22 1,29 3 -0,08 0,60 0,87 1 2 2 NA 0 0 0 0 0 3 0 2 2 2 1 1 2 1 3 NA 3 3 2 3 0 0 0 0 1 2 1 2 2 1 0 2 1 2 2 0 3 0 1 1
89 Firmicutes Streptococcus Streptococcus salivarius_ot755_X06 0,09 0,09 0,09 0,33 0,14 2 0,13 0,41 0,87 0 0 0 NA 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 NA 1 1 1 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
90 Firmicutes Streptococcus Streptococcus sanguinis and sp clone C3MLM097_ot058_758_AB75 3,09 3,55 3,45 2,78 3,24 5 -0,07 0,65 0,87 4 5 5 NA 5 4 4 4 4 5 3 2 4 4 4 3 5 5 5 NA 2 3 2 2 2 3 3 2 4 5 4 5 2 3 4 4 0 0 0 0 2 2 4 3
91 Firmicutes Streptococcus Streptococcus sanguinis and sp clone C3MLM097_ot058_758_AB78 3,09 3,36 3,18 2,89 3,14 5 -0,07 0,64 0,87 4 5 5 NA 5 4 4 4 4 5 3 2 4 4 4 3 5 4 4 NA 2 3 2 2 2 3 3 3 4 4 3 5 2 3 3 4 0 0 0 0 2 2 4 3
92 Firmicutes Streptococcus Streptococcus sobrinus_ot768_Q60 0,36 0,36 0,00 0,44 0,29 4 -0,03 0,86 0,93 0 0 0 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 NA 4 4 0 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
93 Firmicutes Streptococcus Streptococcus sp strains Hans H6 and 7A_ot070_071_N20 0,09 0,36 0,45 0,56 0,36 3 0,20 0,20 0,69 0 0 0 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 NA 1 2 2 3 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 1 2 1
94 Firmicutes Streptococcus Streptococcus Cluster I_ot058_398_423_728_734_AB98 0,45 0,91 1,45 1,11 0,98 2 0,37 0,02 0,42 2 2 2 NA 0 1 1 1 0 0 2 1 0 0 1 1 0 2 2 NA 0 1 0 0 0 0 2 0 1 2 2 2 0 1 1 1 1 1 1 2 1 0 2 2
95 Firmicutes Streptococcus Streptococcus Cluster II_ot071_755_758_Q59 4,09 4,00 4,00 3,78 3,98 5 -0,15 0,34 0,82 5 5 5 NA 5 4 4 4 4 4 4 2 4 4 4 4 5 5 5 NA 4 4 4 4 5 4 4 5 4 4 4 5 2 4 3 3 4 4 3 4 3 2 4 3
96 Firmicutes Streptococcus Streptococcus Cluster III_ot755_758_767_768_Q65 4,82 4,91 5,00 5,00 4,93 5 0,28 0,07 0,69 5 5 5 NA 5 5 5 5 4 5 5 5 5 4 5 5 5 5 5 NA 5 5 5 5 5 5 5 5 5 5 5 5 4 5 5 5 5 5 5 5 5 5 5 5
97 Fusobacteria Fusobacterium Fusobacterium periodontium_ot201_R20 0,36 0,18 0,18 0,11 0,21 4 0,04 0,80 0,90 4 2 1 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 NA 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1
98 Fusobacteria Fusobacterium Fusobacterium nucleatum ss nucleatum and animalis_ot420_698_AD99 0,18 0,09 0,00 0,00 0,07 2 -0,19 0,22 0,69 2 1 0 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
99 Fusobacteria Fusobacterium Fusobacterium nucleatum ss nucleatum and animalis_ot420_698_AE01 0,36 0,27 0,27 0,22 0,29 4 0,09 0,56 0,87 4 2 2 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1
100 Fusobacteria Leptotrichia Leptotrichia hofstadii_ot224_AA58 0,00 0,00 0,09 0,00 0,02 1 0,09 0,59 0,87 0 0 0 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
101 Fusobacteria Leptotrichia Leptotrichia hofstadii and sp strain _F138_ot223_224_Y55 0,09 0,00 0,09 0,00 0,05 1 -0,09 0,59 0,87 0 0 0 NA 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
102 Fusobacteria Leptotrichia Leptotrichia buccalis and goodfellowii and Sneathia sanguinegens_ot563_837_845_AA45 0,45 0,82 0,64 0,56 0,62 3 0,03 0,83 0,92 3 1 2 NA 1 2 1 2 0 0 0 0 0 3 2 1 1 2 2 NA 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0
103 Synergistetes Synergistetes Synergistetes[G-3] sp clone BH007_ot359_AC53 0,09 0,09 0,09 0,00 0,07 1 -0,11 0,50 0,87 1 1 1 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
104 Synergistetes Synergistetes Synergistetes[G-3] sp clone BH017_ot360_AD66 0,09 0,18 0,09 0,00 0,10 2 -0,11 0,50 0,87 0 0 0 NA 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 2 1 0 0 0 0 0 0 0 0 0
105 TM7 TM7 TM7[G-1] sp clone BE109 and TM7[G-2] sp clone BU080_ot347_350_Y77 0,18 0,27 0,27 0,00 0,19 2 -0,10 0,55 0,87 0 1 1 NA 0 0 0 0 0 0 0 0 0 1 0 0 2 1 2 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
106 Actinobacteria Actinomyces Actinomyces gerencseriae_ot618_E46 0,45 0,55 0,45 0,11 0,40 4 -0,10 0,52 0,87 0 0 0 NA 0 0 0 0 0 0 0 0 4 0 0 0 1 2 0 NA 0 2 0 0 0 0 0 0 0 1 3 1 0 0 0 0 0 0 2 0 0 1 0 0
107 Actinobacteria Actinomyces Actinomyces israelii and sp clone EP053_ot177_645_AA82 0,18 0,09 0,00 0,00 0,07 1 -0,28 0,07 0,69 0 0 0 NA 1 1 0 0 1 0 0 0 0 0 0 0 0 0 0 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
108 Actinobacteria Actinomyces Actinomyces naeslundii_ot176_AC71 0,27 0,36 0,00 0,22 0,21 2 -0,08 0,63 0,87 0 0 0 NA 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 NA 0 1 0 0 2 0 0 1 0 2 0 1 0 0 0 0 0 0 0 0 0 0 0 0
109 Actinobacteria Actinomyces Actinomyces viscosus and sp clone AG004_ot169_688_AD82 0,64 0,18 0,18 0,11 0,29 2 -0,29 0,06 0,69 0 0 0 NA 2 0 0 0 2 1 0 0 0 0 0 0 1 0 1 NA 0 0 0 0 1 1 1 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0
110 Actinobacteria Actinomyces Actinomyces sp clone AP064_ot170_T61 0,00 0,18 0,09 0,00 0,07 2 0,02 0,92 0,93 0 0 0 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 NA 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0
111 Actinobacteria Actinomyces Actinomyces sp clone EP005_ot175_P91 0,27 0,09 0,00 0,11 0,12 3 -0,04 0,82 0,92 0 0 0 NA 3 1 0 1 0 0 0 0 0 0 0 0 0 0 0 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
112 Actinobacteria Actinomyces Actinomyces sp clone EP053_ot177_X45 1,18 0,82 0,64 0,89 0,88 3 -0,13 0,42 0,87 0 0 0 NA 2 2 1 2 3 1 1 1 1 2 2 2 2 1 2 NA 1 2 0 1 0 0 0 0 2 1 0 2 2 0 1 0 0 0 0 0 0 0 0 0
113 Actinobacteria Actinomyces Actinomyces sp clone IP073_ot448_AB36 0,09 0,00 0,00 0,00 0,02 1 -0,21 0,19 0,69 0 0 0 NA 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
114 Actinobacteria Actinomyces Actinomyces sp clone IP073_ot448_AC69 0,09 0,09 0,00 0,00 0,05 1 -0,19 0,23 0,69 0 0 0 NA 0 0 0 0 0 1 0 0 1 0 0 0 0 0 0 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
115 Actinobacteria Actinomyces Actinomyces Cluster I_ot671_688_701_708_AB35 1,36 1,18 0,73 0,89 1,05 3 -0,25 0,12 0,69 1 1 0 NA 2 2 1 1 2 0 1 0 2 2 1 2 3 2 2 NA 1 2 0 1 2 0 0 1 1 2 1 2 1 0 0 0 0 0 1 0 0 2 1 1
116 Actinobacteria Corynebacterium Corynebacterium matruchotii_ot666_AC67 0,00 0,09 0,00 0,00 0,02 1 -0,06 0,71 0,87 0 0 0 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 NA 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
117 Actinobacteria Propionibacterium Propionibacterium propionicum_ot739_AB72 0,00 0,18 0,00 0,11 0,07 1 0,06 0,71 0,87 0 0 0 NA 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 NA 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0
118 Actinobacteria Rothia Rothia dentocariosa_ot587_Q66 0,09 0,18 0,27 0,11 0,17 2 0,06 0,71 0,87 0 0 0 NA 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 NA 1 0 0 1 0 2 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
119 Actinobacteria Rothia Rothia dentocariosa_ot587_W97 0,00 0,09 0,18 0,00 0,07 2 0,02 0,89 0,93 0 0 0 NA 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 NA 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
120 Actinobacteria Rothia Rothia dentocariosa_ot587_W98 0,27 0,18 0,36 0,11 0,24 2 -0,07 0,65 0,87 0 0 0 NA 1 0 0 0 0 0 2 0 0 0 0 0 1 0 0 NA 1 0 0 1 0 2 1 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0
121 Actinobacteria Rothia Rothia dentocariosa and mucilaginosa_ot587_681_E52 1,09 1,45 1,64 1,67 1,45 3 0,19 0,22 0,69 0 0 1 NA 2 2 2 1 0 2 3 2 2 1 1 1 2 2 2 NA 3 2 0 2 1 3 2 2 0 2 2 3 2 2 3 2 0 0 1 1 0 0 1 1
122 Actinobacteria Rothia Rothia mucilaginosa_ot681_AB62 0,00 0,18 0,09 0,22 0,12 2 0,11 0,51 0,87 0 0 0 NA 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 NA 0 0 0 0 0 0 0 0 0 1 1 2 0 0 0 0 0 0 0 0 0 0 0 0
123 Actinobacteria Rothia Rothia mucilaginosa_ot681_AB63 0,00 0,00 0,00 0,22 0,05 2 0,22 0,16 0,69 0 0 0 NA 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 NA 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0






Supplemental Table 3. Temporal changes of bacterial prevalence and proportions during the first six hours of biofilm 
formation assessed by computing the within subject Spearman correlation coefficient (rho). Each column represents 
one subject, and each cell represent the correlation coefficient of the HOMIM score for the four time points of biofilm 
formation. Red and blue indicate rho values of +1 and -1, respectively, indicating that the proportion of a given species 
continuously increased or decreased, respectively. White indicates a rho value of 0, indicating that the scores showed no 
pattern of increase or decrease over time. Gray indicates that all four HOMIM scores for a subject are identical and rho is 





























































































































59 Firmicutes Gemella Gemella haemolysans_ot626_K63 0,91 2,18 2,82 3,00 2,19 5 0,56 0,00 0,01 0,87 0,77 0,95 0,95 0,50 0,32 0,40 1,00 0,95 0,95 0,95
85 Firmicutes Streptococcus Streptococcus oralis and sp clones C5MLM037 and EK048_ot064_707_F46 3,45 4,36 5,00 4,67 4,36 5 0,50 0,00 0,05 NA 0,95 0,80 0,74 0,87 0,77 0,32 0,89 0,77 0,77 NA
82 Firmicutes Streptococcus Streptococcus mitis bv2 and sp clone FP064_ot069_398_Q64 0,18 0,45 0,73 1,11 0,60 2 0,45 0,00 0,12 -0,87 0,74 0,77 0,95 0,00 0,95 NA 0,77 0,89 NA 0,74
94 Firmicutes Streptococcus Streptococcus Cluster I_ot058_398_423_728_734_AB98 0,45 0,91 1,45 1,11 0,98 2 0,37 0,02 0,42 NA 0,77 0,74 0,89 0,87 -0,26 0,26 0,77 0,77 0,77 0,74
79 Firmicutes Streptococcus Streptococcus anginosus and intermedius_ot543_644_Q62 2,00 2,91 3,27 2,89 2,76 5 0,32 0,04 0,69 0,00 0,45 0,63 0,26 0,87 0,77 0,26 0,95 0,77 -0,26 0,74
96 Firmicutes Streptococcus Streptococcus Cluster III_ot755_758_767_768_Q65 4,82 4,91 5,00 5,00 4,93 5 0,28 0,07 0,69 NA NA 0,77 0,26 NA NA NA NA 0,77 NA NA
86 Firmicutes Streptococcus Streptococcus parasanguis I and II and sp clone BE024_ot057_411_721_V77 0,00 0,55 0,45 0,56 0,38 2 0,27 0,09 0,69 0,00 NA 0,32 NA NA 0,63 NA 0,95 NA NA 0,26
13 Proteobacteria Haemophilus Haemophilus sp clone BJ095_ot036_AA97 0,64 0,27 1,00 1,11 0,74 4 0,25 0,12 0,69 -0,50 NA NA NA 0,00 -0,11 -0,63 0,89 0,89 0,95 0,80
65 Firmicutes Granulicatella Granulicatella adiacens and elegans_ot534_596_W81 0,27 0,55 0,82 0,67 0,57 4 0,24 0,13 0,69 0,87 NA NA NA 0,50 NA 0,74 0,89 NA 0,32 0,95
30 Proteobacteria Kingella Kingella denitrificans_ot582_X41 0,00 0,00 0,09 0,22 0,07 2 0,22 0,16 0,69 NA NA NA NA NA NA NA NA NA 0,95 NA
57 Firmicutes Filifactor Filifactor alocis_ot539_AB94 0,00 0,00 0,09 0,22 0,07 2 0,22 0,16 0,69 NA NA NA NA NA NA NA NA NA NA 0,95
58 Firmicutes Filifactor Filifactor alocis_ot539_AB95 0,00 0,00 0,09 0,22 0,07 2 0,22 0,16 0,69 NA NA NA NA NA NA NA NA NA NA 0,95
76 Firmicutes Streptococcus Streptococcus cristatus and sp clone BM035_ot058_578_AA47 0,82 1,55 1,55 1,44 1,33 3 0,22 0,16 0,69 -0,87 0,45 0,26 -0,26 0,87 0,45 0,26 0,00 0,32 0,77 0,77
123 Actinobacteria Rothia Rothia mucilaginosa_ot681_AB63 0,00 0,00 0,00 0,22 0,05 2 0,22 0,16 0,69 NA NA NA NA NA NA NA 0,77 NA NA NA
7 Bacteroidetes Prevotella Prevotella Cluster II_ot291_685_782_X13 0,09 0,27 0,64 0,33 0,33 2 0,21 0,18 0,69 NA NA 0,26 NA 1,00 0,45 0,26 0,26 NA NA 0,95
93 Firmicutes Streptococcus Streptococcus sp strains Hans H6 and 7A_ot070_071_N20 0,09 0,36 0,45 0,56 0,36 3 0,20 0,20 0,69 NA NA NA NA 0,87 0,95 NA 0,77 NA NA 0,63
66 Firmicutes Granulicatella Granulicatella elegans_ot596_AB28 0,18 0,45 0,45 0,56 0,40 3 0,20 0,20 0,69 0,87 -0,32 NA 0,26 0,00 NA NA NA NA 0,77 0,95
121 Actinobacteria Rothia Rothia dentocariosa and mucilaginosa_ot587_681_E52 1,09 1,45 1,64 1,67 1,45 3 0,19 0,22 0,69 0,87 -0,77 0,63 -0,77 NA -0,63 0,32 0,95 0,26 0,89 0,89
14 Proteobacteria Pseudomonas Pseudomonas Cluster I_ot536_612_740_834_O96 0,00 0,09 0,36 0,33 0,19 3 0,18 0,25 0,70 NA NA NA NA 1,00 NA NA NA NA NA 0,95
73 Firmicutes Streptococcus Streptococcus australis and sp clone FN042_ot065_073_U50 0,18 0,55 0,55 0,56 0,45 2 0,18 0,25 0,70 -0,87 0,00 -0,26 0,26 0,00 NA NA 0,77 0,74 NA 0,89
124 Actinobacteria Slackia Slackia exigua_ot602_AC97 1,64 1,73 2,45 1,89 1,93 5 0,18 0,25 0,70 0,00 -0,77 0,40 0,26 NA NA -0,32 NA 0,89 0,77 0,60
29 Proteobacteria Eikenella Eikenella corrodens and Kingella denitrificans and sp clone DE012_ot012_577_582_AD98 0,00 0,18 0,27 0,22 0,17 2 0,17 0,27 0,74 NA NA NA 0,00 NA NA NA NA NA 0,95 NA
31 Proteobacteria Kingella Kingella oralis_ot706_AA77 0,45 1,18 0,91 0,89 0,86 3 0,16 0,31 0,79 0,00 -0,11 NA NA 0,87 0,21 NA 0,95 NA 0,45 0,74
72 Firmicutes Streptococcus Streptococcus australis and sp clone FN042_ot065_073_AB83 0,18 0,55 0,73 0,22 0,43 4 0,16 0,31 0,79 0,50 NA 0,26 NA 0,87 NA NA 0,89 NA NA 0,89
32 Proteobacteria Kingella Kingella oralis and Neisseria sp clone BM052_ot009_706_O86 0,82 1,36 1,27 1,33 1,19 3 0,15 0,33 0,81 0,50 0,00 NA NA 0,87 0,00 0,26 0,63 0,26 0,21 0,89
89 Firmicutes Streptococcus Streptococcus salivarius_ot755_X06 0,09 0,09 0,09 0,33 0,14 2 0,13 0,41 0,87 NA NA 0,77 NA NA 0,77 NA NA NA NA NA
70 Firmicutes Streptococcus Streptococcus anginosus and gordonii_ot543_622_F49 1,45 2,09 2,45 1,67 1,93 5 0,13 0,41 0,87 0,00 0,26 0,40 0,77 0,00 -0,77 NA -0,95 0,95 0,40 0,77
4 Bacteroidetes Capnocytophaga Capnocytophaga ochracea and sp clones A47ROY and BB167_ot323_326_700_Y83 0,00 0,00 0,18 0,00 0,05 1 0,12 0,43 0,87 0,87 NA NA NA NA NA NA NA NA NA 0,26
37 Proteobacteria Neisseria Neisseria gonorrhoeae and polysaccharea_ot621_737_O76 0,27 0,27 0,73 0,22 0,38 2 0,12 0,45 0,87 -0,87 NA 0,26 NA 0,87 -0,26 0,32 0,26 NA NA 0,89
87 Firmicutes Streptococcus Streptococcus parasanguis I and II_ot411_721_AB05 1,00 1,45 1,55 1,11 1,29 3 0,12 0,47 0,87 -0,87 NA 0,00 0,00 0,87 -0,26 -0,77 0,77 0,77 0,26 0,74
11 Proteobacteria Haemophilus Haemophilus parainfluenzae_ot718_W79 2,64 2,91 3,45 3,00 3,00 5 0,11 0,47 0,87 0,00 0,40 -0,11 0,63 0,50 -0,26 -0,40 0,26 0,95 0,89 0,26
78 Firmicutes Streptococcus Streptococcus infantis and sp clone FN042_ot065_638_Y74 0,27 0,82 0,73 0,44 0,57 2 0,11 0,49 0,87 -0,87 0,00 -0,26 0,26 0,87 NA NA 0,95 0,77 NA 0,26







122 Actinobacteria Rothia Rothia mucilaginosa_ot681_AB62 0,00 0,18 0,09 0,22 0,12 2 0,11 0,51 0,87 NA NA -0,26 NA NA NA NA 0,95 NA NA NA
67 Firmicutes Granulicatella Granulicatella elegans_ot596_AB29 0,36 0,64 0,73 0,78 0,62 5 0,10 0,55 0,87 0,87 0,00 NA 0,26 0,00 NA NA NA NA 0,32 0,95
99 Fusobacteria Fusobacterium Fusobacterium nucleatum ss nucleatum and animalis_ot420_698_AE01 0,36 0,27 0,27 0,22 0,29 4 0,09 0,56 0,87 -0,87 NA NA NA 0,87 NA NA NA NA 0,77 0,77
56 Firmicutes Eubacterium Eubacterium[14][G-1] saburreum_ot494_W21 0,00 0,00 0,09 0,00 0,02 1 0,09 0,59 0,87 NA NA NA NA NA NA NA NA NA 0,26 NA
68 Firmicutes Lactobacillus Lactobacillus acidophilus_ot529_AC30 0,00 0,00 0,09 0,00 0,02 1 0,09 0,59 0,87 NA NA NA NA 0,87 NA NA NA NA NA NA
100 Fusobacteria Leptotrichia Leptotrichia hofstadii_ot224_AA58 0,00 0,00 0,09 0,00 0,02 1 0,09 0,59 0,87 NA NA NA NA 0,87 NA NA NA NA NA NA
35 Proteobacteria Neisseria Neisseria elongata_ot598_AA75 0,45 1,00 1,09 0,56 0,79 3 0,07 0,64 0,87 -1,00 0,32 NA 0,32 0,00 NA NA 0,26 0,63 NA 0,26
61 Firmicutes Gemella Gemella morbillorum_ot046_K64 0,91 1,55 1,55 1,00 1,26 4 0,07 0,65 0,87 -1,00 -0,26 0,26 -0,11 0,87 NA 0,77 0,26 0,32 NA 0,95
20 Proteobacteria Campylobacter Campylobacter concisus and rectus_ot575_748_T86 0,09 0,00 0,18 0,22 0,12 2 0,07 0,66 0,87 NA 0,77 NA NA -0,87 NA NA NA NA NA 0,26
8 Bacteroidetes Prevotella Prevotella Cluster III_ot306_310_313_AB01 0,00 0,09 0,18 0,00 0,07 1 0,07 0,67 0,87 NA NA NA NA 0,87 -0,26 NA NA NA NA 0,26
9 Proteobacteria Cardiobacterium Cardiobacterium hominis_ot633_O97 0,27 0,73 0,55 0,33 0,48 3 0,06 0,71 0,87 -0,87 -0,63 NA 0,32 0,87 NA 0,77 NA NA NA NA
117 Actinobacteria Propionibacterium Propionibacterium propionicum_ot739_AB72 0,00 0,18 0,00 0,11 0,07 1 0,06 0,71 0,87 NA -0,26 NA NA 0,00 NA NA 0,77 NA NA NA
118 Actinobacteria Rothia Rothia dentocariosa_ot587_Q66 0,09 0,18 0,27 0,11 0,17 2 0,06 0,71 0,87 NA NA 0,26 NA NA 0,00 -0,11 NA NA NA NA
51 Firmicutes Parvimonas Parvimonas micra_ot111_L97 0,18 0,18 0,27 0,22 0,21 2 0,06 0,72 0,87 NA NA NA NA NA NA NA NA NA NA 0,95
64 Firmicutes Granulicatella Granulicatella adiacens_ot534_AB30 0,18 0,18 0,27 0,11 0,19 2 0,05 0,77 0,89 -0,87 NA NA NA 0,00 NA 0,26 0,77 NA NA 0,26
27 Proteobacteria Burkholderia Burkholderia cepacia_ot571_AC05 0,73 0,36 0,09 0,56 0,43 5 0,05 0,78 0,89 NA NA -0,32 0,77 NA -0,26 NA NA -1,00 NA 0,77
52 Firmicutes Parvimonas Parvimonas micra_ot111_V05 0,18 0,18 0,27 0,11 0,19 2 0,05 0,78 0,89 NA NA NA NA NA NA NA NA NA NA 0,89
38 Proteobacteria Neisseria Neisseria Cluster II_ot014_609_682_764_O45 1,18 1,27 1,36 1,22 1,26 4 0,04 0,79 0,89 0,87 -0,63 NA 0,00 -0,87 0,00 -0,32 0,80 NA NA 0,89
97 Fusobacteria Fusobacterium Fusobacterium periodontium_ot201_R20 0,36 0,18 0,18 0,11 0,21 4 0,04 0,80 0,90 -1,00 NA NA NA NA NA NA 0,26 NA NA 0,77
102 Fusobacteria Leptotrichia Leptotrichia buccalis and goodfellowii and Sneathia sanguinegens_ot563_837_845_AA45 0,45 0,82 0,64 0,56 0,62 3 0,03 0,83 0,92 -0,50 0,45 NA 0,20 0,87 -0,26 NA NA NA 0,77 NA
19 Proteobacteria Campylobacter Campylobacter gracilis_ot623_X34 0,64 1,09 1,00 0,67 0,86 3 0,03 0,86 0,93 0,00 0,21 0,77 -0,45 0,87 -0,77 NA -0,21 NA 0,11 0,32
28 Proteobacteria Eikenella Eikenella corrodens and Kingella denitrificans and sp clone DE012_ot012_577_582_AD97 0,00 0,09 0,18 0,00 0,07 2 0,02 0,89 0,93 NA NA NA 0,11 NA NA NA NA NA NA NA
75 Firmicutes Streptococcus Streptococcus cristatus and sp clone BM035_ot058_578_AD89 0,00 0,09 0,18 0,00 0,07 2 0,02 0,89 0,93 NA NA NA NA NA NA NA 0,11 NA NA NA
119 Actinobacteria Rothia Rothia dentocariosa_ot587_W97 0,00 0,09 0,18 0,00 0,07 2 0,02 0,89 0,93 NA NA 0,26 NA NA NA -0,26 NA NA NA NA
12 Proteobacteria Haemophilus Haemophilus sp clone BJ021_ot035_P07 0,00 0,18 0,18 0,00 0,10 2 0,02 0,90 0,93 0,87 NA NA NA NA NA NA NA NA NA NA
69 Firmicutes Streptococcus Streptococcus anginosus_ot543_AB84 0,00 0,09 0,09 0,00 0,05 1 0,02 0,90 0,93 0,87 NA NA NA NA NA NA NA NA NA NA
6 Bacteroidetes Sphaerocytophaga Sphaerocytophaga S3_ot337_O04 0,09 0,00 0,00 0,22 0,07 2 0,02 0,92 0,93 NA NA NA NA NA NA -0,77 NA 0,77 NA NA
110 Actinobacteria Actinomyces Actinomyces sp clone AP064_ot170_T61 0,00 0,18 0,09 0,00 0,07 2 0,02 0,92 0,93 NA NA NA NA 0,87 NA NA -0,26 NA NA NA
5 Bacteroidetes Capnocytophaga Capnocytophaga sputigena_ot775_W46 0,09 0,64 0,36 0,22 0,33 2 0,00 0,99 0,99 -0,87 0,00 NA 0,00 0,00 -0,26 NA NA NA 0,77 NA
74 Firmicutes Streptococcus Streptococcus cristatus and sp clone BM035_ot058_578_AD88 0,00 0,18 0,18 0,00 0,10 2 -0,02 0,92 0,93 NA -0,26 NA NA NA NA NA 0,11 NA NA NA
92 Firmicutes Streptococcus Streptococcus sobrinus_ot768_Q60 0,36 0,36 0,00 0,44 0,29 4 -0,03 0,86 0,93 NA NA NA NA NA -0,26 NA NA NA NA NA
44 Firmicutes Veillonella Veillonella atypica_ot524_W88 0,09 0,18 0,00 0,11 0,10 2 -0,03 0,85 0,93 NA NA NA NA NA -0,32 NA NA NA NA NA
111 Actinobacteria Actinomyces Actinomyces sp clone EP005_ot175_P91 0,27 0,09 0,00 0,11 0,12 3 -0,04 0,82 0,92 NA -0,63 NA NA NA NA NA NA NA NA NA
3 Bacteroidetes Capnocytophaga Capnocytophaga granulosa and sp clone BB167_ot325_326_AA89 0,55 1,18 0,64 0,44 0,71 4 -0,04 0,78 0,89 -1,00 -0,63 NA -0,11 0,00 NA NA NA 0,95 NA NA
36 Proteobacteria Neisseria Neisseria flavescens_ot610_AA76 0,27 0,27 0,27 0,22 0,26 2 -0,05 0,76 0,89 -1,00 NA NA 0,77 NA NA NA NA NA NA 0,26
25 Proteobacteria Burkholderia Burkholderia cepacia_ot571_AB64 0,27 0,18 0,00 0,22 0,17 3 -0,06 0,72 0,87 NA NA -0,32 NA NA -0,26 NA NA -0,26 NA NA
10 Proteobacteria Cardiobacterium Cardiobacterium hominis_ot633_AD16 0,00 0,18 0,00 0,00 0,05 2 -0,06 0,71 0,87 NA -0,26 NA NA NA NA NA NA NA NA NA
47 Firmicutes Veillonella Veillonella sp clones FO009 and HB016_ot780_AD02 0,00 0,09 0,00 0,00 0,02 1 -0,06 0,71 0,87 NA NA NA NA 0,00 NA NA NA NA NA NA
49 Firmicutes Solobacterium Solobacterium moorei_ot678_AC01 0,00 0,09 0,00 0,00 0,02 1 -0,06 0,71 0,87 0,00 NA NA NA NA NA NA NA NA NA NA
116 Actinobacteria Corynebacterium Corynebacterium matruchotii_ot666_AC67 0,00 0,09 0,00 0,00 0,02 1 -0,06 0,71 0,87 NA NA NA NA NA -0,26 NA NA NA NA NA
120 Actinobacteria Rothia Rothia dentocariosa_ot587_W98 0,27 0,18 0,36 0,11 0,24 2 -0,07 0,65 0,87 NA -0,77 0,26 NA -0,87 0,00 -0,11 NA 0,26 NA NA
90 Firmicutes Streptococcus Streptococcus sanguinis and sp clone C3MLM097_ot058_758_AB75 3,09 3,55 3,45 2,78 3,24 5 -0,07 0,65 0,87 0,87 -0,77 -0,80 -0,77 NA -0,26 0,00 0,45 0,95 NA 0,74
91 Firmicutes Streptococcus Streptococcus sanguinis and sp clone C3MLM097_ot058_758_AB78 3,09 3,36 3,18 2,89 3,14 5 -0,07 0,64 0,87 0,87 -0,77 -0,80 -0,77 -0,87 -0,26 0,77 0,32 0,95 NA 0,74
108 Actinobacteria Actinomyces Actinomyces naeslundii_ot176_AC71 0,27 0,36 0,00 0,22 0,21 2 -0,08 0,63 0,87 NA -0,89 NA NA NA -0,26 -0,32 0,21 NA NA NA
55 Firmicutes Eubacterium Eubacterium[11][G-7] yurii_ot377_W84 0,18 0,09 0,09 0,11 0,12 1 -0,08 0,62 0,87 -0,87 0,00 NA NA 0,87 NA NA NA NA NA NA
24 Proteobacteria Campylobacter Campylobacter Cluster I_ot580_748_763_T87 0,09 0,00 0,18 0,00 0,07 2 -0,08 0,61 0,87 -0,87 NA NA 0,26 NA NA NA NA NA NA NA
88 Firmicutes Streptococcus Streptococcus salivarius and sp clone FO042_ot067_755_E34 1,36 1,45 1,09 1,22 1,29 3 -0,08 0,60 0,87 0,87 NA 0,21 -0,89 0,50 -0,26 NA 0,45 -0,11 -0,32 -0,32
18 Proteobacteria Campylobacter Campylobacter gracilis_ot623_Q04 0,00 0,27 0,00 0,00 0,07 2 -0,09 0,59 0,87 0,00 NA NA NA NA NA NA NA NA NA -0,26
2 Bacteroidetes Bergeyella Bergeyella sp clone AK152_ot322_AD84 0,09 0,00 0,09 0,00 0,05 1 -0,09 0,59 0,87 0,00 NA NA NA NA NA NA NA NA NA NA
21 Proteobacteria Campylobacter Campylobacter concisus and rectus_ot575_748_X36 0,09 0,00 0,09 0,00 0,05 1 -0,09 0,59 0,87 -0,87 NA NA NA NA NA NA NA NA NA 0,26
101 Fusobacteria Leptotrichia Leptotrichia hofstadii and sp strain _F138_ot223_224_Y55 0,09 0,00 0,09 0,00 0,05 1 -0,09 0,59 0,87 NA -0,77 NA NA 0,87 NA NA NA NA NA NA
105 TM7 TM7 TM7[G-1] sp clone BE109 and TM7[G-2] sp clone BU080_ot347_350_Y77 0,18 0,27 0,27 0,00 0,19 2 -0,10 0,55 0,87 0,87 NA NA -0,26 0,00 NA NA NA NA NA NA
106 Actinobacteria Actinomyces Actinomyces gerencseriae_ot618_E46 0,45 0,55 0,45 0,11 0,40 4 -0,10 0,52 0,87 NA NA NA -0,77 -0,50 -0,26 NA 0,63 NA 0,26 -0,26
71 Firmicutes Streptococcus Streptococcus anginosus and intermedius_ot543_644_AB82 0,18 0,55 0,09 0,22 0,26 2 -0,10 0,52 0,87 -0,50 NA NA NA 0,87 0,21 NA NA NA -0,26 NA













104 Synergistetes Synergistetes Synergistetes[G-3] sp clone BH017_ot360_AD66 0,09 0,18 0,09 0,00 0,10 2 -0,11 0,50 0,87 NA NA -0,77 NA NA NA NA NA -0,11 NA NA
103 Synergistetes Synergistetes Synergistetes[G-3] sp clone BH007_ot359_AC53 0,09 0,09 0,09 0,00 0,07 1 -0,11 0,50 0,87 NA NA NA NA NA NA NA NA NA NA NA
83 Firmicutes Streptococcus Streptococcus mutans_ot686_X04 0,55 0,73 0,18 0,44 0,48 4 -0,11 0,48 0,87 NA NA -0,26 NA NA 0,40 NA -0,95 NA NA NA
77 Firmicutes Streptococcus Streptococcus anginosus and gordonii_ot543_622_X11 0,18 0,00 0,27 0,00 0,12 2 -0,12 0,46 0,87 NA NA 0,26 NA 0,00 -0,77 NA NA NA NA NA
60 Firmicutes Gemella Gemella morbillorum_ot046_AB09 0,36 0,36 0,36 0,00 0,29 3 -0,12 0,44 0,87 -1,00 NA NA NA 0,00 NA 0,26 NA NA NA NA
22 Proteobacteria Campylobacter Campylobacter showae_ot763_W36 0,18 0,18 0,18 0,00 0,14 2 -0,12 0,43 0,87 -1,00 NA NA 0,11 NA NA NA NA NA NA NA
112 Actinobacteria Actinomyces Actinomyces sp clone EP053_ot177_X45 1,18 0,82 0,64 0,89 0,88 3 -0,13 0,42 0,87 NA -0,26 -0,77 0,77 0,00 -0,32 NA -0,11 -0,63 NA NA
81 Firmicutes Streptococcus Streptococcus constellatus and intermedius_ot576_644_F48 1,00 1,36 0,64 0,78 0,95 4 -0,14 0,39 0,87 0,00 NA NA -0,77 0,00 -0,26 0,63 NA -0,26 -0,74 0,00
84 Firmicutes Streptococcus Streptococcus mutans_ot686_AC57 0,27 0,27 0,00 0,22 0,19 2 -0,14 0,38 0,87 NA NA NA NA NA 0,32 NA -0,89 NA NA NA
26 Proteobacteria Burkholderia Burkholderia cepacia_ot571_AB65 0,45 0,36 0,00 0,22 0,26 4 -0,15 0,35 0,83 NA NA -0,32 NA NA -0,26 NA NA -0,74 NA NA
95 Firmicutes Streptococcus Streptococcus Cluster II_ot071_755_758_Q59 4,09 4,00 4,00 3,78 3,98 5 -0,15 0,34 0,82 NA -0,77 -0,77 NA NA NA 0,00 0,77 0,32 -0,26 0,32
45 Firmicutes Veillonella Veillonella parvula_ot161_AC37 1,00 0,64 0,64 0,56 0,71 3 -0,16 0,33 0,81 NA NA NA -0,95 0,00 0,21 NA -0,77 NA NA NA
46 Firmicutes Veillonella Veillonella parvula_ot161_M04 0,73 0,36 0,27 0,44 0,45 2 -0,17 0,28 0,75 NA NA NA -0,77 -0,50 0,21 NA -0,77 NA NA NA
34 Proteobacteria Lautropia Lautropia mirabilis_ot022_X44 0,73 0,36 0,36 0,33 0,45 2 -0,18 0,24 0,70 NA -0,77 -0,77 -0,26 NA NA -0,32 NA NA NA 0,26
80 Firmicutes Streptococcus Streptococcus constellatus and intermedius_ot576_644_AB77 1,00 0,91 0,55 0,56 0,76 3 -0,19 0,23 0,69 0,00 NA NA -0,77 0,00 -0,26 0,77 NA -0,26 -0,80 0,11
39 Proteobacteria Neisseria Neisseria Cluster IV_ot009_014_015_016_Y58 0,09 0,09 0,00 0,00 0,05 1 -0,19 0,23 0,69 NA -0,77 NA -0,26 NA NA NA NA NA NA NA
50 Firmicutes Solobacterium Solobacterium moorei_ot678_AC02 0,09 0,09 0,00 0,00 0,05 1 -0,19 0,23 0,69 -0,87 NA NA NA NA NA NA NA NA NA NA
54 Firmicutes Eubacterium Eubacterium[11][G-3] brachy_ot557_AC03 0,09 0,09 0,00 0,00 0,05 1 -0,19 0,23 0,69 -0,87 -0,26 NA NA NA NA NA NA NA NA NA
114 Actinobacteria Actinomyces Actinomyces sp clone IP073_ot448_AC69 0,09 0,09 0,00 0,00 0,05 1 -0,19 0,23 0,69 NA NA -0,26 -0,77 NA NA NA NA NA NA NA
63 Firmicutes Staphylococcus Staphylococcus caprae and epidermidis_ot567_601_AC14 0,18 0,09 0,00 0,00 0,07 2 -0,19 0,22 0,69 NA NA NA NA NA NA NA NA -0,95 NA NA
98 Fusobacteria Fusobacterium Fusobacterium nucleatum ss nucleatum and animalis_ot420_698_AD99 0,18 0,09 0,00 0,00 0,07 2 -0,19 0,22 0,69 -1,00 NA NA NA NA NA NA NA NA NA NA
1 Bacteroidetes Bacteroidetes Bacteroidetes[G-2] sp clone AU126_ot274_X57 0,18 0,00 0,00 0,00 0,05 2 -0,21 0,19 0,69 NA NA -0,77 NA NA NA NA NA NA NA NA
17 Proteobacteria Ochrobactrum Ochrobactrum anthropi_ot544_AB24 0,09 0,00 0,00 0,00 0,02 1 -0,21 0,19 0,69 NA NA NA NA -0,87 NA NA NA NA NA NA
33 Proteobacteria Lautropia Lautropia mirabilis_ot022_O88 0,09 0,00 0,00 0,00 0,02 1 -0,21 0,19 0,69 NA NA NA NA NA NA -0,77 NA NA NA NA
40 Firmicutes Anaeroglobus Anaeroglobus geminatus_ot121_AA56 0,09 0,00 0,00 0,00 0,02 1 -0,21 0,19 0,69 -0,87 NA NA NA NA NA NA NA NA NA NA
41 Firmicutes Dialister Dialister invisus_ot118_P73 0,09 0,00 0,00 0,00 0,02 1 -0,21 0,19 0,69 -0,87 NA NA NA NA NA NA NA NA NA NA
42 Firmicutes Megasphaera Megasphaera sp clone CS025_ot123_AD11 0,09 0,00 0,00 0,00 0,02 1 -0,21 0,19 0,69 -0,87 NA NA NA NA NA NA NA NA NA NA
43 Firmicutes Selenomonas Selenomonas sp clones DS071 and EW084_ot138_146_Q52 0,09 0,00 0,00 0,00 0,02 1 -0,21 0,19 0,69 -0,87 NA NA NA NA NA NA NA NA NA NA
53 Firmicutes Lachnospiraceae Lachnospiraceae[G-4] sp clone DO016_ot097_R64 0,09 0,00 0,00 0,00 0,02 1 -0,21 0,19 0,69 NA NA NA NA -0,87 NA NA NA NA NA NA
113 Actinobacteria Actinomyces Actinomyces sp clone IP073_ot448_AB36 0,09 0,00 0,00 0,00 0,02 1 -0,21 0,19 0,69 NA NA NA -0,77 NA NA NA NA NA NA NA
23 Proteobacteria Campylobacter Campylobacter showae_ot763_X35 0,27 0,45 0,18 0,00 0,24 2 -0,21 0,17 0,69 -1,00 -0,74 NA 0,00 NA NA NA NA NA NA NA
62 Firmicutes Gemella Gemella sanguinis_ot757_AB17 0,27 0,18 0,00 0,11 0,14 1 -0,23 0,15 0,69 -0,87 -0,77 -0,77 NA NA NA NA 0,45 -0,26 NA NA
115 Actinobacteria Actinomyces Actinomyces Cluster I_ot671_688_701_708_AB35 1,36 1,18 0,73 0,89 1,05 3 -0,25 0,12 0,69 -0,87 -0,89 -0,63 -0,26 -0,87 -0,32 -0,32 0,45 -0,77 0,26 0,32
107 Actinobacteria Actinomyces Actinomyces israelii and sp clone EP053_ot177_645_AA82 0,18 0,09 0,00 0,00 0,07 1 -0,28 0,07 0,69 NA -0,89 -0,77 NA NA NA NA NA NA NA NA
109 Actinobacteria Actinomyces Actinomyces viscosus and sp clone AG004_ot169_688_AD82 0,64 0,18 0,18 0,11 0,29 2 -0,29 0,06 0,69 NA -0,77 -0,95 NA 0,00 NA -0,77 0,00 NA NA NA
15 Proteobacteria Stenotrophomonas Stenotrophomonas maltophilia_ot663_AB85 0,27 0,00 0,00 0,00 0,07 2 -0,30 0,06 0,69 -0,87 -0,77 NA NA NA NA NA NA NA NA NA











The present study focused on the early dental integuments, with respect to 
protein and microbial compositions. The major aims of the first study focusing on 
pellicle composition were to a) determine which saliva and serum proteins adsorb 
to hydroxyapatite (HA) using LC-ESI-MS/MS, b) investigate whether there was 
competition for attachment sites among the serum and saliva-derived proteins, 
and c) explore whether the composition of experimental pellicles formed on 
serum- and saliva-coated tooth surfaces in vivo differed. The major findings were 
that WSS protein adsorption to HA occurs in a very rapid and selective manner. 
The major proteins in the WSS-derived pellicles included statherin, acidic proline-
rich proteins (aPRPs), cystatin S, cystatin SN, α-amylase 1, carbonic anhydrase 
6 and lactoperoxidase. Adsorbed HS proteins included albumin, apolipoprotein 
A-I (apoA-I), serotransferrin and annexin A1. Competition was demonstrated with 
respect to adsorption among salivary and serum proteins. Lower molecular 
weight proteins (<50 kDa) as well as higher MW proteins (>75 kDa) from HS that 
did adsorb to HA in the absence of WSS proteins did not adsorb in the presence 
of even low percentages of WSS proteins. In the in vitro HS:WSS mixtures 
incubated with HA rapid adsorption was observed for aPRPs, statherin and 
cystatin and the most rapid displacement was noted for the apolipoproteins 
(apoC-III, apoA-II and apoA-I). 
The results strongly suggested that the HS proteins have a lower affinity for HA 
than salivary proteins, and this was confirmed in vivo with AEP removed from 
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tooth surfaces which had been coated with serum. The affinity of salivary 
phosphoproteins for the HA surface is known to be high. It is still debated how 
proteins interact with tooth surfaces, and if true electrostatic interactions 
predominate or whether hydrophobic and van der Waals bonds are also 
important driving forces for this attachment. Strong salivary adsorbers such as 
statherin, histatin 1, and aPRPs attach via electrostatic interactions due to 
negative charges associated with the phosphate groups and the side chain 
carboxyl groups of aspartic and glutamic acid that are predominantly present in 
the N-terminal regions of these proteins. Unlike aPRPs, the serum-derived 
apolipoproteins are not phosphorylated, and although they are acidic in nature, it 
is likely that the strength of their ionic interactions with the HA surface is lower 
than that of the phosphorylated salivary proteins. Our findings of their 
displacement from the tooth surface by the phosphorylated WSS proteins are in 
support of this notion.  
Earlier in vitro studies (Kajisa et al., 1990) showed that the addition of glandular 
secretion to plasma initially enhanced the adsorption of both types of proteins to 
enamel. Upon longer incubation times, however, desorption of proteins occurred. 
At that time, the proteins that were adsorbed and displaced could not be 
identified apart from albumin. With the approaches described in our investigation, 
it became clear that the proteins desorbed are primarily serum derived and that 
the salivary proteins are the main constituents of the experimental pellicles 
formed in mixtures of WSS and HS. 
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In addition to these in vitro studies, the data obtained by Carlen and coworkers 
(Carlen et al., 1998, 2003; Rudiger et al., 2012) on in vivo AEP showed that the 
plasma proteins fibrinogen, fibronectin, albumin and IgG were part of the tooth 
integument. They detected these serum proteins however more readily on tooth 
surfaces in closer vicinity to the gingival margin. It is feasible that serum proteins 
will ultimately contribute to some extent to the in vivo AEP since the serum 
protein concentration in GCF is 70-fold the protein concentration of saliva.  This 
is only true in close proximity to the gingival sulcus. It is clear from our data that 
serum protein adsorption is primarily transient due to a weaker affinity for HA, 
since both the in vitro and in vivo formed AEP studies showed clear evidence for 
HS displacement by WSS proteins. 
The functional role of serum proteins in the AEP, however, cannot be completely 
ruled out. For instance, experimental pellicles formed in vitro consisting entirely 
of HS have been shown to modulate biofilm formation, and to favor adsorption of 
pathogenic microorganisms such as P. gingivalis (Xie et al., 1991; Babu et al., 
1995; Nakamura et al., 1999; Biyikoglu et al., 2012, Custodio et al., 2014). 
Moreover, HS proteins adsorbed to titanium were found to induce hyphae 
formation in C. albicans, and the latter is considered to be an important virulence 
factor (Cavalcanti et al., 2016).  Based on our data, the adherence of pathogenic 
strains to serum proteins in the AEP would be only be relevant subgingivally in 
the gingival sulcus or the periodontal pocket which are hardly accessible to whole 
saliva.  
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In the second part of this dissertation studies are described which are related to 
the bacterial component of dental integuments. We investigated the first 
colonizers of the tooth surface and the compositional changes that occur during 
the first hours of dental biofilm formation. With the rapid development of new 
microbial identification technologies in the past decade, it has become feasible to 
identify readily and reliably both cultivable and uncultivable microorganisms. 
Techniques utilizing DNA probe hybridization, for instance the checkerboard 
DNA-DNA hybridization assay (Socransky et al., 1994), and more recently 16S 
rRNA-based microarray techniques (Paster et al. 2001, 2006, Colombo et al. 
2009) have provided insights into the early steps of biofilm formation, and the 
contribution of the non-cultivable microbiome in this process. Moreover, the 
dental biofilm is a complex microbial community that varies between individuals 
and different sites in the oral cavity. Methods that allow for the analysis of large 
sample numbers carried out simultaneously, and that permit the identification of 
essentially all microbial species are part of the current armentarium in biofilm 
research.  
The Human Oral Microbe Identification Microarray (HOMIM) technology was 
introduced in 2008 by Drs Paster and Dewhirst at the Forsyth Institute, allowing 
for the first time, the identification of about 270 of the most predominant oral 
bacterial species in the same assay. More recently, in 2014 the same group 
introduced the Human Oral Microbe Identification using Next Generation 
Sequencing (HOMINGS) technology. HOMINGS allows for species-level 
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identification of nearly 600 oral microbial taxa, through high throughput Illumina 
sequencing followed by in silico 16S rDNA probe analysis (Cotton et al., 2014). A 
very recent study has compared HOMIM and HOMINGS and showed 
concordance between the two technologies with no statistically significant 
differences in the overall results at the phylum, genus, or species taxonomic 
levels (Mougeot et al., 2016).  
Our studies provided insights into the cultivable as well as the uncultivable early 
in vivo tooth surface colonizers. We found that a total of 124 probes reacted 
positively in the HOMIM assay, giving evidence for the presence of a minimum of 
92 bacterial species, belonging to 40 genera and 7 phyla. Among those, eight 
non-cultivable phylotypes were identified, belonging to the genera Bergeyella sp., 
Haemophilus sp., Fretibacterium sp., TM7 sp., Actinomyces sp., Megasphaera 
sp. and Stomatobaculum sp.  
Overall, the data showed that the formation of dental biofilm is specific and 
exhibits considerable bacterial diversity, already in its incipient stages. With the 
now feasible identification of not-yet cultivated species among the early 
colonizers, the next step will be to cultivate these microorganisms to establish 
their bacteria-specific interactions via adhesin-receptors to the AEP. 
Furthermore, the cultivation of these fastidious microorganisms is critical as to be 
able to establish their functional roles at the tooth surface. Such functions could 
relate to biofilm formation as well as interactions with host cells and disease 
progression. 
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The early events in the formation of oral biofilm are of high interest in dental 
medicine because modulation at this early stage may provide means to reduce or 
prevent plaque formation, and/or at least generate ways to control the 
pathogenicity of dental biofilm. Not yet investigated in this study, but of high 
interest for future explorations, will be to investigate if differences in composition 
of the AEP will ultimately result in differences in biofilm composition, and 
downstream progression to disease. These studies could be carried out by in 
parallel assessment of AEP composition by quantitative mass spectrometry and 
microbial composition analysis using e.g. 16S rRNA-based HOMINGS 
technologies. Additional dimensions of exploration in this area are based on 
metagenomics approaches. Metagenomics applies genomic technologies and 
bioinformatics tools to access the genetic content of entire communities of 
organisms such as present in the dental biofilm (Bashan et al., 2016). Analysis of 
the combined proteomic and genomic datasets should provide extensive 
information on the interrelationship between protein adsorption and microbial 
attachment. The observations made in this study show that serum proteins can 
be considered of less importance in affecting microbial attachment than salivary 
proteins. Future efforts to culture and sequence species participating in oral 
biofilm formation as well as metagenomics approaches could significantly 
augment our understanding of the biofilm-associated etiology of dental caries 
and periodontal disease. Considering the wide-spread affliction of the population 
with these opportunistic oral infections, scientific dental integument research 
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